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CHAPTER I 
 
INTRODUCTION 
 
Xin Tang 
 
GABA is important for inhibitory signaling in the CNS 
γ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the 
CNS  In GABAergic neurons, glutamate is decarboxylated to form GABA by 
glutamic acid decarboxylase (GAD).  Once synthesized, GABA is packaged into 
presynaptic vesicles and then released into the synaptic cleft where it binds to 
postsynaptic receptors and is taken up by GABA transporters (GATs).  Although 
GABA can be transported rapidly by GATs into presynaptic terminals or into 
neighboring glial cells, where it is metabolized by GABA-transaminase (GABA-T), 
there is some GABA spillover from synaptic to extrasynaptic sites.  Three classes of 
GABA receptors, termed GABAA, GABAB and GABAC receptors, mediate 
GABAergic transmission.  Among these receptors, GABAA and GABAC receptors are 
ionotropic GABA receptors and belong to the superfamily of ligand-gated ion 
channels (LGICs), while GABAB receptors are metabotropic G-protein-coupled 
receptors (Bormann, 2000).   
In adult brain, GABAA receptor channels are activated by GABA to 
selectively conduct chloride ion influx through its pore, resulting in neuronal 
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hyperpolarization.  This causes an inhibitory effect on neurotransmission by 
decreasing the chance of evoking action potentials.  However, early in development, 
GABAergic synaptic transmission is excitatory.  The nature of GABAergic 
transmission depends on the intra- and extracellular concentration of Cl-, which sets 
the reversal potential for GABAergic currents.  The shift from excitatory to inhibitory 
transmission is coupled to a developmental induction of the expression of the 
neuronal (Cl-)-extruding K+/Cl- co-transporter (KCC2), which cause a significant drop 
of intracelluar Cl- concentration (Ganguly et al., 2001;Rivera et al., 1999).  
Brain function is based on an exquisite balance between excitatory and 
inhibitory neurotransmission.  Aside from the natural agonist GABA, GABAA 
receptors are also regulated by many allosteric modulators including benzodiazepines 
(BDZs), barbiturates, anesthetics, neurosteroids, anti-convulsants and ethanol 
(Macdonald and Olsen, 1994;Hevers and Luddens, 1998).  GABAergic signaling is 
essential to set the inhibitory tone of neurons in the brain by controlling spike timing 
and sculpting neuronal rhythms.  Impaired GABA signaling has been implicated in a 
wide variety of CNS disorders including epilepsy, anxiety, cognitive disorders, 
insomnia, and drug addiction (Johnston, 2005;Mohler, 2006;Moult, 2009).  Therefore, 
many receptor modulators may be targeted as potential therapeutic drugs. 
 
GABAA receptors mediate phasic and tonic inhibition in CNS 
GABAA receptors are the major inhibitory neurotransmitter receptors in the 
adult mammalian CNS.  Two types of inhibitory neurotransmission, phasic and tonic 
3 
inhibition, are mediated by GABAA receptors (Farrant et al., 2005) (Figure 1.1).  
Phasic inhibition is produced by rapid, synchronous activation of GABAA receptors at  
 
Figure 1.1.  Modes of GABAA receptor activation. 
 
A, The release of a single vesicle from a presynaptic terminal activates only those
GABAA receptors that are clustered in the postsynaptic membrane immediately 
beneath the release site (yellow).  The diffuse blue shading indicates the spread of 
released GABA.  The current record shows an averaged waveform of miniature
inhibitory postsynaptic currents (mIPSCs) recorded in the presence of the sodium
channel blocker tetrodotoxin.  The area beneath the record is shaded to indicate the 
charge transfer.  After synaptic release, GABA is quickly up-taken by GABA 
transporters (GATs).  B, Action potential-dependent release of multiple vesicles or
evoked release from several terminals promotes GABA ‘spillover’ and activates both 
synaptic receptors and perisynaptic or extrasynaptic receptors (blue).  The current 
record shows the larger and much slower averaged waveform of IPSCs evoked by
electrical stimulation.  The area of the mIPSC is superimposed for comparison.  C, A 
Low concentrations of ambient GABA, which persist despite the activity of the 
neuronal and glial GABA transporters (GAT1 and GAT3), tonically activates high-
affinity extrasynaptic receptors.  The trace shows the ‘noisy’ tonic current that results 
from stochastic opening of these high-affinity GABAA receptors, with superimposed
phasic currents.  A high concentration (10 μM) of the GABAA antagonist gabazine 
(SR-95531) blocks the phasic IPSCs and tonic channel activity, causing a change in
the ‘holding’ current and a reduction in current variance.  The shaded area beneath the 
current record before SR-95531 application represents the charge carried by tonically 
active GABAA receptors.  The current records are from whole-cell patch-clamp 
recordings of granule cells in acute cerebellar slices from adult mice. The recordings
were made with symmetrical chloride concentrations at a holding voltage of –70mV 
and a temperature of 25°C. pA 
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synapses by action-potential-dependent release of high concentrations of GABA from 
presynaptic terminals; in contrast, tonic inhibition is produced by persistent activation 
of GABAA receptors outside of synapses at low ambient GABA concentrations that is 
due to spillover from the synapses or release from glia.  Phasic and tonic inhibition 
play different, but important, roles in regulating neuronal and network excitability.  
Phasic inhibition is important for timing-based signaling, setting the temporal window 
for synaptic integration and synchronizing networks of neurons.  Tonic inhibition 
plays an important role in maintaining baseline inhibitory tone and neuronal 
membrane input resistance. 
Phasic and tonic currents have been shown to have different pharmacological 
and current kinetic properties.  Specific receptor populations are expressed and 
localized in different brain regions and have different subcellular localizations, which 
allow phasic and tonic currents mediated by different receptor subtype to have 
different sensitivity to GABA and other modulators like BDZs and neurosteroids.  
The majority of native GABAA receptor isoforms are thought to be composed of αβγ 
or αβδ subunit combinations with distinct functional and pharmacological properties.  
αβδ receptors are commonly found in peri- and extrasynaptic locations and contribute 
to tonic inhibition with high GABA sensitivity.  Synaptic GABAA receptor currents 
are mostly mediated by αβγ receptors as γ subunits contribute to synaptic targeting of 
GABAA receptors by associated proteins such as GABAA receptor-associated protein 
(GABARAP) (Wang et al., 1999) and gephryin (Kneussel and Betz, 2000).  However, 
some γ subunit-containing receptors, like α5β3γ2 receptors in hippocampal CA1 
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pyramidal neurons, are also found in extrasynaptic regions and are involved in 
conducting tonic currents in those brain areas (Caraiscos et al., 2004).  For tonic 
currents mediated by γ subunit-containing receptors, it is also possible that synaptic γ 
subunit-containing receptors can respond to both local synaptically released GABA 
and to ambient extracellular GABA.   
 
Expression and regional CNS localization of GABAA receptor subunit subtypes 
GABAA receptors belong to the cys-loop superfamily of ligand-gated ion 
channels (LGICs) that also includes nicotinic acetylcholine (nACh) receptors, 5-
hydroxytryptamine type 3 (5-HT3) receptors, glycine receptors and GABAC 
receptors .Being heteropentameric LGICs, GABAA receptors are assembled from 
seven subunit families: α1-6, β1-3, γ1-3, δ, ε, θ and π (Macdonald and Olsen, 
1994;Hedblom and Kirkness, 1997;Davies et al., 1997;Bonnert et al., 1999;Mehta and 
Ticku, 1999).  There is a high degree of sequence identity (70-80%) within each 
subunit family.  The sequence identity among different subunit families is around 30-
40%.  About 20-30% sequence homology exists among all GABAA receptor subunit 
and other Cys-loop receptor families (Burt and Kamatchi, 1991;Macdonald and Olsen, 
1994). 
The expression pattern of GABAA receptor subunits has been studied in adult 
rat brain using immunohistochemical staining (Pirker et al, 2000).  Among α subunit 
subtypes, the α1 subtype was widely expressed, while the other α subtypes were more 
confined to certain brain areas.  The α2 subtype was preferentially located in forebrain 
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areas and the cerebellum.  The α3 subtype was found in the olfactory bulb, septal and 
basal forebrain areas, hippocampus, hypothalamus, and amygdala.  The α4 subtype 
was most prominent in thalamus and dentate gyrus, and then in striatum and cortex.  
The α5 subtype expression was highest in hippocampus, the olfactory bulb and 
hypothalamus.  And the α6 subtype was only present in cerebellum and cochlear 
nucleus.  All three β subtypes were widely distributed in the brain, notably in the 
cerebral cortex.  And β2 subtype was found distributed similarly as α1 subtypes in 
many interneurons throughout the brain.  Among all the γ subtypes, the γ2 subtype 
was the most highly and widely expressed one in the whole brain except in thalamus.  
Finally, the δ subunit was found in cerebellum, thalamus, dentate gyrus, striatum and 
cortex often co-distributed with α4 or α6 subunit.  
Although α1β2γ2 receptors are thought to be the dominant receptor isoform in 
the CNS, α4 subunit-containing receptors are relatively abundant in brain regions 
involved in both partial and generalized epilepsies, including cortex, hippocampus, 
and thalamus.  Compared to α1 and most other α subunits, α4 and α6 subunit-
containing receptors have unique sensitivity to specific allosteric modulators such as 
diazepam and zinc.  Deletion of α4 subunits in engineered mice substantially reduced 
extrasynaptic, tonic inhibition in thalamus and dentate gyrus, as well as significantly 
modified frequency and kinetics of mIPSCs in dentate granule cells (DGCs) (Chandra 
et al., 2006;Liang et al., 2008).  The α4 subunits were often assembled with γ or δ 
subunits in combination with β2/3 subunits as well as without γ and δ subunits.  The 
α4β3δ isoform is predominantly localized peri- and extrasynaptically (Nusser and 
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Mody, 2002;Wei et al., 2003;Belelli et al., 2005;Cope et al., 2005), while the α4βγ2 
isoform has been shown to have both synaptic and extrasynaptic localization in 
specific brain regions (Hsu et al., 2003;Peng et al., 2004;Liang et al., 2006;Chandra et 
al., 2006). 
In addition to the relative abundance of α4 subunits in brain regions involved 
in both partial and generalized epilepsies, another interesting feature of α4 subunit-
containing receptors is the substantial plasticity of α4 subunit expression in a variety 
of experimental and pathophysiological situations.  The α4 subunit has been shown to 
be up-regulated in multiple animal models of chronic epilepsy, and the increase in 
expression was reported to be accompanied by up-regulation of γ2 subunits in some 
epileptic animals and in δ subunit KO mice (Peng et al., 2002;Cagetti et al., 
2003;Peng et al., 2004).  The sub-cellular localization of α4 subunits has been shown 
to be regulated and α4 subunit-containing receptors have been shown to move from 
extra-synaptic to synaptic locations in the hippocampus (Liang et al., 2006).  Due to 
this intriguing plasticity of α4 subunits, it is important to investigate the intrinsic 
properties and modulation of α4 subunit-containing receptors, such as α4βγ2 and α4βδ 
GABAA receptors.  Understanding the differences between α4βγ2 and α4βδ receptors 
and the differences between α4 subunit-containing and other α subunit-containing 
receptors will help clarify the functional deficits such as increased seizure 
susceptibility reported in some pathological situations.   
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Modulation of ligand-gated ion channels by phosphorylation 
Neuronal activity is mediated by changes in electrical activity, which depends 
on the movement of ions across cell membranes through ion channels.  In fact, the 
patterns of neuronal electrical activity are not static and are subject to dynamic 
regulation by a variety of external influences.  Therefore, modulation of the properties 
of membrane ion channels is of fundamental importance for the regulation of neuronal 
electrical activity and of higher neural functions.  Protein phosphorylation is the 
dominant means, among all potential molecular mechanisms, to modulate the 
properties of ion channels. 
In respect of the fact that most ion channels are regulated by protein kinases 
and phosphatases, protein phosphorylation plays a central role in a wide variety of 
cellular, metabolic, and signaling processes (Levitan 1994, 1999).  Meanwhile, most 
ion channels can be phosphorylated by several different protein kinases and regulated 
in different protein kinase signaling pathways, each influencing channel activity in a 
unique way.  Thus, mechanisms of modulation by phosphorylation exhibit a striking 
diversity that ranges from changes in subunit assembly and receptor aggregation at the 
synapse to shifts in the voltage-dependence and kinetics of channel activities.  The 
technology of patch-clamp even allowed the identification of particular amino acid 
residues in ion channel proteins that participate in specific modulatory changes in 
channel biophysical properties by using engineering mutagenesis. 
The research of nACh receptors is the earliest studies revealing regulation of 
ion channel properties by protein kinases and phosphatases.  In early experiments 
9 
using Torpedo nACh receptors to study their modulation by phosphorylation, the 
receptors were found to be a substrate for protein kinase A (PKA), protein kinase C 
(PKC) and protein tyrosine kinase (PTK). Furthermore, the rate of current 
desensitization is affected by the status of phosphorylation on nACh receptors in the 
presence of agonist.  Intriguingly, the phosphorylation by PKA also facilitates the 
assembly of receptors in the plasma membrane and stabilizes receptor subunits.  In 
addition, tyrosine phosphorylation promotes accumulation of nicotinic receptors in 
arrays resembling postsynaptic receptor aggregation at the vertebrate neuromuscular 
junction (Ross et al., 1987,1991;Qu et al., 1990).  In neuronal nACh receptor channels, 
which consist of different α and β subunits but having similar overall structure and 
consensus phosphorylation sequences with their Torpedo and muscle counterparts, 
similar phenomena were observed.  The conserved phosphorylation sites are potent to 
regulate the amount of functional receptors on plasma membrane and the receptor 
desensitization rate.  These observations suggest the different types of nACh receptor 
are modulated by a common mechanism of protein phosphorylation.. 
The other LGICs examined to date also have been shown either to be regulated 
by protein phosphorylation or to contain consensus sequences for phosphorylation by 
protein kinases.  The two ionotropic glutamate receptors, N-methyl-D-aspartic acid 
receptors (NMDARs) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
receptors (AMPARs), are also regulated by protein phosphorylation.  PKA, PKC, 
Ca2+/calmodulin-dependent protein kinase II (CaMKII), and various tyrosine kinases 
are among key protein kinases that regulate NMDAR function.  PKC phosphorylation 
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of serine 890 disrupted surface clusters of the NR1 subunits whereas PKC/PKA 
phosphorylation of serine 896 and 897 had no effect (Tingley et al., 1997).  
Phosphorylation of the PKC-sensitive serine sites in the NR1 subunit also prevented 
calmodulin binding to the NR1 subunit and thereby inhibited inactivation of 
NMDARs by calmodulin (Hisatsune et al., 1997).  Phosphorylation of NR2A or 
NR2B at either tyrosine or serine sites usually positively regulated NMDAR-mediated 
currents (Wang and Salter, 1994; Rostas et al., 1996; Liao et al., 2001) and altered 
NMDAR glutamatergic transmission by regulating receptor trafficking and 
interactions with various synaptic scaffold/signaling proteins in response to changing 
inputs (Hall and Soderling, 1997;Dunah et al., 2004).  
Like NMDARs, AMPARs are regulated by protein kinases and phosphatases.  
Phosphorylation of GluR1 subunits on PKA (serine 845) and PKC/CaMKII (serine 
831) sites generally potentiated AMPAR currents (Roche et al., 1996; Derkach et al., 
1999; Banke et al., 2000), which could contribute to augmentation of the AMPAR-
dependent form of synaptic plasticity such as long-term potentiation (LTP).  PKA, 
PKC, and CaMKII phosphorylation of GluR1 and GluR4 also drove AMPARs into 
synapses (Estaban et al., 2003).  AMPARs interact with various intracellular proteins 
through their C-termini to organize into macromolecular complexes.  The C-terminus 
of the GluR1 subunit interacts with a PDZ domain-containing protein SAP97 
(Leonard et al., 1998; Tavalin et al., 2002) and A-kinase-anchoring proteins 79/150 
(AKAP79/150) (Snyder et al., 2005), which targets PKA to GluR1 for serine 845 
phosphorylation (Leonard et al., 1998; College et al., 2000).  In the course of long-
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term depression (LTD), SAP97/AKAP/PKA complexes recruit and activate protein 
phosphatase 2B to dephosphorylate serine 845, leading to AMPAR internalization and 
the expression of LTD (College et al., 2000; Tavalin et al., 2002).  Through a binding 
motif overlapped with the phosphorylation sites on tyrosine 876 and serine 880, the 
C-terminus of the GluR2 subunit interacts with multiple scaffold proteins including 
AMPA receptor binding protein (ABP)/GRIP, ATPase N-ethylmaleimide-sensitive 
fusion protein or N-ethylmaleimide-sensitive factor (NSF), α- and β-soluble NSF 
attachment proteins (SNAPs), and protein interacting with C-kinase 1 (PICK1) (Kim 
and Sheng, 2004).  Phosphorylation of GluR2 on tyrosine 876 by tyrosine kinases or 
serine 880 by PKC decreased the affinity of GluR2 to GRIP (Lau and Huganir, 1995; 
Carvalho et al., 1999; Chung et al., 2000), which triggered GluR2 internalization and 
thus reduced surface GluR2 expression. This process is believed to mediate the 
expression of hippocampal LTD ( Seidenman et al., 2003).  
Although both GABAA and glycine receptors are chloride ion channels and 
mediate inhibitory transmission in the CNS, glycine receptors, which play a 
prominent inhibitory role in the spinal cord and brainstem, are less well characterized 
than GABAA receptors and the other LGIC receptors discussed above (with regard to 
phosphorylation).  Glycine receptors also contain consensus phosphorylation sites and 
are substrates for several protein kinases.  PKA and PKC have both been shown to 
potentiate glycine receptor currents in response to activation of Gs or Gq coupled 
pathways in spinal trigeminal neurons and in substantia nigra neurons, respectively 
(Song and Huang, 1990;Nabekura et al., 1996b).  However, single channel recording 
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indicated that the probability of channel opening or mean open time was altered by 
activation of PKA or PKC, respectively, in two different studies, accounting for the 
increase of whole cell currents by the kinases.  Controversially, activation of α2-
adrenoceptors and its downstream Gi coupled pathway in substantia nigra neurons and 
in rat sacral dorsal commissural neurons has been reported to increase glycinergic 
input that is believed to be mediated by inhibition of PKA (Nabekura et al., 
1996a;Nabekura et al., 1999), but this is controversial since PKA was activated 
directly or indirectly by different methods with involvement of different G-protein 
coupled pathways in those studies.  Thus, in substantia nigra neurons, glycine 
receptors are positively regulated by PKC and negatively regulated by PKA.  
Regulation of glycine receptor function by PKC is accomplished by activation of 
5HT2 receptors in rat sacral dorsal horn neurons (Xu et al., 1996) and activation of αl-
adrenoceptors in substantia nigra neurons (Nabekura et al., 1996b), which all indicate 
crosstalk between different receptors in signal transduction.  
In summary, complex modulation by protein phosphorylation is generally 
observed in most ligand-gated ion channels.  The molecular mechanisms responsible 
for the diversity of functional effects are not clear.  Nevertheless, it suggests that 
neurons can finely tune their synapses by altering expression of receptor subunit 
subtypes and various protein kinases.  Changes in receptor desensitization or open-
channel probability would have profound effects on the efficacy of synaptic 
transmission.  In addition, regulation of receptor density at the postsynaptic membrane 
through an alteration in the aggregation of receptors or the local assembly of the 
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subunits could modify postsynaptic responses.  Finally, the ability of other signaling 
pathways at the synapse to modulate phosphorylation of the receptors allows these 
properties to be dynamically regulated, resulting in short- or long-term changes in 
synaptic transmission.  To significantly advance our understanding of molecular 
mechanisms of neuronal plasticity, the next direction is to employ more and more 
novel approaches and new technology to investigate the ways in which channel 
modulation contributes to the regulation of cellular physiology in neurons. 
 
Phosphorylation sites of GABAA receptors  
As a member of the cys-loop receptor family, each GABAA receptor subunit 
contains a large extracellular N-terminal domain that has a conserved disulfide 
cysteine loop and one or more glycosylation sites (Figure 1.2).  The extracellular N-
terminal domain is followed by four membrane-spanning domains connected by either 
short segments (TM1-TM2 and TM2-TM3) or a long cytoplasmic domain (TM3-
TM4).  This large intracellular domain, which links the third and fourth 
transmembrane domains, contains several functional domains such as the sequences 
interacting with cytoplasmic proteins that are involved in regulation of receptor such 
as receptor clustering and subcellular localization.  There are also consensus 
sequences for phosphorylation by multiple kinases in this major intracellular loop, 
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β1 S384
CAMKII
γ2L S343
PKC
PKC
γ2L S327
M2M 1 3 M
γ2 Q351X
γ2 K 289Mα1 Α 32D
M2M1 M3 M4
γ2S S348,T350
CAMKII
γ2S Y365,Y367
PTK  
Figure 1.2. Phosphorylation sites in GABAA receptor subunit. 
 
A schematic presentation of a GABAA receptor subunit is presented.  In the large 
extracellular N-terminal domain, there is a disulfide bond between two cysteines 
(yellow) in the conserved cysteine loop.  The large intracellular TM3-TM4 loop 
contains many consensus sequences for phosphorylation by multiple kinases, 
including PKA, PKC, CaMKII, PTK and cGMP-protein kinase (PKG).  Four serines 
in β3 and γ2L subunits are indicated by red circles. 
 
including PKA, PKC, CaMKII, PTK and cGMP-protein kinase (PKG).  Extensive 
studies using GST-fusion proteins have led to characterization of some major targets 
for different kinases.  Among all the investigated subunits, GABAA receptor β and γ 
subunits have been identified as substrates for various protein kinases (Moss et al., 
1992;McDonald and Moss, 1997).  
To examine the potential phosphorylation sites in mapped consensus 
sequences, point mutation by site-directed mutagenesis was commonly used to 
determine if replacing serine or threonine residues could eliminate phosphorylation.  
For example, in in vitro experiments using GST-fusion proteins encoding only the 
soluble TM3-TM4 intracellular loop of each individual receptor subunit, the 
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conserved β subunit serines (S409 in β1,β3 and S410 in β2 subunits) were shown to 
be phosphorylated by several serine/threonine protein kinases including PKA, PKC, 
PKG and CaMKII (McDonald and Moss, 1994;McDonald and Moss, 1997;Moss et al., 
1992).  Besides the conserved β subunit serines (S409 of β1,β3 and S410 of β2), 
additional phosphorylation sites for different protein kinases were identified in the β 
and γ subunit major intracellular loops (Moss et al., 1992;Krishek et al., 
1994;McDonald et al., 1998;Brandon et al., 2000;Brandon et al., 2001).  Serine 408 in 
β3 subunits is also a substrate for PKA and PKC and β1 subunit serine 384 is 
specifically phosphorylated by CaMKII.  The two alternative splice variants γ2L and 
γ2S, which differ by 8 amino acids (LLRMFSFK), both contain a PKC 
phosphorylation site at serine 327.  However, the γ2L subunit fusion protein could be 
phosphorylated to a higher stoichiometry due to phosphorylation of serine 343 within 
the 8 amino acid insertion.  The γ2 subunits also contain two CaMKII substrates at 
serine 348 and threonine 350 and two substrates for PTKs at tyrosine 365 and 367 
(residue number in γ2S).  
Development of antibodies recognizing specific GABAA receptor subunits 
allowed study of phosphorylation of GABAA receptors in the brain.  The 
phosphorylation patterns of subunits in vitro were usually verified in vivo.  However, 
some interesting differences were observed.  For example, although all three β 
subunits are substrates of PKA in vitro, in recombinant expression systems like HEK 
cells or in native cortical neurons in vivo, β2 subunits were not phosphorylated by 
PKA, because the adaptor protein AKAP79/150, critical for PKA signaling in 
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different contexts, selectively targets β1 and β3 subunits but not β2 subunits (Brandon 
et al., 2003).  Thus, for those phosphorylation sites that are substrates of multiple 
kinases, they are likely phosphorylated by only one protein kinase in a specific cell 
type.  For example, S409 of β1,3 subunits was mainly phosphorylated by PKC rather 
than by PKA or CaMKII in cortical and striatal neurons (Brandon et al., 
1999;Brandon et al., 2003).  To be the predominant protein kinase that phosphorylates 
a given site, the kinase might have a higher affinity for the phosphorylation site or be 
anchored by some adaptor proteins to facilitate protein-protein interaction. 
 
Dynamic modulation of GABAA receptors by multiple protein kinases 
Diverse effects of protein kinase activation/inhibition were observed in 
different studies focusing on specific properties of GABAA receptors.  
Phosphorylation is involved in the dynamic modulation of GABAA receptors 
including subunit expression, current kinetics, pharmacological properties, 
postsynaptic clustering and, receptor recycling.  The effects of activation or inhibition 
of a variety of protein kinases on GABAA receptor function have been examined in a 
range of neuronal preparations.  In particular, the effects of PKA and PKC have been 
studied extensively.  In many studies focusing on the synaptic activities of GABAA 
receptors, the results are complex and often contradictory, with effects ranging from 
potentiation to inhibition of GABA-evoked currents (Brandon et al., 2000b; Smart et 
al., 2001).  The variability of reported results reflects the complexity of the 
modulatory mechanisms of protein phosphorylation and indicates that several 
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different pathways for receptor modulation might be stimulated simultaneously to 
different extents and to cause the varying results in different systems.  For example, 
peak current amplitudes can be altered by changes in both ion channel function and 
surface expression.  Receptor function might be modulated by direct phosphorylation 
of GABAA subunits, while the modulation of receptor density on the cell surface 
might be affected by cellular machineries like protein internalization or recycling.  In 
some circumstances, the mechanism can be determined by using proper approaches.  
Using detailed analysis of phosphorylation modulation of receptor function, the 
diverse modulatory actions of protein phosphorylation can be understood, and thus, 
better predictions can be made of the consequence of activation of individual protein 
kinases under specific in vivo conditions.   
With neuronal preparations, some of the differences observed in modulation of 
GABAA receptor function by protein kinases could be due to extensive receptor 
heterogeneity in the native environment.  Thus, the functional effects of GABAA 
receptor phosphorylation have been characterized extensively in heterologous cells, 
which allow investigation of GABAA receptors with a relatively uniform composition 
and also allow determination of direct correlations between the phosphorylation of 
individual residues and channel function using a mutation strategy.  Even though the 
use of recombinant receptors simplified the studies, modulatory effects by protein 
kinases were still diverse and complex.  Several studies reported that PKA activation 
decreased GABAA receptor current (Gyenes et al., 1994;Harrison and Lambert, 
1989;Moss et al., 1992;Porter et al., 1990;Chen et al., 1990;Poisbeau et al., 
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1999;Capogna et al., 1995;Robello et al., 1993), whereas others reported that PKA 
enhanced GABAA receptor current (Angelotti et al., 1993;Feigenspan and Bormann, 
1994;Kapur and Macdonald, 1996;Cheun and Yeh, 1992;Cheun and Yeh, 1996;Kano 
and Konnerth, 1992;Nusser et al., 1999).  Activation of PKC by phorbol esters 
resulted in down-modulation of GABAA receptors (Kellenberger et al., 1992;Krishek 
et al., 1994;Leidenheimer et al., 1992;Sigel et al., 1991).  However the active catalytic 
domain of PKC (PKM) enhanced GABA-stimulated currents in L929 cells (Lin et al., 
1994;Lin et al., 1996).  The γ subunit was found to be specifically phosphorylated by 
PKC but not by PKA.  The γ2L subunit contains one more PKC phosphorylation site, 
S343 in the alternative spliced 8 amino acid insert, than the γ2S subunit, with one 
common PKC site S327 within the major intracellular loop that provides a basis for 
differential regulation of γ2L and γ2S subunit-containing receptors.  Indeed, ethanol 
potentiation of GABAA receptors requires phosphorylation of the additional PKC site 
S343 in γ2L subunits.  And the postsynaptic clustering of cytoplasmic loops of γ2L, 
but not γ2S, subunits could be facilitated by PKC at rat spinal cord inhibitory 
synapses.  Finally, phosphorylation of two Tyr residues (Y365/367) in the γ2-subunit 
by SRC tyrosine kinase enhanced the function of α1β1γ2 and α1β3γ2 GABAA 
receptors ( Wafford et al., 1992; Moss et al., 1995).   
Different effects of PKA activation on peak currents have been proposed to be 
due to different subunit compositions of GABAA receptor isoforms employed in 
different studies.  In HEK-293 cells, receptors containing one of the three β subunits 
(β1-3) in combination with α1 and γ2S subunits were modulated differently by PKA.  
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Phosphorylation of the β1 subunit Ser409 by PKA resulted in a time-dependent 
decrease of GABA-induced currents.  The β3 subunit differs from the other β subunits 
in having two adjacent Ser at positions 408 and 409, which, when both are 
phosphorylated by PKA, caused enhanced GABA-activated current.  No functional 
effects of PKA activation were seen for receptors containing the β2 subunit due to a 
lack of PKA-dependent phosphorylation of this subunit in HEK-293 cells (McDonald 
et al., 1998;Brandon et al., 2003).  However, specific effects associated with different 
receptor subunits could not explain everything.  In some studies using the same 
combination of recombinant GABAA receptor subunits, contradictory effects of PKA 
on GABAA receptor currents have been reported (Moss et al., 1992;Angelotti et al., 
1993;Hinkle and Macdonald, 2003), suggesting complicated and very plastic 
mechanisms of PKA modulation in different experimental system.  For the conflicting 
effects of PKC, the presence of different PKC isozymes might provide a basis for the 
variable effects of PKC activation on GABAA receptor currents.  However, specific 
PKC isozymes were not identified in those studies with different methods to activate 
PKC.  The fact that both β and γ2 subunits are substrates of PKC could also contribute 
to diversity of the PKC effect due to different types of crosstalk between two subunits.   
 
Involvement of protein phosphorylation in epilepsy 
Epileptogenesis is a complex result of both genetic and acquired factors, 
expressed as an imbalance between activating systems of neuronal depolarization 
(excitatory amino acid release with postsynaptic NMDA receptor activation, 
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spreading depolarization following abnormal progression) and the inhibiting systems 
of neuronal hyperpolarization (GABAergic synapses).  It is widely accepted that a 
deficiency of GABAergic neurotransmission could contribute to the development of 
epileptic seizures.  The positive allosteric modulators of GABAA receptors, such as 
the benzodiazepines, have been used widely to treat epilepsy (Macdonald et al., 
2004;Foster and Kemp, 2006).  
Abnormalities of protein phosphorylation have been reported in some animal 
models of epilepsy.  For example, the prolonged seizures of status epilepticus (SE) 
caused decreased phosphorylation of β3 subunits by PKC associated with a deficit in 
receptor stability on the cell surface (Terunuma et al., 2008), although most previous 
papers reported elevated PKC activation with both seizures and SE.  The explanation 
for this discrepancy most likely lies in the experimental details.  For example, PKC 
responses to the same event may yield different responses among cell types.  Kainate-
induced seizures have been reported to reduce PKC mRNA levels in hippocampus but 
to increase mRNA levels in dentate gyrus (Guglielmetti et al. 1997).  There have also 
been reports of elevated cAMP levels as well as PKA activity in the hippocampus of 
experimental animal models with epilepsy (Tehrani and Barnes, Jr., 1995;Yechikhov 
et al., 2001) and repeated injections of an initially subconvulsant dose of cAMP into 
the rat amygdala has been shown to produce seizures (Yokoyama et al., 1989).   
These data suggest that protein phosphorylation by multiple protein kinases 
may be involved in the pathogenesis of acquired epilepsies, although the relationship 
between phosphorylation and seizures might not be unidirectional and differ with 
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various protein kinases.  Generally, cellular proteins, such as ion channels or enzymes, 
are all under constant modulation and regulation by processes that drive their 
phosphorylation and dephosphorylation.  Kinases will phosphorylate proteins by 
transferring a phosphate group from a molecule of ATP, while phosphatases will 
remove the phosphate group, thereby dephosphorylating the protein in question.  The 
presence or absence of a phosphate group on a critical amino acid within the protein 
will alter the configuration of the protein and may have functional consequences to 
either enhance or impair the activity of the channel or enzyme.  Depending on which 
amino acids are within the target of phosphorylation, the functional impact on the cell 
could be excitatory or inhibitory.  Giving the various results of functional modulation 
of GABAA receptors from inhibition to potentiation, we can expect that 
phosphorylation of GABAA receptors could have opposite consequences in 
epileptogenesis.  It is possible that impaired activity of GABAA receptors after protein 
phosphorylation underlies development or progression of SE; alternatively, prolonged 
excitation associated with SE may trigger autoregulatory processes, such as 
preventing excessive excitation by enhancement of GABAergic inhibition by protein 
phosphorylation.  In addition, protein kinases might be temporarily activated by 
reactions activated during seizures which might reverse to its previous level following 
seizure termination.  Therefore, protein kinase-mediated inhibition of GABAA 
receptors could contribute to a mechanism to cause temporary loss of function of ion 
channels only during seizures with normal ion channel function during interseizure 
intervals.  Thus, further study of protein phosphorylation levels before, during and 
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after seizures and determination of its role in epileptogenesis may be helpful in 
developing therapies for epilepsy.   
 
Rationale for experimental design of the thesis 
Phosphorylation has been of intense interest for several decades.  So far, the 
effects of phosphorylation by multiple protein kinases of the subunits of the most 
prevalent α1βγ2 GABAA receptor have been studied the most.  Following 
identification of specific phosphorylation sites, numerous reports of protein kinase 
modulation of GABAA receptor subunits have been made and reveal the complexity 
of modulation of several properties of GABAA receptors by multiple protein kinases.  
The complexity of modulation by protein phosphorylation provides mechanisms for 
neurons to finely tune their GABAergic inhibition in specific brain areas with 
different receptor composition in response to various protein kinases.  Given the 
extensive heterogeneity of GABAA receptors in the native environment and the 
differential pattern of phosphorylation and modulatory effects associated with 
different subunits such as β(1-3) subunit subtypes and two γ2(S and L) subunit 
variants, it has been extremely difficult to explain results obtained using native 
neuronal preparation composed of a mixture of several subunit subtypes.  Therefore, 
in this dissertation, I studied individual recombinant GABAA receptors of known 
subunit composition in a heterologous expression system and compared the 
modulatory effects of several protein kinases on specific GABAA receptor isoforms.  
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It should be noted that most studies of phosphorylation have focused on the 
effects on synaptic inhibition, using mainly the synaptic α1βγ2 GABAA receptor 
isoform.  However, other receptor isoforms with more restricted expression areas such 
as α4 subunit-containing receptors and δ subunit-containing receptors outside 
synapses have not been studied before.  Thus, the first goal of this dissertation was to 
determine the modulatory effects of two protein kinases, PKA and PKC, on the 
macroscopic current properties of α4β3γ2 and α4β3δ receptors, which each have very 
different current properties and localization.  As expected, there were differential 
effects of phosphorylation on α4β3γ2 and α4β3δ GABAA receptor isoforms, 
implicating different consequence for synaptic and extrasynaptic events in response to 
protein phosphorylation.  Meanwhile, there is evidence for plasticity of α4 subunits 
coassembled with γ2 or δ subunits under pathological conditions.  Thus, 
characterization of the differential modulation of these two different receptor isoforms 
will help also to understand the pathogenesis of diseases such as epilepsy that are due 
to modification of GABAergic inhibition.   
Another novel investigation of this dissertation was to focus on properties of 
macroscopic currents that have not been studied previously as synaptic phenomena.  
Activated by saturating concentration of agonist, macroscopic currents were evoked to 
replicate IPSPs and the effects of phosphorylation on their non-equilibrium properties, 
including peak amplitude, desensitization and deactivation, were characterized.  These 
non-equilibrium properties are subject to modification by subtle changes in receptor 
activation or gating, and thus provide the opportunity for regulation by protein kinase 
24 
modulation (Jones and Westbrook, 1995, 1996; Haas and Macdonald, 1999; 
Overstreet et al., 2000; Bianchi and Macdonald, 2002).  In contrast, the equilibrium 
properties of macroscopic currents reflect a stabilized activity that is only attained by 
sustained exposure of GABAA receptors to low GABA concentrations in the 
extrasynaptic space in contrast to the brief, synaptic exposure that occurs following 
release of GABA during synaptic transmission.  The equilibrium properties of 
GABAA receptors are also important for GABAergic inhibitory transmission, since 
they affect the activity levels of neuronal networks that include inhibitory neurons.   
It has been clearly demonstrated that protein kinases have diverse effects that 
are both dependent and independent of receptor phosphorylation, which may explain 
why some of the effects have not been replicated by mutations that mimic 
phosphorylation at conserved sites.  The last aim of this dissertation is to explore 
phosphorylation-dependent effects specifically mediated by receptors composed of 
different subunits, as well as phosphorylation-independent effects that are usually 
specifically associated with different protein kinases.  Using site-directed mutagenesis, 
I was able to determine the specific effects of modifying the PKA and PKC 
phosphorylation sites in β or γ subunits to mimic phosphorylation.  There are some 
effects produced by PKA and PKC activation that are demonstrated to be dependent 
of direct phosphorylation of those specific sites, but many effects of PKA and PKC 
activation have been shown not to be due simply to direct phosphorylation of the 
receptor.  The results suggested that the direct phosphorylation of β or γ subunits only 
contributed partial effects by protein kinases.  There were other mechanisms beyond 
25 
the phosphorylation of those sites that also contributed to PKA- or PKC-specific 
effects, such as phosphorylation of related proteins involved GABAA receptor 
regulatory mechanism.  Since most protein kinases, including PKA and PKC, can be 
recruited to macromolecular protein complexes bound to the receptor by different 
adaptor proteins, crosstalk between GABAA receptors and other cellular proteins in 
the complex might be involved in those protein kinase-specific effects.  In the future, 
it will be beneficial to determine which proteins are in the receptor-protein complex 
and to characterize their roles in transducing the effects of phosphorylation to clarify 
mechanisms underlying the specific modulatory actions of different protein kinases. 
Based on my preliminary data, I decided to investigate modulation of the 
current properties of α4β3δ and α4β3γ2L GABAA receptor isoforms by different 
protein kinases: 
1. Comparison of PKA modulation of α4β3δ and α4β3γ2L GABAA 
receptor isoform currents 
  Spontaneous current:  Chapter II 
  GABA-activated tonic current:  Chapter II 
  Total tonic current:  Chapter II 
  Phasic current:  Chapter III 
2. Determine the roles of different subunits in mediating PKC modulation 
of α4β3γ2L currents kinetics: Chapter IV 
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CHAPTER II 
 
MODULATION OF SPONTANEOUS AND GABA-EVOKED TONIC α4β3δ AND 
α4β3γ2L GABAA RECEPTOR CURRENTS BY PROTEIN KINASE A 
 
Xin Tang, Ciria C. Hernandez and Robert L. Macdonald 
 
Abstract  
Protein kinase A (PKA) has been reported to regulate synaptic αβγ GABAA 
receptor currents, but whether or not PKA regulates GABAA receptor peri- and 
extrasynaptic tonic currents is unknown.  GABAA receptors containing α4 subunits 
are important in mediating tonic inhibition and exist as both α4βδ and α4βγ receptors 
in the brain.  To mimic GABA-independent and GABA-dependent tonic currents, we 
transfected HEK 293T cells with α4β3δ or α4β3γ2L subunits and recorded 
spontaneous currents in the absence of applied GABA and steady-state currents in the 
presence of 1 μM GABA.  Both α4β3δ and α4β3γ2L receptors displayed spontaneous 
currents, but PKA-activation increased spontaneous α4β3δ currents substantially more 
than spontaneous α4β3γ2L currents.  The increase in spontaneous α4β3δ currents was 
due to an increase in single channel open frequency.  In contrast, PKA-activation did 
not alter steady state, tonic currents recorded in the presence of 1 μM GABA.  We 
concluded that PKA had a GABA concentration-dependent effect on α4β3δ and 
α4β3γ2L currents.  In the absence of GABA, spontaneous α4β3δ, and to a lesser 
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extent α4β3γ2L currents, could provide a basal, tonic current that could be regulated 
by PKA.  With increasing concentrations of extracellular GABA, however, tonic 
α4β3δ and α4β3γ2L currents would become more GABA-dependent and less PKA-
sensitive.  Thus, in brain regions with fluctuating extracellular GABA levels, the 
dynamic range of GABA-activated tonic currents would be set by PKA, and the 
increase in tonic current produced by increasing GABA would be reduced by PKA 
mediated phosphorylation.  When ambient GABA reaches micromolar concentrations, 
PKA would have no effect on steady-state tonic currents. 
 
Introduction 
GABAA receptors are the major inhibitory neurotransmitter receptors in the 
adult mammalian CNS and mediate both phasic and tonic inhibition (Farrant and 
Nusser 2005).  Phasic inhibition is produced primarily by rapid, synchronous 
activation of post-synaptic αβγ receptors with brief pre-synaptic release of high 
concentrations of GABA, and in contrast, tonic inhibition is produced by persistent 
activation of peri- and extra-synaptic αβδ receptors at low concentrations of ambient 
GABA (Essrich et al. 1998; Nusser et al. 1998; Semyanov et al. 2004) as well as 
some αβγ receptors that are located outside of synapses (Caraiscos et al. 2004; Zhang 
et al. 2007).  Tonic currents play critical roles in regulating neuronal excitability.  
Time-averaged net charge transferred by peri- or extrasynaptic GABAA receptors can 
be larger than time-averaged charge transferred by phasic currents conducted by 
synaptic receptors.  In addition to GABA-activated tonic currents, there is also 
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evidence that some GABAA receptor channels conduct persistent spontaneous 
currents in the absence of GABA (McCartney et al. 2007).  In the presence of ambient, 
extracellular GABA in brain areas where those receptors are expressed, total tonic 
inhibitory currents could be composed of varying combinations of both GABA-
activated current and spontaneous current.  In the current study, we studied both types 
of tonic current, spontaneous currents in the absence of applied GABA and steady-
state currents in the presence of a low (1 μM) concentration of GABA.  The increase 
in tonic current produced by applied GABA from the spontaneous baseline current 
was a measure of GABA-activated tonic current, which reflected the change of tonic 
currents during fluctuation of extracellular GABA concentration.  
Phosphorylation by PKA has been shown to have complicated effects on the 
kinetic properties of phasic currents, but the effects of PKA on tonic currents have not 
been reported.  In the current study, we examined the effects of PKA on spontaneous 
and GABA-evoked steady state currents that contribute to tonic inhibition.  Tonic 
inhibition has been shown to be mediated by a number of different GABAA receptors 
including those that contain α4 subunits, which are expressed primarily at extra-
synaptic sites in thalamus and dentate gyrus (Sun et al. 2004; Jia et al. 2005; Sun et al. 
2007).  Substantially reduced tonic inhibition was found in both brain areas of α4 
subunit knockout mice (Chandra et al. 2006; Liang et al. 2008), suggesting an 
important role for α4 subunit-containing receptors in mediating tonic inhibition.  α4 
subunits were found to be co-assembled with β2/3 subunits and often with γ or δ 
subunits to produce α4βγ2 and α4βδ receptors.  These two receptors have been shown 
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to have distinct physiological and pharmacological properties (Brown et al. 2002; You 
and Dunn 2007).  Comparison of the modulatory effects of PKA on α4β3δ and 
α4β3γ2L receptor currents may help clarify the pathogenesis of neurological diseases, 
since α4 subunits were up-regulated in several animal models of chronic epilepsy and 
alcohol withdrawal syndrome (Brooks-Kayal et al. 1998; Cagetti et al. 2003; Peng et 
al. 2004; Zhang et al. 2007), and γ2 and δ subunits also showed plasticity in 
expression and might be co-regulated with α4 subunits in these animal models.   
 
Methods and Materials 
Transient transfection of GABAA receptor subunits into HEK 293T cells 
The cDNAs encoding rat α4, β3, γ2L and δ GABAA receptor subunit subtypes 
were subcloned into the expression vector pCMVNeo.  A 60 mm cell dish of HEK 
293T cells was co-transfected with 1 or 2 μg of each subunit plasmid with a 1:1:1 
cDNA ratio and 1 μg of the pHook-1 cDNA (Invitrogen, Carlsbad, CA) by FuGene6 
transfection reagent (Roche) using a ratio of 3 µl of reagent per 1 µg of cDNA.  
pHook-1 was used as a marker of positively transfected cells, which were selected 24 
hrs after transfection by magnetic hapten-coated beads (Greenfield, Jr. et al. 1997).   
Electrophysiological recordings 
Whole cell and single channel recordings were performed at room temperature.  
Signals were processed by using an Axopatch 200B amplifier (Molecular Devices, 
Union City, CA) in voltage-clamp mode.  Currents were obtained from HEK 293T 
cells transfected with α4β3γ2L and α4β3δ GABAA receptor subunits.   
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Patch pipettes (resistance 1-1.5 MΩ) used for whole-cell recording were 
pulled from thin-walled borosilicate capillary glass (World Precision Instruments, 
Sarasota, FL) on a P-2000 laser electrode puller (Sutter Instrument Co., San Rafael, 
CA) and filled with an internal solution containing 153 mM KCl, 1 mM MgCl2, 5 mM 
EGTA, 10 mM HEPES pH 7.3, with 4 mM ATP added on the day of recording.  The 
pipette potential was held at -20 mV during recordings.  Lifted cells were subjected to 
continuous background perfusion of the external solution consisting of 142 mM NaCl, 
8 mM KCl, 6 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.4.   
Single-channel currents were recorded using a patch-clamp technique in the 
cell-attached configuration (Hamill et al. 1981).  The bath solution contained (mM): 
140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose and 10 Hepes at pH 7.4.  The pipette 
solution contained (mM): 120 NaCl, 5 KCl, 10 MgCl2, 0.1 CaCl2, 10 glucose, 10 
Hepes at pH 7.4.  In addition, the pipette solution contained the indicated 
concentration of GABA when needed.  The pipette potential was held at +80 mV.  
Glass electrodes were pulled from thick-walled borosilicate capillary glass (World 
Precision Instruments, Inc.) on a P-2000 Quartz Micropipette Puller (Sutter 
Instruments, Novato, CA) and fire-polished to a resistance of 10-20 MΩ on an MF-
830 Micro Forge (Narishige, Tokyo, Japan) before use.   
GABA application and kinase modulation 
GABA (Sigma, St. Louis, MO) was prepared as 1 mM stock in distilled water 
and kept frozen.  The stock solution of GABA was diluted to the final concentration 
of 1 μM prior to experiments.  Activators and inhibitors of PKA were purchased from 
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Calbiochem (San Diego, CA).  PKA was activated by application of 8Br-cAMP (1 
mM; 8-Bromoadenosine-3',5'-cyclic monophosphate, sodium salt) or blocked by 
specific PKA inhibitory peptide (PKI; 100 μg/ml).   
In the cell-attached configuration for single channel recording, GABA was 
applied in the pipette solution while 8Br-cAMP was applied in bath solution.  For 
lifted whole-cell recording, GABA and kinase modulators were delivered through a 
four parallel glass square barrel to lifted HEK 293T cells using a modified SF-77B 
Perfusion Fast-Step application system (Warner Instrument Corp., Hamden, CT) 
(Hinkle et al. 2003).  The drug application was initiated by an analog pulse triggered 
by the pClamp 9 software (Molecular Devices, Union City, CA) that caused the motor 
of the Warner Fast-Step to reposition the multi-barrel array from one barrel to another 
(e.g., external solution to GABA).  By using this modified application system, we 
consistently obtained rise times (10–90%) less than 800 μsec with open-tip electrodes 
stepped from standard bath solution to bath solution.  Alternatively, PKA was 
activated or inhibited by internal application of 8Br-cAMP or PKI in the whole-cell 
recording pipette solution. 
Prolonged application (28 sec) of GABA (1 μM) to lifted whole cells was used 
to assess steady-state currents.  Between every two applications of GABA, external 
solution was applied for at least 3 min to ensure maximal recovery from the GABA 
exposure.  We also added pre-application steps to the protocol for modulator 
experiments to enable us to pre-apply a membrane-permeable modulator such as 8Br-
cAMP.  In the pre-application experiments, GABA was first applied to lifted cells 
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expressing α4β3γ2L or α4β3δ GABAA receptors as a pre-control.  After washout of 
GABA, the PKA activator 8Br-cAMP (1 mM) was applied for 4 min and then the 
lifted cell was stepped back into external solution for a brief washout (3 sec) of any 
residual external 8Br-cAMP before it was subjected to a second GABA application.  
This second GABA-activated current, recorded immediately after an 8Br-cAMP pre-
application, was defined as the experimental current.  After the second GABA 
application, the cell was washed in external solution for more than 6 min before it was 
subjected to the final GABA application to evoke a post-control current.  Due to the 
variability of currents among cells, the experimental currents were normalized to their 
matched pre-control currents so that differences made by pre-application were shown 
as a ratio of the control current.   
Data analysis 
Macroscopic whole-cell currents were low-pass filtered at 2 kHz, digitized at 
10 kHz, and analyzed using pClamp9 software.  Single channel currents were also 
low-pass filtered at 2 kHz and digitized at 20 kHz.  Single channel currents were 
analyzed using TAC (Bruxton, Seattle, WA) software.  Open and closed times were 
analyzed by using the "50% threshold criterion".  All events were carefully checked 
visually before being accepted.  Open and closed time histograms as well as 
amplitude histograms were generated using TACFit (Bruxton).  The single-channel 
amplitude (i) was calculated by fitting all-point histograms with single or multiple 
Gaussian curves.  The difference between the fitted "closed" and "open" peaks was 
taken as i.  Duration histograms were fitted by a maximum likelihood method with 
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exponential components in the form: ∑ Ai τi-1exp[-t/τi] , where Ai and τi are the 
relative area and the time constant of the ith component, respectively, and t is the time.  
Mean open or close time was calculated as follow: ∑ Aiτi (Fisher and Macdonald 
1997; Hernandez et al. 2008).  The number of components required to fit the interval 
histograms was increased until an additional component did not significantly improve 
the fit with 95% confidence interval (Fisher and Macdonald 1997).   
Single channel openings occurred as bursts of one or more openings or 
clusters of bursts.  Bursts were defined as one or more consecutive openings that were 
separated by closed times that were shorter than a specified critical duration (tcrit) prior 
to and following the openings (Twyman et al. 1990).  A tcrit duration of 5 ms was used 
in the current study.  Clusters were defined as a series of bursts preceded and followed 
by closed intervals longer than a specific critical duration (tcluster).  A tcluster of 10 ms 
was used in this study.  All numerical and bar graph data were expressed as mean ± 
standard error.  Statistical significance was compared between the kinase modulator 
group and the control solution group.  Statistical analyses were performed using 
Graph Pad Prism 4.  Student’s paired or unpaired t tests were used to compare pairs of 
data, or appropriate ANOVA analyses were used for comparing three or more groups.  
Statistical significance was taken as: *p<0.05, **p <0.01, or ***p<0.001.   
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Results 
Spontaneous currents were recorded from α4β3δ and α4β3γ2L receptors. 
To characterize α4β3δ and α4β3γ2L currents, we co-transfected HEK 293T 
cells with α4, β3 and δ or γ2L subunits and recorded from control untransfected 
(Figure 2.1 A1) and transfected lifted whole cells (Figure 2.1 A2,3).  In the absence of 
GABA, we recorded significantly larger holding currents from cells transfected with 
α4β3δ or α4β3γ2L subunits than from untransfected cells (Figure 2.1 B).  When 
untransfected cells were voltage clamped to -20 mV, holding currents averaged 33.4 ± 
8.6 pA (n = 8) (Figure 2.1 B, left open bar).  In contrast, holding currents in cells 
voltage clamped to the same membrane potential expressing α4β3δ or α4β3γ2L 
receptors were significantly larger (Figure 2.1 B, middle and right open bars), 
averaging 81.8 ± 10.8 pA (n = 22) and 154.4 ± 25.3 pA (n = 20), respectively (p < 
0.01 α4β3δ transfected vs. untransfected cells; p < 0.001 α4β3γ2L transfected vs. 
untransfected cells).  The larger holding currents in cells expressing α4β3δ or 
α4β3γ2L receptors were caused by spontaneous receptor channel openings since they 
were reversibly blocked by applying the non-competitive GABAA receptor antagonist 
picrotoxin (PTX) (100 μM) (Figure 2.1 A2, 3).  The holding currents of untransfected 
cells, however, were not altered by PTX (Figure 2.1 A1) (0.3 ± 2.7 pA, n = 8) (Figure 
2.1 B, left slashed bar).  PTX-sensitive spontaneous α4β3δ and α4β3γ2L currents 
averaged 54.1 ± 9.3 pA (n = 22) and 120.0 ± 18.6 pA (n = 20), respectively (Figure 
2.1 B, middle and right slashed bars), which were significantly larger than those of 
untransfected cells.  After PTX application, the remaining holding currents averaged  
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Figure 2.1. α4β3δ and α4β3γ2L receptors exhibit agonist-independent spontaneous 
currents. 
 
A, Holding and spontaneous currents were recorded from untransfected cells (A1) and 
cells transfected with α4β3δ (A2) or α4β3γ2L subunits (A3).  With all three 
transfection conditions, cells had baseline holding currents in external bath control 
(Ext) in the absence of applied GABA, but only cells transfected with α4β3δ or 
α4β3γ2L subunits had spontaneous currents that could be blocked by the GABAA 
receptor antagonist PTX (100 μM).  B, The amplitude of total holding currents (open 
bars), picrotoxin-sensitive spontaneous currents (slashed bars) and baseline, 
picrotoxin-insensitive, leak currents (solid bars) were recorded from untransfected 
cells and from cells transfected with α4β3δ or α4β3γ2L GABAA subunits.  Currents 
were significantly different from control current at * p < 0.05, **p < 0.01, or ***p < 
0.001.   
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27.7 ± 5.1 pA (n = 22) and 34.3 ± 10.6 pA (n = 20) for cells expressing α4β3δ and 
α4β3γ2L receptors, respectively (Figure 2.1 B, middle and right solid bars), 
respectively, which were not different from those recorded from untransfected cells 
after PTX application (33.1 ± 8.5 pA, n = 8) (Figure 2.1 B, left solid bar).  The most 
accurate assessment of spontaneous current is to determine the difference between the 
holding currents recorded before and after PTX application (PTX sensitive 
spontaneous current).  With or without transfection, cells had consistent baseline leak 
currents (Figure 2.1 B, solid bars).  Thus, when it was not practical to apply PTX 
repeatedly, we used the total holding current as an indicator of spontaneous current, 
recognizing that a small, ~30 pA baseline leak current should be subtracted to 
estimate the true spontaneous current mediated by GABAA receptors.   
PKA-activation enhanced spontaneous α4β3δ currents more extensively than 
spontaneous α4β3γ2L currents.   
To determine if spontaneous α4β3δ and α4β3γ2L currents were subject to 
PKA modulation, we applied the PKA activator, 8Br-cAMP (1 mM), for 4 min to 
cells expressing each receptor isoform.  8Br-cAMP slowly increased spontaneous 
α4β3δ currents (Figure 2.2 A) to a maximal extent in about 3 min, but had only a 
small effect on spontaneous α4β3γ2L currents (Figure 2.2 B).  We confirmed that the 
8Br-cAMP-induced current was due to increased GABAA receptor channel activity by 
applying PTX (100 μM), which reversibly blocked both basal and PKA-enhanced 
spontaneous α4β3δ and α4β3γ2L receptor currents (Figure 2.2 A, B).   
 
45 
 
Figure 2.2.  The PKA activator, 8Br-cAMP, increased spontaneous α4β3δ, but not 
α4β3γ2L, receptor currents. 
 
A and B, Spontaneous whole cell α4β3δ (A) and α4β3γ2L (B) currents in external 
bath control (Ext) were increased with application of the membrane permeable PKA 
activator, 8Br-cAMP (1 mM).  The spontaneous and 8Br-cAMP-activated α4β3δ and 
α4β3γ2L currents were reversibly blocked by 100 μM PTX.  C, Amplitudes of PTX-
sensitive spontaneous α4β3δ (left) and α4β3γ2L (right) currents before (open bar) and 
at the end of a 4 min 8Br-cAMP (1 mM) application (gray bar) were compared.  D, 
The enhancement of PTX-sensitive spontaneous current amplitudes and the 
percentage increase of holding currents after 4 min 8Br-cAMP applications were 
plotted for α4β3δ (open bars) and α4β3γ2L (solid bars) currents.  Currents were 
significantly different from control current at **p < 0.01 or ***p < 0.001.   
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Before application of 8Br-cAMP, basal PTX-sensitive spontaneous α4β3δ and 
α4β3γ2L currents averaged 52.2 ± 15.3 pA (n = 10) and 113.4 ± 29.8 (n = 10) pA, 
respectively (Figure 2.2 C, open bars).  After 8Br-cAMP treatment, PTX-sensitive 
spontaneous α4β3δ and α4β3γ2L currents increased to 128.0 ± 30.3 pA (n = 10) and 
134.0 ± 34.0 (n = 10) pA, respectively (Figure 2.2 C, gray bars).  The increase of 
PTX-sensitive spontaneous α4β3δ currents produced by 8Br-cAMP averaged 75.8 ± 
15.2 pA (n = 10), which was a 195.5 ± 26.1% increase compared to the basal PTX-
sensitive spontaneous currents (Figure 2.2 D, open bars).  The 8Br-cAMP-enhanced 
PTX-sensitive spontaneous α4β3γ2L currents was very small and averaged only 20.6 
± 5.3 pA (n = 10), which was a 20.3 ± 4.1% increase compared to the basal PTX-
sensitive spontaneous currents (Figure 2.2 D, filled bars) and was significantly smaller 
than the increase of PTX-sensitive spontaneous α4β3δ currents produced by 8Br-
cAMP (p < 0.001).   
To determine if the changes in spontaneous currents associated with 
application of extracellular 8Br-cAMP were due to activation of intracellular PKA, 
we added 8Br-cAMP (1 mM) or PKA kinase inhibitor (PKI, 100 μg/ml) to the intra-
pipette solution to constitutively activate or inhibit PKA and recorded holding 
currents as measures of spontaneous currents.  With intracellular 8Br-cAMP, α4β3δ 
receptor holding currents (Figure 2.3 A1, solid bar) were significantly larger (177.3 ± 
57.8 pA, n = 7) than those obtained with control intra-pipette solution (87.3 ± 9.9 pA, 
n = 30, p < 0.01) (Figure 2.3 A1, open bar) or with PKI (100 μg/ml) in the recording  
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Figure 2.3.  8Br-cAMP-induced increase of spontaneous α4β3δ and α4β3γ2L currents
was due to activation of PKA. 
 
A, Amplitudes of α4β3δ (A1) and α4β3γ2L (A2) holding currents with intra-pipette
control solution (Control, open bar) and with intra-pipette solution containing the 
PKA activator 8Br-cAMP (1 mM, solid bar) or the PKA inhibitor PKI (100 μg/ml,
grey bar) were compared.  B, Spontaneous α4β3δ (left) and α4β3γ2L (right) currents 
after a 4 min application of extracellular 8Br-cAMP (1 mM) were recorded from cells 
with pipettes filled with control solution (Control, open bar) or containing (Internal 
PKI, solid bar).  Currents were significantly different from control current at *
p<0.05, **p <0.01, or ***p<0.001.  ### p < 0.001 internal 8r-cAMP vs. internal PKI. 
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pipette (44.7 ± 10.0 pA, n = 18, p < 0.001) (Figure 2.3 A1, gray bar).  Since 
intracellular and extracellular application of 8Br-cAMP caused the same effect on 
α4β3δ holding currents, it is likely that the effect of extracellular 8Br-cAMP was due 
to activation of intracellular PKA rather than to a direct, nonspecific extracellular 
effect on the receptors.  α4β3δ holding currents recorded with intracellular PKI 
(Figure 2.3 A1, gray bar) were also significantly smaller than α4β3δ holding currents 
recorded with control intra-pipette solution (Figure 2.3 A1, open bar) , suggesting 
some basal PKA-activation of spontaneous α4β3δ currents.   
With α4β3γ2L receptors, holding currents with internal 8Br-cAMP (97.1 ± 
17.0 pA, n = 3) (Figure 2.3 A2, solid bar) were slightly, but not significantly, larger 
than holding currents with intracellular PKI (69.2 ± 22.6 pA, n = 17) (Figure 2.3 A2, 
gray bar), and neither current was significantly different from α4β3γ2L holding 
currents with control intra-pipette solution (89.8 ± 14.3 pA, n = 7) (Figure 2.3 A2, 
open bar).  The inclusion of a constant baseline leak current (~30 pA) in each 
condition and a smaller effect of PKA on spontaneous α4β3γ2L currents may have 
contributed to the failure to detect a significant difference in holding currents.   
To exclude the possibility that the 8Br-cAMP-induced increase in spontaneous 
α4β3δ current was non-specific, we applied extracellular 8Br-cAMP (1 mM) and 
recorded spontaneous α4β3δ currents from cells with PKI (100 μg/ml) in the intra-
pipette solution.  The average increase of spontaneous α4β3δ currents after a 4 min 
incubation in 8Br-cAMP decreased from 75.8 ± 15.2 pA (n = 10) in cells with control 
intra-pipette solution (Figure 2.3 B, open bar) to 19.1 ± 9.3 pA (n = 4, p < 0.01) in 
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cells with internal PKI (Figure 2.3 B, solid bar), indicating that inhibition of 
intracellular PKA significantly blocked the effect of 8Br-cAMP applied 
extracellularly.  Intracellular application of PKI also reduced the 8Br-cAMP-induced 
spontaneous α4β3γ2L current from 20.6 ± 5.3 pA (n = 10) (Figure 2.3 B, open bar) to 
10.4 ± 3.2 pA (n = 6, p > 0.05) (Figure 2.3 B, solid bar), but this was not a significant 
difference.  These results demonstrated that both α4β3δ and α4β3γ2L receptor 
channels opened spontaneously, but that PKA-activation was much more effective in 
increasing spontaneous α4β3δ than α4β3γ2L receptor currents.   
PKA-activation did not alter total tonic α4β3δ and α4β3γ2L currents in the presence 
of a low concentration of GABA. 
Tonic current usually reflects activation of GABAA receptors by a low, 
ambient concentration of GABA, while for receptors with spontaneous openings like 
α4β3δ and α4β3γ2L receptors, tonic current could be contributed both by spontaneous 
current and current activated by ambient GABA.  As extracellular GABA can be 
detected at micromolar concentrations in several brain regions such as hippocampus 
where tonic inhibition is present (Lerma et al. 1986; Nusser and Mody 2002), we 
recorded total tonic α4β3δ and α4β3γ2L currents as well as their holding currents in 
the presence of 1 μM GABA with and without PKA-activation.  To determine if total 
tonic currents were also regulated by PKA phosphorylation, the PKA activator 8Br-
cAMP (1 mM) was pre-applied for 4 min to α4β3δ and α4β3γ2L receptors (see 
methods section).  Before and immediately after 8Br-cAMP pre-application, GABA 
(1 µM) was applied for 28 sec to the cells to reach a steady-state, total tonic current.  
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After termination of the GABA application, the cells were washed extensively (> 6 
min) with external solution to ensure maximal reversal of any 8Br-cAMP effect.   
For each 8Br-cAMP pre-application experiment, we recorded three GABA-
activated currents: pre-control currents recorded prior to 8Br-cAMP pre-application 
(Figure 2.4, green traces), currents recorded immediately after 8Br-cAMP pre-
application (Figure 2.4, black traces) and post-control currents recorded after wash 
(Figure 2.4, gray traces).  With activation of PKA, alterations of both transient and 
steady-state α4β3δ and α4β3γ2L currents were observed.  PKA-activation affected 
GABAA receptor currents in minutes, altering the transient properties of α4β3δ 
currents more than those of α4β3γ2L currents.  Specifically, fast phases of 
desensitization were accelerated, and current peak amplitudes were increased.  
Enhancement of α1β1,3γ2L GABAA receptor current desensitization by PKA has also 
been reported (Hinkle and Macdonald 2003), suggesting that a common mechanism 
of PKA modulation to change the current kinetic properties of different GABAA 
receptor isoforms.  The alteration in time course of these currents indicate that PKA-
activation modified the kinetic properties of α4β3δ and α4β3γ2L receptors; however, 
the time course of currents activated by low concentrations of GABA has less 
physiological relevance than their steady-state current levels, and thus, only steady-
state currents were assessed.  The steady-state current at the end of a 28 sec 
application of GABA (1 μM) was a measure of total tonic current (Figure 2.3 A, B; 
grey arrows).  The GABA-activated increase in current from holding baseline at the 
end of application to the steady-state, tonic current was also measured as  
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Figure 2.4.  PKA-activation did not alter α4β3δ or α4β3γ2L total tonic currents, but
did increase spontaneous and decrease GABA-activated tonic α4β3δ, and to a lesser 
extent α4β3γ2L, currents. 
 
A and B, Pre-application of 8Br-cAMP (1 mM) had different effects on spontaneous 
currents and GABA-evoked tonic and total tonic currents recorded from α4β3δ (A)
and α4β3γ2L (B) receptors.  Control currents (Pre-control, left green), currents 
immediately after 8Br-cAMP pre-application (8Br-cAMP, middle black) and currents 
after wash (Post-control, right gray) evoked by 1 μM GABA were recorded from the
same cell.  C, The amplitudes of spontaneous (vertical striped bars), GABA-evoked 
tonic (slashed bars) and total tonic (stippled bars) α4β3δ (left) and α4β3γ2L (right) 
pre-control (white) currents were compared to currents recorded following pre-
application in 8Br-cAMP (red).  D, Amplitudes of spontaneous, GABA-evoked tonic 
and total tonic currents recorded from α4β3δ and α4β3γ2L receptors were normalized
to pre-control amplitudes. 
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GABA-activated tonic currents (Figure 2.4 A, B; two-headed arrows).  Due to the 
lack of full recovery of currents with repeated application of picrotoxin, we measured 
the total holding currents (Figure 2.4 A, B; black arrows) as a measure of spontaneous 
currents before GABA application.  Although we can measure the sum of spontaneous 
and the additional GABA-activated currents, it is not possible to determine the 
relative contributions of these two currents to the total tonic current at a given ambient 
GABA concentration since it is very likely that GABA binding to receptors would 
prevent spontaneous openings.   
To easily visualize the changes in steady-state currents, we drew two lines to 
align the three currents with the pre-control baseline holding current (upper) and the 
pre-control steady-state, total tonic current (lower).  Holding currents, indicated by the 
black arrows, were reversibly increased by PKA-activation to a larger extent for 
α4β3δ (Figure 2.4 A) than for α4β3γ2L currents (Figure 2.4 B).  In contrast to the 
effect of PKA-activation on holding currents, steady-state, total tonic currents, 
indicated by the grey arrows, were unchanged by PKA-activation for both α4β3δ and 
α4β3γ2L receptors (Figure 2.4 A, B).  As a result, the magnitude of the increase in 
GABA-activated tonic current, indicated by the vertical two-headed arrows, was 
decreased by PKA-activation for α4β3δ receptors (Figure 2.4 A) more than for 
α4β3γ2L receptors (Figure 2.4 B).   
To quantify the effects of PKA-activation on basal spontaneous currents 
before GABA application, the increase of current evoked by 1 µM GABA and steady-
state, tonic currents at the end of the GABA application, we compared the amplitudes 
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of holding, GABA-activated and steady-state, tonic currents of pre-control currents 
(Figure 2.4 C, white) and of currents following 8Br-cAMP treatment (Figure 2.4 C, 
red) for α4β3δ (Figure 2.4 C, left) and α4β3γ2L (Figure 2.4 C, right) receptor 
isoforms.  The amplitudes of steady-state, total tonic α4β3δ currents were not altered 
by 8Br-cAMP pre-application (300.5 ± 47.7 vs. 307.6 ± 53.6 pA, n = 11) (Figure 2.4 
C, cross hatched bars).  However, α4β3δ holding currents were increased by 8Br-
cAMP (67.9 ± 9.6 vs. 160.5 ± 37.0 pA, n = 11) (Figure 2.4 C, vertical striped bars).  
Since the holding currents, but not steady-state currents, were increased by 8Br-cAMP, 
this resulted in smaller GABA-activated tonic α4β3δ currents (232.7 ± 42.1 vs. 147.1 
± 34.5 pA, n = 11) (Figure 2.4 C, slashed bars).  Compared to pre-control currents, 
α4β3δ holding currents were increased by 127.4 ± 26.2% (n = 11) (Figure 2.4 D, open 
bar), and total tonic α4β3δ currents were unaltered (+3.9 ± 4.8%, n = 11) (Figure 2.4 
D, black bar) after 8Br-cAMP pre-application.  As a result, the magnitude of α4β3δ 
GABA-activated currents was decreased by 33.2 ± 7.8% (n = 11) after 8Br-cAMP 
pre-application (Figure 2.4 D, gray bar).   
The amplitudes of steady-state, total tonic α4β3γ2 currents were not altered by 
8Br-cAMP pre-application (538.8 ± 142.1 vs. 505.6 ± 172.0 pA, n = 5) (Figure 2.4 C, 
cross hatched bars).  Similarly, α4β3γ2 holding currents (150.7 ± 85.9 vs. 179.0 ± 
119.3 pA, n = 5) (Figure 2.4 C, vertical striped bars) and GABA-activated tonic 
α4β3γ2 currents (356.5 ± 99.2 vs. 326.7 ± 134.2 pA, n = 5) (Figure 2.4 C, slashed bars) 
were not significantly altered by 8Br-cAMP pre-application.  Compared to the effects 
on α4β3δ currents, PKA had much smaller effects on the holding (+14.6 ± 13.2%, n = 
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5) (Figure 2.4 D, open bar) and GABA-activated (-10.2 ± 10.9%, n = 5) (Figure 2.4 D, 
grey bar) α4β3γ2L currents and also did not alter total tonic α4β3γ2L currents (-2.7 ± 
10.9%, n = 5) (Figure 2.4 D, black bar).  Our results suggest that PKA-activation 
enhanced spontaneous α4β3δ currents but reduced the magnitude of GABA-activated 
tonic α4β3δ currents, had no significant effects on spontaneous and GABA-activated 
tonic α4β3γ2L currents and had no effect on total tonic α4β3δ and α4β3γ2L currents 
in the presence of micromolar ambient GABA.   
PKA-activation enhanced spontaneous single channel α4β3δ currents by increasing 
open frequency. 
To determine the mechanisms underlying the enhancement of spontaneous 
α4β3δ currents by PKA-activation, we obtained cell-attached patch clamp recordings 
in the absence of applied GABA from cells transfected with α4β3δ subunits and 
compared the properties of spontaneous single channel openings obtained with and 
without activation of PKA.  In the cell-attached patch clamp configuration at an intra-
pipette potential of +80 mV, α4β3δ GABAA receptors displayed spontaneous single 
channel openings with an amplitude of 1.02 pA (n = 5, Table 1).  The spontaneous 
α4β3δ single channel currents occurred as frequent isolated single openings and brief 
bursts of a few openings, but no prolonged clusters of bursts were evident (Figure 2.5 
A).  When 1 mM 8Br-cAMP was added to the bathing solution, the amplitude of 
spontaneous single channel α4β3δ currents was not altered (1.03 pA, n = 5, p > 0.05, 
Table 1).  However in addition to the brief bursts of openings, frequent prolonged (1 
to 2 sec) clusters of bursts were apparent (Figure 2.5 B).  Thus, PKA-activation 
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caused the single channel opening pattern to change due to modulation of spontaneous 
channel openings, rather than altering single channel conductance.   
To characterize the effect of PKA-activation on the kinetic properties of 
spontaneous α4β3δ single channel currents, we first measured the durations of  
 
Values represent mean ± S.E.M.  *, ** and *** indicate p < 0.05, p < 0.01 and p < 0.001 
(unpaired t-test) relative to control conditions, respectively.  
Table 1. Kinetic properties of α4β3δ GABAA receptors. 
 Spontaneous GABA 1µM 
 Control (n = 5) 
+8Br-cAMP 
(n = 5) 
Control 
(n = 4) 
+8Br-
cAMP 
(n = 4) 
Current amplitude (pA) 1.02 ± 0.05 1.03 ± 0.04 1.07 ± 0.08 1.03 ± 0.04 
Open duration (ms) 5.82 ± 0.59 3.98 ± 0.32* 3.99 ± 0.48 2.58 ± 0.23* 
Closed duration (ms) 661.4 ± 86.1 158.3 ± 1.3*** 401.5 ± 53.9 271.6 ± 66.1 
Open probability 0.006 ± 0.002 0.027 ± 0.005** 0.011 ± 0.001 0.017 ±0.005
Burst duration (ms) 7.01 ± 0.97 6.75 ± 1.24 6.07 ± 1.27 6.94 ± 1.55 
Burst frequency (S-1) 0.99 ± 0.18 4.58 ± 0.62*** 1.34 ± 0.07 2.96 ± 0.40**
Po 0.25 ± 0.02 0.63 ± 0.03*** 0.72 ± 0.05 0.85 ± 0.06 
τo1 (ms) 0.81 ± 0.18 0.69 ± 0.07 0.66 ± 0.08 0.43 ± 0.10 
Weight τo1 (%) 14 ± 4 21 ± 4 21 ± 3 17 ± 5 
τo2 (ms) 6.85 ± 1.05 3.45 ± 0.31* 3.40 ± 0.46 2.14 ± 0.18 
Weight τo2 (%) 75 ± 8 70 ± 3 69 ± 1 77 ± 4 
τo3 (ms) 13.63 ± 1.58 11.22 ± 1.09 7.87 ± 0.56 4.81 ± 0.24**
Weight τo3 (%) 11 ± 4 9 ± 2 10 ± 2 6 ± 2 
Mean open duration (ms) 6.36 ± 0.65 3.89 ± 0.27** 3.88 ± 0.43 2.44 ± 0.10* 
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Figure 2.5.  PKA-activation increased spontaneous, single channel α4β3δ receptor
current by increasing channel open frequency. 
 
A and B, Spontaneous single channel current traces recorded from cells expressing
α4β3δ receptors in the absence (A) and presence (B) of 1 mM 8Br-cAMP.  The
portion of the single channel current trace below the filled bar was expanded below.
C, D, E, F and G, Single channel burst analysis was performed for spontaneous
currents recorded without (white) and with (grey) 1 mM 8Br-cAMP application.
Representative open duration histograms obtained with and without 8Br-cAMP were 
fitted to three exponential functions with mean open durations of 6.69 ms and 3.64 
ms, respectively (C).  Comparisons of single channel mean open duration (D), burst 
duration (E), burst frequency (F) and open probability (F) were made between control
currents (white) and currents recorded in the presence of 1 mM 8Br-cAMP (grey). 
Values represent mean ± S.E.M. * and *** indicate p < 0.05 and p < 0.001 (unpaired 
t-test) relative to control conditions, respectively. 
 
openings and closings and determined the open probability of single channel α4β3δ 
currents in the absence and presence of 8Br-cAMP.  In the absence of 8Br-cAMP, the 
mean durations of openings and closings of spontaneous α4β3δ receptor single 
channel currents were 5.82 ms and 661.4 ms (n = 5, Table 1), respectively, and the 
open probability of spontaneous openings was 0.006.  In the presence of 8Br-cAMP, 
both mean open and closed durations were significantly decreased (open duration 3.98 
ms, p = 0.025; closed duration 158.3 ms, p = 0.0006; n = 5, Table 1).  However, the 
mean open (32 % reduction) and closed (76 % reduction) durations were reduced to 
different extents, resulting in a spontaneous α4β3δ channel open probability that was 
significantly increased to 0.027 (n = 5, p = 0.0023, Table 1).  The increased overall 
open probability with shorter mean open duration and even larger reduction of mean 
close duration strongly suggests that 8Br-cAMP substantially increased channel 
opening frequency to produce an overall increase of open probability.   
We also compared the single channel kinetic properties of spontaneous α4β3δ 
currents evoked in the absence and presence of 1 mM 8Br-cAMP.  Representative 
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open duration histograms from both control and experimental conditions were fitted 
best by three exponential probability density functions (Figure 2.5 C).  The mean open 
duration time constants and their respective mean distribution weights are 
summarized in Table 1.  Interestingly, spontaneous α4β3δ currents recorded with 
application of 1 mM 8Br-cAMP displayed an approximately twofold reduction in the 
second time constant (τo2 = 3.45 ms, p < 0.05) when compared with that from control 
currents recorded without 8Br-cAMP (τo2 = 6.85 ms), but there were no differences in 
the respective weights of the time duration functions (Table 1).  Thus, with PKA-
activation spontaneous α4β3δ single channel currents displayed a significant decrease 
in the mean open duration (control = 6.36 ms; 8Br-cAMP = 3.89 ms, p < 0.01) (Figure 
2.5 D; Table 1).  Although enhancement of spontaneous α4β3δ currents by 8Br-cAMP 
did not affect mean burst duration (control = 7.01 ms; 8Br-cAMP = 6.75 ms) (Figure 
2.5 E; Table 1), we found significant increases in both burst frequency (control = 0.99 
s-1; 8Br-cAMP = 4.58 s-1, p < 0.001) and open probability (Po) (control = 0.25; 8Br-
cAMP = 0.63, p < 0.001) (Figure 2.5 F, G; Table 1).  Furthermore, these effects 
shifted the channel to a higher activity level by producing an approximately fivefold 
increase in burst frequency and a threefold increase in open probability compared 
with control conditions, respectively.  Thus in the presence of 8Br-cAMP, unbound 
α4β3δ receptors open in bursts with shorter mean open duration, higher burst 
frequency and higher open probability with no changes in burst duration.   
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PKA had minimal effects on α4β3δ receptor single channel open probabilities in 
the presence of bath applied (ambient) GABA.   
To determine how PKA-activation affects steady-state, tonic currents in the 
presence of low concentrations of GABA, we determined the effect of 8Br-cAMP on 
α4β3δ receptor single channel currents in the presence of 1 μM GABA, an ambient 
GABA concentration detected in many brain areas.  We added GABA to the intra-
pipette solution in the cell-attached configuration and recorded α4β3δ receptor single 
channel currents in the absence (Figure 2.6 A) and presence (Figure 2.6 B) of 8Br-
cAMP.  The amplitudes of α4β3δ single channel currents with 1 μM GABA with 
(1.03 pA, n = 4, p > 0.05) and without (1.07 pA, n = 4, p > 0.05) PKA-activation were 
not different from those of spontaneous currents (1.02 pA, n = 5) (Table 1).  However, 
compared to spontaneous single channel currents, openings in the presence of 1 μM 
GABA contained more bursts of openings and many clusters of bursts (<1 s) and only 
rarely occurred as isolated, brief openings (Figure 2.6 A).  It is worth noting that 
α4β2δ single channel currents also displayed one main conductance level in the 
presence of GABA similar to α4β3δ receptors, but without discrete clusters of 
openings (Akk et al. 2004; Keramidas and Harrison 2008).  This difference in single 
channel open properties could be due to the expression of different β subunits, and 
more clusters of openings may result in larger whole cell currents conducted by β3 
subunit-containing receptors.  The clusters of openings of α4β3δ receptors were 
consistently evoked by 1 μM GABA in the presence of 1 mM 8Br-cAMP (Figure 2.6 
B).  Application of 8Br-cAMP resulted only in small effects on single channel mean  
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Figure 2.6.  PKA-activation did not significantly increase single channel opening of
α4β3δ receptors in the presence of ambient GABA. 
 
A and B, Single channel currents activated by 1 μM GABA were recorded from cells
expressing α4β3δ receptors in the absence (A) and presence (B) of 1 mM 8Br-cAMP. 
The portion of the single channel current trace below the filled bar was expanded
below.  C, D, E, F and G, Single channel burst analysis was performed for currents 
evoked by 1 μM GABA without (white) and with (grey) 1 mM 8Br-cAMP 
application.  Representative open duration histograms obtained with and without 8Br-
cAMP were fitted to three exponential functions with mean open durations of 3.15 ms 
and 2.59 ms, respectively (C).  Comparisons of single channel mean open duration
(D), burst duration (E), burst frequency (F) and open probability (F) were made
between control currents (white) and currents recorded in the presence of 1 mM 8Br-
cAMP (grey). Values represent mean ± S.E.M. * and ** indicate p < 0.05 and p <
0.01 (unpaired t-test) relative to control conditions, respectively. 
 
open and closed durations.  The mean open duration in the presence of 1 μM GABA 
and 8Br-cAMP (2.58 ms, n = 4, Table 1) was decreased by 35% compared to control 
mean open duration (3.99 ms, n = 4, p = 0.036, Table 1).  The mean closed duration in 
the presence of 1 μM GABA and 8Br-cAMP (271.6 ms, n = 4, Table 1), however, was 
not different from the mean close duration in the absence of 8Br-cAMP (401.5 ms, n 
= 4, p = 0.1786, Table 1).  As a result, the open probabilities of α4β3δ receptor single 
channel currents in presence of 1 μM GABA with (0.017, n = 4) and without (0.011, n 
= 4, p = 0.21) PKA-activation were not significantly different (Table 1).  
In addition, kinetic analysis was performed for both spontaneous and GABA(1 
µM)-evoked α4β3δ currents in the absence and presence of 1 mM 8Br-cAMP.  As 
with spontaneous currents, α4β3δ currents evoked by 1 µM GABA with and without 
8Br-cAMP displayed open duration distributions that were fitted best by three 
exponential probability density functions as shown in the representative open duration 
histograms (Figure 2.6 C).  In contrast to spontaneous currents, in the presence or 
absence of 8Br-cAMP, α4β3δ currents evoked by 1 µM GABA had a decrease in the 
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largest time constant (τo3 = 4.81 ms, p < 0.01) when compared with that from control 
currents recorded without 8Br-cAMP (τo3 = 7.87 ms), but with no effects in their 
distribution weights within bursts (Table 1).  Nonetheless, the mean open durations 
were slightly reduced when compared to bursts recorded in the absence of 1 mM 8Br-
cAMP (control = 3.88 ms; 8Br-cAMP = 2.44 ms, p < 0.05) (Figure 2.6 D, Table 1).  
On the other hand, burst duration (Figure 2.6 E) and open probability were not 
affected (Figure 2.6 G) (Table 1).  Thus, 8Br-cAMP application produced about a 
twofold increase in burst frequency (Figure 2.6 F) (control = 1.34 s-1; 8Br-cAMP = 
2.96 s-1, p < 0.01).  The small changes produced by application of 8Br-cAMP on the 
open probabilities of α4β3δ receptor single channel currents in the presence of 1 μM 
GABA was consistent with the observation that PKA-activation had no significant 
effect on macroscopic total tonic currents recorded in the presence of 1 μM GABA. 
 
Discussion 
In this study we demonstrated that both α4β3δ and α4β3γ2L receptors conduct 
spontaneous currents in addition to GABA-activated phasic and tonic currents.  PKA-
activation increased spontaneous α4β3δ currents, did not alter total tonic α4β3δ 
currents, and thus decreased GABA-activated tonic α4β3δ currents.  In contrast, PKA 
only had minimal effects on spontaneous, GABA-activated tonic and total tonic 
α4β3γ2L currents, suggesting that PKA differentially modulates α4β3δ and α4β3γ2L 
receptor currents, and that the extent of modulation is affected by the concentration of 
GABA.  When ambient GABA is maintained at low, sub micromolar levels, 
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spontaneous α4β3δ current would provide a background tonic current that could be 
regulated by PKA, but when ambient GABA is at micromolar levels, total tonic 
α4β3δ current would not be altered by PKA.  As a result, we conclude that PKA 
phosphorylation could play a key role in determining the magnitude of spontaneous 
(agonist-independent) α4β3δ currents and also could set the dynamic range of GABA-
activated (agonist-dependent) tonic currents in response to changes in ambient GABA 
level.  Furthermore, using the single channel recording technique, we determined that 
increased single channel burst frequency was responsible for the alterations in current 
caused by activation of PKA. 
α4β3δ and α4β3γ2L receptor channels open spontaneously. 
Although spontaneous GABAA receptor channel openings have been reported 
previously, the specific GABAA receptor isoform(s) that contribute to the spontaneous 
currents was not clearly due to GABAA receptor heterogeneity and the relatively 
small magnitude of spontaneous currents.  Homomeric β1 and β3 receptors and 
dimeric α4β1 receptors exhibited spontaneous currents; however, these receptors were 
reported to be insensitive to GABA (Sigel et al. 1989; Khrestchatisky et al. 1989; 
Krishek et al. 1996; Wooltorton et al. 1997).  More recently, αβε receptors were 
reported to generate spontaneous currents (Neelands et al. 1999; Maksay et al. 2003; 
Wagner et al. 2005), and there have also been reports of spontaneous currents 
recorded from different αβδ/γ receptor isoforms, including α6β2δ, α6β2γ2, α1β3γ2 
and α4β2δ receptors, in different cell types (Knoflach et al. 1996; Bianchi and 
Macdonald 2001; Hadley and Amin 2007).  In our recombinant expression system, 
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we recorded significant spontaneous currents from both α4β3δ and α4β3γ2L receptors. 
These currents were not likely contributed by formation of homomeric β3 subunit 
receptors or dimeric α4β3 receptors because transfection of β3 subunit alone or of α4 
and β3 subunits did not produce detectable spontaneous currents.  Although this result 
seemed contradictory to the previous founding of spontaneous currents of homomeric 
β and dimeric α4β receptors expressed in Xenopus oocytes, it could be due to low 
expression or surface targeting of those two receptors in our expression systems.  In 
brain areas expressing either of the two α4 subunit-containing receptors, spontaneous 
currents mediated by α4β3δ and α4β3γ2L receptors could play an important role in 
setting resting neuronal inhibitory tone.   
Single channel recordings from α4β3δ receptor channels demonstrated that 
spontaneous single channel currents were composed of low frequency, isolated, brief 
openings.  Thus spontaneously opening channels have a low open probability, and 
therefore, conduct relatively small currents.  Nonetheless, spontaneous currents could 
provide a significant fraction of a neuron’s resting input conductance and have a 
substantial influence on neuronal excitability since spontaneous currents are 
continuous and independent of neurotransmitter release.  
For receptors with spontaneous openings, spontaneous current could also 
contribute to total tonic current in the presence of low concentration of ambient 
GABA; however, the relative contributions of these two currents to the total tonic 
current could vary at different ambient GABA levels if GABA binding to receptors 
prevents spontaneous openings.  At low, nanomolar GABA concentrations it is 
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possible that there is a mixture of unbound, spontaneously opening channels and 
GABA-bound GABA-activated receptors that contribute to total tonic current, but at 
micromolar GABA concentrations, which are high ambient GABA concentrations 
that occur in the extracellular space, it is likely that most if not all steady-state current 
is GABA-evoked.   
PKA increased α4β3δ channel open frequency in the absence of GABA but not in 
the presence of GABA. 
We demonstrated that spontaneous α4β3δ currents were enhanced by PKA, 
which would provide a regulatory mechanism that would be particularly important in 
maintaining the basal inhibitory tone in the context of very low extracellular GABA 
concentrations.  In contrast, we demonstrated that at micromolar GABA 
concentrations, total tonic α4β3δ currents were not altered by PKA.  To understand 
the mechanism of this modulation by PKA, we acquired single channel currents in the 
absence and presence of 1 μM GABA.  The results obtained for modulation of 
macroscopic and single channel α4β3δ receptor currents by PKA were consistent.  
The increased spontaneous whole cell current produced by PKA-activation was 
associated with no alteration of single channel conductance, a moderate decrease in 
single channel mean open duration, a large decrease in single channel mean closed 
duration and an increase in single channel open probability.  Thus, we concluded that 
the decrease in mean closed duration with PKA was consistent with an increased open 
frequency, although we could not exclude the possibility of more than one channel on 
the patch so that mean close time cannot be used as a clear measure of open frequency.  
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The increase in open frequency was associated with a PKA-induced change from 
spontaneous, brief isolated single channel openings to more frequent bursts and 
clusters of openings.  Kinetic analysis of spontaneous single channel currents in the 
absence and presence of 8Br-cAMP (1 mM) indicated an increase of burst frequency 
and a higher open probability induced by PKA, which could cause increased 
spontaneous current.  However, in the presence of 1 μM GABA, no significant 
increase in channel open frequency or open probability was observed, consistent with 
the finding that 1 μM GABA minimized the PKA effect on the total tonic α4β3δ 
currents.   
There have been numerous reports that modulators of GABAA receptors 
regulated receptor function by altering the efficacy or potency of GABA (Bianchi and 
Macdonald 2003; Zheleznova et al. 2008).  In our study, PKA phosphorylation clearly 
increased the efficacy of α4β3δ spontaneous openings, which were independent of 
GABA-binding.  The absence of alteration of tonic current by PKA in the presence of 
GABA does not necessarily suggest that GABAA receptor gating was unaffected by 
PKA-activation.  Failure to have a PKA effect could also be explained by saturation 
of α4β3δ receptors at 1 μM of GABA, so that any changes produced by PKA on 
receptor affinity would not occur at a saturating concentration of GABA.  More data 
obtained with sub-micromolar concentrations of GABA would help address this issue  
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The extent of PKA modulation of tonic α4β3δ currents should differ at different 
concentrations of ambient GABA. 
Extracellular neurotransmitter concentrations always vary temporally and 
spatially, and therefore, the relative proportion of spontaneous and GABA-evoked 
tonic currents should change with changes in regional ambient GABA level.  In the 
absence of GABA, tonic current would be composed only of GABA-independent, 
spontaneous α4β3δ current that would be regulated by PKA.  In contrast, in the 
presence of 1 μM GABA, total tonic α4β3δ currents were not altered by PKA.  
However, the magnitude of the increase in α4β3δ current produced by GABA was 
reduced by the “floor effect” produced by the PKA-induced increase in spontaneous 
current.  These results suggest that PKA phosphorylation has complex effects on 
spontaneous and GABA-activated α4β3δ currents, which would vary in type and 
extent with different extracellular ambient GABA concentrations.  Without PKA-
activation, α4β3δ steady-state currents were primarily dependent on GABA-activation 
because their spontaneous currents are low, resulting in a large dynamic range for 
GABA-activated tonic current.  With PKA-activation, however, spontaneous α4β3δ 
currents were elevated and the magnitude of GABA-activated tonic currents was 
reduced, resulting in a smaller GABA-activated tonic current dynamic range.  In other 
words, PKA-activation can drive the channels to activities that are close to those 
produced by 1 μM GABA and therefore addition of 1 μM GABA in the presence of 
PKA-activation results in only small additional current.  Therefore, given a high 
spontaneous basal current upon PKA-activation, during an increase of extracellular 
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ambient GABA concentration that might occur with a local or regional physiological 
or pathological decrease in local neuronal excitability, the increase in tonic α4β3δ 
current produced by GABA would be restricted to a small range, and thus, the 
response to a change in extracellular GABA would be reduced.  We suggest that PKA 
could help maintain tonic inhibition mediated by α4β3δ receptors at a stable level to 
avoid large changes in neuronal excitability due to changes of extracellular GABA 
concentration.  Thus, this result suggests that some antiepileptic drugs such as 
tiagabine and vigabatrin, which potentiate GABAergic tonic currents by increasing 
extracellular GABA (Suzdak and Jansen1995; Overstreet and Westbrook2001), would 
be less effective in conditions with higher PKA-activation.  
The difference in PKA-modulation of tonic α4β3δ currents at different 
ambient GABA levels could also have physiological significance since there are 
regional and developmental variation in extracellular GABA concentrations (Hamori 
and Somogyi 1983; Engel et al. 1998; Frahm and Draguhn 2001).  Various 
mechanisms can affect ambient GABA concentrations by regulating the release and 
uptake of extracellular GABA by neurons and glia.  For example, GABA uptake in 
the hippocampus is developmentally regulated and cell type-specific (Draguhn and 
Heinemann 1996; Semyanov et al. 2003).  In mature guinea pig hippocampus, 
interneurons expressed GABAA receptor-mediated tonic currents in response to 
extracellular GABA, while pyramidal neurons were selectively shielded by GABA 
transporters with more efficient GABA uptake leaving very little GABA in the 
extracellular space.  In neurons exposed to relatively low extracellular ambient GABA 
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concentrations, our results suggest that expression of α4β3δ receptors would 
contribute to tonic current by opening spontaneously, and that PKA phosphorylation 
would affect tonic α4β3δ current by elevating agonist-independent spontaneous tonic 
current.  In contrast, in early development when there is less effective GABA uptake 
or in specific cell types in brain areas like the cerebellar granule cells that have unique 
morphology to trap GABA and impede diffusion of GABA away from release sites, 
we proposed that a stable micromolar ambient concentrations could work as a buffer 
system to minimize PKA modulation of total tonic α4β3δ currents.   
PKA differentially modulated spontaneous and GABA-activated tonic α4β3δ and 
α4β3γ2L currents. 
There is substantial evidence that αβδ and αβγ GABAA receptor currents have 
distinct properties and are differentially regulated by numerous drugs including 
neurosteroids, barbiturates and propofol.  Here, we have shown a significant 
differential extent of effects of PKA-activation on α4β3δ and α4β3γ2L receptor tonic 
currents.  The differential modulation of α4β3δ and α4β3γ2L currents by PKA could 
have physiological significance in normal or pathological conditions such as epilepsy 
by providing precise regulation of different receptor isoforms in their specific 
locations.  For example, in the rat thalamus, α4 subunits preferentially co-assemble 
with δ subunits (Sur et al. 1999), suggesting a high capacity for PKA modulation in 
that brain area.  In the pilocarpine rodent model of epilepsy, perisynaptic α4βδ 
receptors in the dentate granule cell dendrites were suggested to be replaced with 
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α4βγ2 receptors (Zhang et al. 2007), which would result in loss of sensitivity to PKA-
modulation.  
In addition, abnormalities in protein phosphorylation have been reported in 
several animal models of epilepsy, although a clear relationship between 
phosphorylation and seizures has not yet been established.  For example, status 
epilepticus (SE) was demonstrated to cause decreased phosphorylation of β3 subunits 
associated with a deficit in receptor stability on the cell surface (Terunuma et al. 
2008).  PKA plays a particularly important role in phosphorylation of GABAA 
receptors relative to other protein kinases.  There have also been reports of elevated 
cAMP levels as well as PKA activity in the hippocampus of experimental animal 
models with epilepsy (Tehrani and Barnes, Jr. 1995; Yechikhov et al. 2001), and 
repeated injections of an initially subconvulsant dose of cAMP into the rat amygdala, 
has been shown to produce seizures (Yokoyama et al. 1989).  These data suggest that 
PKA activation may be involved in the pathogenesis of acquired epilepsies, and thus, 
further study of PKA-mediated phosphorylation of GABAA receptors before and after 
seizures, and determination of how PKA modulation of different GABAA receptor 
isoforms alters inhibitory signaling during seizures will help understanding the role of 
PKA in epileptogenesis. 
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CHAPTER III 
 
MODULATION OF THE KINETICS OF PHASIC CURRENTS MEDIATED BY 
α4β3γ2L AND α4β3δ GABAA RECEPTOR BY PROTEIN KINASE A  
 
Introduction 
GABAA receptors containing α4 subunits are highly expressed in the dentate 
gyrus and thalamus, with lower levels of expression in cortex, striatum and other brain 
areas (Chandra et al., 2006), and are up-regulated in many pathological conditions 
such as epilepsy and alcohol withdrawal syndrome and also in δ knock out mice 
(Brooks-Kayal et al., 1998;Peng et al., 2002;Cagetti et al., 2003;Peng et al., 
2004;Zhang et al., 2007).  α4 subunits were found coassembled with β subunits and 
with γ2 or δ subunits to form either ternary α4βγ2 and α4βδ in thalamus and dentate 
gyrus, while still a portion of α4 subunit-containing receptors in brain membrane 
extracts were believed to be binary α4β receptors (Bencsits et al., 1999).  In rat 
thalamus immunoprecipitation experiments using antisera against multiple subunits 
showed coassembly of δ or γ2 subunits with α4 subunits and further pharmacological 
analyses confirmed the presence of both α4βγ2 and α4βδ receptor isoforms in this 
brain region (Sur et al., 1999).  In addition to reports of extra-synaptic, tonic 
inhibition mediated by α4 subunit-containing receptors in thalamus and dentate gyrus 
(Chandra et al., 2006;Liang et al., 2008), α4βγ2 receptors also have synaptic 
localization in specific brain regions.  Even more interesting, α4βγ2 receptors have 
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been reported to move between synaptic and extra-synaptic locations under certain 
pathological conditions (Hsu et al., 2003;Peng et al., 2004;Liang et al., 2006;Zhang et 
al., 2007).  Therefore, it is important to understand the effects of protein 
phosphorylation on the properties occurring under different conditions including 
spontaneous openings, tonic currents activated by low GABA concentrations and 
phasic currents activated by high GABA concentrations.  Any differences in the 
effects of PKA phosphorylation on α4β3γ2L and α4β3δ receptors and on other α 
subunit-containing receptors will help to clarify the role of PKA phosphorylation in 
regulating synaptic and extrasynaptic GABAA receptor inhibition in the central 
nervous system.   
In the last Chapter, I reported that both α4β3δ and α4β3γ2L receptors 
displayed spontaneous currents, but that PKA-activation increased spontaneous α4β3δ 
currents substantially more than spontaneous α4β3γ2L currents.  The increase in 
spontaneous α4β3δ currents was due to an increase in single channel open frequency.  
In contrast, PKA-activation did not alter steady state, tonic currents recorded in the 
presence of 1 μM GABA but altered the transient properties of α4β3δ currents more 
than those of α4β3γ2L currents.  Specifically, fast phases of desensitization were 
accelerated, and current peak amplitudes were increased.  Enhancement of α1β1,3γ2L 
GABAA receptor current desensitization by PKA has also been reported (Hinkle and 
Macdonald, 2003), suggesting that a common mechanism of PKA modulation to 
change the current kinetic properties of different GABAA receptor isoforms.  As 
α4β3δ receptors have a higher affinity for GABA than α4β3γ2L receptors, the 
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differential alteration in time course of their currents at low concentrations of GABA 
might be due to different activation levels of the two receptor isoforms, and therefore, 
I activated GABAA receptors with a saturating concentration of GABA to study how 
PKA-activation modifies the kinetic properties of α4β3δ and α4β3γ2L receptor 
currents. 
In vitro experiments using purified GABAA receptors or recombinant subunit 
polypeptides revealed that β and γ subunits are primary substrates for various protein 
kinases (McDonald and Moss, 1994;McDonald and Moss, 1997;Moss et al., 1992a).  
However, whether or not a specific site is phosphorylated by one protein kinase or 
another is likely dependent on the experimental situation.  In HEK cells, β3 subunit 
residues S408 and S409 are phosphorylated by PKA and PKC.  In cultured cortical 
neurons, those sites are basally phosphorylated in a PKC-dependent manner; however, 
in different cell types such as CA-1 pyramid cells, the receptor is phosphorylated by 
PKA (Brandon et al., 2000;Krishek et al., 1994;McDonald et al., 1998a;Moss et al., 
1992c;Poisbeau et al., 1999).  The γ2L subunit residues S327 and S343 can be 
phosphorylated by PKC, but not by PKA, in vitro, but the kinase responsible for basal 
phosphorylation of the two sites in vivo remains uncertain.  There have been multiple 
studies of the functional effects of phosphorylation.  For example, PKA was reported 
to increase the fast phases of macroscopic desensitization of α1β1γ2L and α1β3γ2L 
GABAA receptor currents by phosphorylation of the conserved β  subunit 
phosphorylation residues described above.  Here, I further studied and compared the 
effects of phosphorylation by PKA of α4β3γ2L and α4β3δ GABAA receptors.  I 
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focused on the effects of PKA on the current kinetic properties of each receptor 
isoform, which reflects their specific gating properties as ion channels.   
 
Methods and Materials 
Transient transfection of GABAA receptor subunits into HEK 293T cells 
The cDNAs encoding rat α4, β3, γ2L and δ GABAA receptor subunit subtypes 
were subcloned into the expression vector pCMVNeo.  A 60 mm cell dish of HEK 
293T cells was co-transfected with 1 or 2 μg of each subunit plasmid with a 1:1:1 
cDNA ratio and 1 μg of the pHook-1 cDNA (Invitrogen, Carlsbad, CA) using a 
modified calcium phosphate precipitation method.  pHook-1 was used as a marker of 
positively transfected cells, which were selected 24 hrs after transfection by magnetic 
hapten coated beads.  In some experiment, mutated β subunits were transfected in 
place of wild-type β subunits.  All point mutations in rat β3 subunit constructs were 
made using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) 
and were confirmed by DNA sequencing.   
Electrophysiological recordings 
All GABAA receptor currents were obtained using a lifted whole-cell voltage-
clamp recording technique.  Patch pipettes (resistance1-1.5 MΩ) were pulled from 
borosilicate capillary glass (World Precision Instruments, Sarasota, FL) on a P-2000 
laser puller (Sutter Instrument Co., San Rafael, CA) and filled with an internal 
solution containing 153 mM KCl, 1 mM MgCl2, 5 mM EGTA, 10 mM HEPES pH 
7.3, with 4 mM ATP added on the day of recording.  The cells were subjected to 
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continuous background perfusion of the external solution consisting of 142 mM NaCl, 
8 mM KCl, 6 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.4.  All 
experiments were performed at room temperature.  Signals were processed by using 
200B amplifier (Molecular Devices, Union City, CA) in voltage-clamp mode.  All 
cells were voltage clamped at -20 mV during recordings.   
GABA application and kinase modulation 
Activators and inhibitors of PKA were purchased from Calbiochem (San 
Diego, CA).  PKA was activated by externally pre-applied 8Br-cAMP (500-1000 μM; 
8-Bromoadenosine-3',5'-cyclic monophosphate, sodium salt) or alternatively by 
internally applied 8Br-cAMP in the recording pipette.  PKA activity was blocked by 
adding the specific PKA inhibitory peptide (PKI; 100 μg/ml) into the internal 
recording solution.   
GABA and kinase modulators were delivered through a four parallel glass 
square barrel to HEK 293T cells using a modified SF-77B Perfusion Fast-Step 
application system (Warner Instrument Corp., Hamden, CT) (Hinkle et al., 2003).  
The drug application was initiated by an analog pulse triggered by the pClamp 9.2 
software (Axon Instruments, Union City, CA) that caused the motor of the Warner 
Fast-Step to reposition the multi-barrel array from one barrel to another (e.g., external 
solution to GABA).  By using this modified application system, I consistently 
obtained rise times (10–90%) less than 800 μsec with open-tip electrodes stepped 
from standard bath solution to 90% bath solution.   
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A high (1 mM) or low (1 μM) concentration of GABA was applied to lifted 
whole cells for 2 sec or 28 sec, respectively.  Between every two applications of 
GABA, external solution was applied for at least 3 min to ensure maximal recovery 
from the GABA exposure.  I also added pre-application steps to the protocol for 
modulator experiments to enable us to pre-apply a membrane-permeable modulator 
such as 8Br-cAMP.  In the pre-application experiments, GABA was first applied to 
lifted cells expressing α4β3γ2L or α4β3δ GABAA receptors as an initial pre-control.  
After washout of GABA, the PKA activator 8Br-cAMP (1 mM) was applied for 4 min 
and then the lifted cell was stepped back into external solution for a brief washout (3 
sec) of any residual external 8Br-cAMP before it was subjected to a second GABA 
application.  This second GABA-activated current recorded immediately after an 8Br-
cAMP pre-application was defined as the experimental current.  After the second 
GABA application, the cell was washed in external solution for more than 6 min 
before it was subjected to the final GABA application to evoke a post-control current.  
Due to the variability of currents among cells, the experimental currents were 
normalized to their matched pre-control currents so that differences made by pre-
application were shown in percentage.  To control for current run-down during the 
whole set of pre-application experiments that were recorded over 10 min, I superfused 
cells with external solution instead of 8Br-cAMP during the 4 min pre-application 
process.  Significant differences between the 8Br-cAMP pre-application group and the 
external control group were used to identify specific and significant effects caused by 
PKA activators. 
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Mutagenesis 
Subunit phosphorylation sites (β3 S408, 409) were mutated using the 
QuikChange Site-Directed Mutagenesis kit (Stratagene) either to block receptor 
phosphorylation entirely with alanine substitutions or to mimic phosphorylation with 
glutamate substitutions.   
Data analysis 
Macroscopic currents were low pass filtered at 2 kHz, digitized at 10 kHz, and 
analyzed using pClamp9.2 software.  For comparison of desensitization among 
currents, currents were normalized first to their peak value (defined as a maximal 
response of 1).  I plotted the relative residual current, which was the residual current 
at the end of a prolonged GABA application divided by the current peak value and 
used as indicator of the overall extent of desensitization.  In addition, the 
desensitization time course of some phasic currents activated by 1 mM GABA was 
fitted to a sum of exponential functions (Lagrange et al., 2007).  The entire 
desensitization time course was fitted with one to five exponential functions using the 
Levenberg–Marquardt least squares method with the form ∑An*e-t/τn + C, where n 
was the number of exponential components, t was time, A was relative amplitude of a 
given component at time 0, τ was the time constant for a given component, and C was 
a constant to account for residual current.  The number of exponential functions 
required to obtain the best fit was determined when adding an additional component 
did not significantly improve the fitting result based on an F test automatically 
performed by the analysis software on the sum of squared residuals.  All the two 
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second and eight second GABA-activated phasic currents were fitted best with two to 
four exponential functions.  All numerical and bar graph data were expressed as mean 
± standard error.  Statistical significance was compared between the kinase modulator 
group and the control solution group or between wild-type and mutant condition being 
examined.  Statistical analyses were performed using Graph Pad Prism 4.  Student’s 
paired or unpaired t tests were used to compare pairs of data, or appropriate ANOVA 
analyses were used for comparing three or more groups.  Statistical significance was 
taken as: *p<0.05, **p <0.01, or ***p<0.001.   
 
Results 
Spontaneous, GABA-evoked tonic and phasic α4β3δ and α4β3γ2L currents 
To characterize α4β3δ and α4β3γ2L currents, I co-transfected HEK 293T cells 
with α4, β3 and δ or γ2L subunits and recorded from lifted whole cells.  As reported 
in chapter II, I recorded large holding currents in cells transfected with α4β3δ or 
α4β3γ2L subunits in the absence of GABA, which were due to spontaneous opening 
of both receptor isoforms and that were blocked by the GABAA receptor antagonist 
picrotoxin (Fig. 3.1 A).  To characterize GABA-evoked α4β3δ and α4β3γ2L currents, 
I applied a low concentration of GABA (1 μM) for a prolonged duration (28 sec), so 
that currents approached their steady state levels at the end of the application (Fig. 3.1 
B) and applied a high GABA concentration (1 mM) for a briefer duration (2 sec) to 
characterize desensitization of these receptors that contributes to determining the time 
course of phasic, synaptic currents (Fig. 3.1 C).  I used a longer application of 
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Figure 3.1.  α4β3δ and α4β3γ2L receptors exhibit agonist-independent spontaneous
currents and GABA-activated steady-state and phasic currents. 
 
A, Spontaneous currents recorded from cells expressing α4β3δ (A1) and α4β3γ2L
(A2) GABAA receptors were reduced reversibly by 100 μM picrotoxin.  B, Steady-
state currents recorded from cells expressing α4β3δ (B1) and α4β3γ2L (B2) GABAA
receptors were activated by prolonged 28 sec applications of 1 μM GABA.  The near
steady state currents were indicated by the black arrows at the end of the GABA
application.  C, Phasic currents recorded from cells expressing α4β3δ (C1) and 
α4β3γ2L (C2) GABAA receptors were activated by brief, 2 sec applications of 1 mM
GABA.  D, The amplitudes of picrotoxin-sensitive spontaneous currents, GABA-
activated steady-state tonic and phasic peak currents recorded from α4β3δ (left) and 
α4β3γ2L (right) receptors were plotted. 
  
GABA than occurs during transmitter release (~1 msec) at synapses to permit 
characterization of PKA activation on desensitization as well as on the magnitude of 
the phasic currents.   
Spontaneous α4β3δ and α4β3γ2L receptor currents were smaller than GABA-
activated currents.  Picrotoxin-sensitive α4β3δ and α4β3γ2L holding currents 
averaged 55.7 ± 11.7 pA (n = 12) and 126.6 ± 23.8 pA (n = 10), respectively (Fig. 3.1 
D, open bars).  Prolonged (28 sec) application of 1 µM GABA elicited α4β3δ (Fig. 
3.1 B1) and α4β3γ2L (Fig. 3.1 B2) currents that desensitized moderately to near 
steady state currents (Fig. 3.1 B, arrows).  The amplitudes of GABA-activated tonic 
α4β3γ2L currents (510.3 ± 101.9 pA, n = 7) at the end of application were twice as 
large as those of GABA-activated tonic α4β3δ currents (257.0 ± 35.5 pA, n = 12) (Fig. 
3.1 D, solid bars).  However, relative to their peak phasic currents, GABA-activated 
tonic currents were larger for α4β3δ (31.2%) than for α4β3γ2L (13.5%) receptors (Fig. 
3.1 D), consistent with the observation that δ subunit-containing receptors conferred 
higher agonist sensitivity than γ2L subunit-containing receptors.  Briefer (2 sec) 
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applications of 1 mM GABA elicited phasic α4β3δ (Fig. 3.1 C1) and α4β3γ2L 
(Fig.3.1 C2) currents that both desensitized rapidly and extensively.  The extents of 
desensitization of phasic α4β3δ and α4β3γ2L currents were similar, except that 
desensitization of α4β3γ2L currents, but not α4β3δ currents, contained a fast phase.  
The peak amplitudes of phasic α4β3γ2L currents (3778 ± 390 pA, n = 23) were more 
than four times larger than those of phasic α4β3δ currents (824.2 ± 110.0 pA, n = 28), 
(Fig. 3.1D, gray bars).  Picrotoxin-sensitive spontaneous α4β3δ and α4β3γ2L currents 
were less than 7% and 4% of their peak phasic currents, respectively, and thus, 
spontaneous currents have little effect on phasic synaptic currents.  However, at low 
concentrations of GABA, spontaneous α4β3δ and α4β3γ2L currents were both more 
than 20% of their GABA-activated tonic currents.  Thus, α4β3δ and α4β3γ2L receptor 
total tonic currents were composed of both GABA-activated tonic currents and 
spontaneous currents. 
PKA activation regulates α4β3δ and α4β3γ2L GABAA receptor current kinetics.   
We have demonstrated that PKA had a GABA concentration-dependent effect 
on α4β3δ and α4β3γ2L steady-state currents (Tang et al., 2010).  Meanwhile, I also 
observed more alteration of transient α4β3δ currents than α4β3γ2L currents at 1 µM 
GABA (Fig. 3.2).  Specifically, fast phases of desensitization were accelerated 
together with a potentiation of current peak amplitudes.  I used pre-incubation of 8Br-
cAMP (1 mM) (see methods) to determine PKA effects on α4β3δ or α4β3γ2 receptor 
currents.  All three α4β3δ (Fig. 3.2 A1) and α4β3γ2L (Fig. 3.2 B1) currents, pre-
control (green), 8Br-cAMP treated (black) and post-control (gray) currents, were 
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normalized to their peak amplitudes and superimposed to identify changes in their 
time course and extent of desensitization.  
 
Figure 3.2.  PKA-activation accelerated the fast phase of α4β3δ currents more extensively than 
α4β3γ2L currents at 1 μM GABA. 
 
A and B, Pre-application of 8Br-cAMP (1 mM) increased the desensitization of α4β3δ (A1), to a 
lesser extent of α4β3γ2L, tonic currents (B1). Pre-control (green), 8Br-cAMP-treated (black) and 
post-control (gray) currents evoked by 1 μM GABA were normalized to peak currents and 
superposed.   The relative residual of α4β3δ (A2) and α4β3γ2L (B2) 8Br-cAMP treatment (solid 
bars) and post-control (gray bars) currents were compared to the pre-control currents (open bar).  
Currents were significantly different from pre-control current at ***p < 0.001.   
 
To quantitatively characterize changes in desensitization produced by PKA 
activation, I measured the relative residual current at the end of GABA application 
before and after a 1 mM 8Br-cAMP application and plotted them as a ratio of the 
relative residual current for matched, pre-control α4β3δ (Fig. 3.2 A1) or α4β3γ2L (Fig. 
3.2 B1) currents.  To control for current rundown during the experiments, I also 
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performed pre-application of external solution that did not change relative residual 
currents.  After application of external solution, relative residual currents were within 
5% of pre-control relative residual currents.  In contrast, pre-application of 8Br-cAMP 
increased the extent of current desensitization, resulting in smaller relative residual 
currents.  Compared to the pre-control currents (Fig. 3.2 A2, B2, open bars set as a 
ratio of 1), only 65.9 ± 7.6% (n = 13) (Fig 2A2, solid bar) residual currents of α4β3δ 
currents remained after pre-application of 8Br-cAMP, resulting in a significant 34.1% 
reduction of relative residual current.  After PKA activation, α4β3γ2L receptors still 
had 84.9 ± 4.6% (n = 5) (Fig 2B2, solid bar) relative residual current, thus having only 
a 15.1% reduction.  After wash with external control medium, the reduction of 
residual currents by PKA activation was reversed (Fig. 3.2 A2, B2, gray bars).   
However, the larger effect of PKA on desensitization of α4β3δ currents than of 
α4β3γ2L currents might simply be because α4β3δ receptors were activated to a higher 
level than α4β3γ2L receptors at this low concentration of GABA.  The acceleration of 
desensitization might be even strengthened when more receptors were activated to 
access desensitization states at a higher GABA concentration.  Thus, I saturated 
α4β3δ and α4β3γ2L receptors with 1 mM GABA and tested PKA effects on the 
desensitization of their phasic currents (Fig. 3.3 A1, B1).  For phasic currents 
activated by 1 mM GABA, pre-application of 8Br-cAMP produced larger reductions 
in both α4β3δ (49.2 ± 6.8%, n = 7) and α4β3γ2L (47.7 ± 5.8%, n = 8) relative residual 
currents (Fig. 3.3 A2, B2 solid bars).  Thus, PKA had less effect on desensitization of 
currents with smaller extent of desensitization at a low activation level, and more  
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Figure 3.3.  PKA-activation increase desensitization of both α4β3δ and α4β3γ2L phasic 
currents. 
 
A1 and B1, Pre-control (green), 8Br-cAMP-treated (black) and post-control (gray) α4β3δ (A1) 
and α4β3γ2L (B1) currents evoked by 1 mM GABA were normalized to the peak currents and 
were superposed to facilitate comparison of the rate and extent of desensitization.  A2 and B2, 
The relative residual of α4β3δ (A2) and α4β3γ2L (B2) 8Br-cAMP treated (solid bars) and post-
control (gray bars) currents were compared to the pre-control currents (open bar).  A3 and B3, 
Relative residual α4β3δ (A3) and α4β3γ2L (B3) currents following different experimental 
treatments were plotted as ratio of their pre-control relative residual currents.  The current ratio 
for external control pre-application (solid bars) was close to 1 and was compared to the current 
ratio obtained for 8Br-cAMP pre-application in the absence (open bars) and presence of internal 
8Br-cAMP (1 mM, gray bars) or PKI (100μg/ml, striped bars) in the recording pipette.  
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effect on currents with a larger extent of desensitization at a high activation level.  
This correlation between the enhancement of desensitization by PKA and receptor 
activation level suggests that PKA phosphorylation may affect states extensively 
accessed during application of high concentrations of GABA such as desensitized 
states. 
8Br-cAMP did not have a direct, PKA independent, effect on α4β3δ or α4β3γ2L 
currents. 
Externally applied cAMP analogs have been reported to decrease GABAA 
receptor currents independent of PKA phosphorylation via an extracellular site 
(Harrison and Lambert, 1989;Lambert and Harrison, 1990).  However, in other studies, 
the analogs were reported to enhance GABAA receptor currents (Cheun and Yeh, 
1992;Kano and Konnerth, 1992).  Thus, it was important to distinguish PKA-
dependent effects of 8Br-cAMP from any non-specific effects of the drug.  In my 
experiments, 8Br-cAMP pre-application produced an increase, not a decrease, of peak 
currents (data not shown) and increased the rates and extents of current 
desensitization as described above.  The reductions of relative residual phasic currents 
produced by 8Br-cAMP pre-application (Fig. 3.3 A3, B3; open bar) were significantly 
different from those produced by pre-control application of external solution (Fig. 3.3 
A3, B3; solid bars) for α4β3δ (1.2 ± 9.1% p<0.01; n = 4) and α4β3γ2L (3.1± 4.0% 
p<0.001; n = 13) currents, respectively.  I also performed several control experiments 
to determine if the effect of 8Br-cAMP on current desensitization was due to PKA 
activation.  First, I added 8Br-cAMP (1 mM) to the internal recording solution to 
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activate PKA constitutively and to occlude the effect of extracellular application of 1 
mM 8Br-cAMP.  With inclusion of 8Br-cAMP in the recording pipette, the reduction 
of relative residual currents by extracellular 8Br-cAMP pre-application decreased 
from 49.2 ± 6.8% to 28.8 ± 10.8% (n = 4) for α4β3δ currents (Fig. 3.3 A1; open vs 
gray bar) and from 47.7 ± 5.8% to 19.0 ± 8.2% (n = 4) for α4β3γ2L currents (Fig. 3.3 
B1; open vs gray bar).  Second, I added the specific PKA inhibitor PKI (100 μg/ml) in 
the recording pipette solution to block PKA activation (Fig. 3.3 A3, B3; striped bars).  
With PKI in the pipette, pre-application of 8Br-cAMP only caused a 19.5 ± 4.2% (n = 
3) reduction of relative residual α4β3δ current and a 10.0 ± 4.1% (n = 6) reduction of 
relative residual α4β3γ2L current, reductions that were significantly less than obtained 
with pre-application of 8Br-cAMP alone for both receptors.  Thus, these data 
suggested that extracellular pre-application of 8Br-cAMP increased the rate and 
extent of desensitization of α4β3δ and α4β3γ2L currents, and that this effect was not 
due to a non-specific effect of 8Br-cAMP at extracellular sites but was specifically 
due to activation of PKA.  
The effect of PKA on desensitization of α4β3γ2L, but not α4β3δ, currents was due 
to phosphorylation of two β3 subunit serines (408, 409).   
Serines 408 and 409 have been reported to be the major GABAA receptor β3 
subunit substrates for PKA in vitro or in heterologous expression systems (Browning 
et al., 1990;Moss et al., 1992b).  Functional studies coupled with site-directed 
mutagenesis of potential PKA sites have also attributed PKA-induced changes in 
current amplitude to phosphorylation of these two adjacent β3 subunit serines 
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(McDonald et al., 1998b).  To determine if the changes in current kinetics observed 
with α4β3δ and α4β3γ2L receptors was also due to phosphorylation of these β3 
subunit residues, I mutated the phosphorylation substrate serines to alanines to block 
their phosphorylation, and pre-applied 8Br-cAMP (1 mM) to mutant α4β3AAδ and 
α4β3AAγ2L receptors.  8Br-cAMP produced similar reductions of relative residual 
α4β3AAδ currents (40.6 ± 6.3%, n = 8) and α4β3δ currents (49.2 ± 6.8%) (Fig. 3.4 A).  
However, the reduction of relative residual α4β3AAγ2L current by PKA (15.1 ± 3.7%, 
n = 5) was significantly less than the reduction of relative residual α4β3γ2L current 
(47.7 ± 5.8%) (Fig. 3.4 B).  Thus, enhancement of phasic α4β3γ2L current  
 
 
Figure 3.4.  PKA enhancement of phasic current desensitization was due to 
phosphorylation of the β3 subunit for α4β3γ2L receptors but not for α4β3δ receptors. 
 
A and B, Changes in phasic current desensitization produced by PKA activation 
between wild type and mutant α4β3δ (A) or α4β3γ2L (B) receptors were compared.  
Adjacent β3 subunit serines, S408 and 409, were mutated to alanines to block 
phosphorylation by PKA.  Pre-application of 8Br-cAMP (4 min, 1 mM) caused 
similar reduction on the relative residual current of phasic wild-type α4β3δ and 
mutant α4β3AAδ currents.  Mutant phasic α4β3AAγ2L currents, however, had 
significantly larger relative residual currents after 8Br-cAMP treatment than phasic 
wild-type α4β3γ2L receptor currents.  Currents were significantly different from 
control current at **p < 0.01.   
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desensitization by 8Br-cAMP was due at least in part to direct phosphorylation of β3 
subunit serines 408 and 409, while the effect of 8Br-cAMP on α4β3δ receptor current 
desensitization likely was not mediated by phosphorylation of the β3 subunits.  
Knowing that increased desensitization of α4β3γ2L current caused by PKA-
activation was mediated by phosphorylation of β3 subunit residues Ser 408 and 409, I 
compared PKA effects to direct receptor “phosphorylation” at those sites.  To mimic 
direct phosphorylation, β3 subunit S408 and 409 were mutated to glutamate residues 
to mimic constitutive phosphorylation.  Currents evoked by 8 sec applications of 
GABA (1 mM) to constitutively “dephosphorylated” α4β3AAγ2L receptors and 
“phosphorylated” α4β3EEγ2L receptors were normalized for comparison (Fig. 3.5 A), 
and α4β3EEγ2L currents had an increased rate and extent of desensitization compared 
to α4β3AAγ2L currents, similar to the enhancement of desensitization produced by 
PKA.  I extended my study to determine the effects of the serine mutations on 
desensitization time courses by fitting the macroscopic desensitization decay with 
multiple exponential functions that were sorted into four discrete groups based on the 
fitted time constants: τ1 (< 20 ms), τ2 (20-150 ms), τ3 (150-800 ms) and τ4 (800-5000 
ms) (Fig. 3.5 B) (Bianchi and Macdonald, 2002;Lagrange et al., 2007).  Interestingly, 
there were no differences in the desensitization time constants (Fig. 3.5 B2).  Current 
desensitization was accelerated mainly by increasing the contribution of the fastest 
desensitization component (A1) and small changes in relative proportion of the other 
components as well as a reduced residual current (C) (Fig. 3.5 B1).   
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Figure 3.5. “Direct Phosphorylation” of β3 subunits increased desensitization of 
phasic α4β3γ2L currents. 
 
A, α4β3AAγ2L and α4β3EEγ2L mutant receptors currents evoked by 8 sec application 
of GABA (1 mM) were normalized to the peak currents and overlaid.  Constitutively 
“phosphorylated” mutant α4β3EEγ2L receptor currents had faster and a larger extent 
of desensitization than constitutively “dephosphorylated” mutant α4β3AAγ2L receptor 
currents.  B, The wild type α4β3γ2 and mutant α4β3AAγ2L and α4β3EEγ2L current 
desensitization phases were fit to the sum of four exponential functions, and the time 
constants (B1) and relative exponential component amplitudes (B2) were plotted.  The 
faster desensitization of α4β3EEγ2L receptor currents and slower desensitization of 
α4β3AAγ2L receptor currents were due to different relative amplitudes of fitted 
exponential components and residual currents.  The exponential component time 
constants were unchanged by the mutations.  
96 
This unique pattern of change in desensitization kinetics was also produced by 
8Br-cAMP pre-application to α4β3γ2L and α4β3δ receptors (Fig. 3.6).  There were 
changes (increases or decreases) in the relative amplitudes of the exponential 
components with a reduction of the residual component (Fig. 3.6 A1, B1), with no 
significant change in the time constants (Fig. 3.6 A2, B2).  For α4β3γ2L receptors, the 
major change in desensitization was due to an increase in the relative amplitude of the 
fastest exponential component and small changes in the relative amplitudes of the 
other components, which was same as the results obtained for α4β3EEγ2L.  Thus, the  
 
 
Figure 3.6. PKA-activation altered the kinetic properties of α4β3δ and α4β3γ2L 
receptor phasic currents. 
 
A and B, Fitting results of 2 sec desensitization time course of pre-control (open bar), 
8Br-cAMP treated (solid bar) and post-control (grey bar) α4β3δ (A1, B1) or α4β3γ2L 
(A2, B2) GABAA receptor currents.  Desensitization enhancement of both of phasic 
α4β3δ and α4β3γ2L currents by 8Br-cAMP pre-application was caused by change of 
relative amplitude of fitting exponential components (B1, B2) with constant time 
constant (A1, A2).  
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results suggested that PKA might affect current kinetics of different receptor isoforms 
using a common mechanism to regulate the contribution of individual phases of 
desensitization without affecting their time constants.  However, the similar 
modulation of current kinetics of both α4β3γ2L and α4β3δ receptor currents by PKA 
could not simply be attributed to phosphorylation on the same sites on their common 
β3 subunit, since the β3AA mutation blocked the PKA effects on the desensitization of 
α4β3γ2L, but not α4β3δ, currents.   
 
Discussion 
The aim of the present study was to investigate modulation by PKA of two α4 
subunit-containing GABAA receptors and identify common and different PKA effects 
on different GABAA receptor isoforms.  By executing parallel experiments on α4β3δ 
and α4β3γ2 GABAA receptor isoforms, I was able to identify different effects that 
were produced at multiple activation levels of the receptors.  Combined with a 
previous study of α1β1/3γ2 receptors (Hinkle and Macdonald, 2003), I observed 
consistent modulation by PKA of current desensitization of different receptor 
isoforms including α4β3δ and α4β3γ2 receptors.  The PKA-induced increase of 
desensitization of both α4β3δ and α4β3γ2 currents was due to alteration in the relative 
amplitudes of the exponential components (usually increase of relative amplitude of 
fast phases and decrease of relative amplitude of slow phases) with no change in the 
time constants.  Thus, I propose a kinetic model to explain this unique pattern of 
change in current desensitization that could also explain the modulation of 
spontaneous and tonic currents by PKA as well.   
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Desensitization of phasic α4β3δ and α4β3γ2L currents was enhanced by PKA-
mediated phosphorylation. 
Although desensitization is usually considered inhibitory, current 
desensitization of GABAA receptor can prolong the deactivation time course of IPSCs 
with prolonged charge transfer due to slowing of dissociation of GABA from the 
receptor.  Thus although total charge transfer is reduced, desensitization has an 
important role in determining the amplitude and time course of individual IPSC and of 
IPSCs activated by repetitive stimulation.  PKA modulation of current desensitization 
could have a significant influence on synaptic α4β3γ2 currents and increase the 
plasticity of synaptic inhibition.  PKA modulation of extrasynaptic α4β3δ receptors 
current desensitization also plays a critical role in regulating tonic inhibition.  
Although αβδ receptors that mediate tonic inhibition are relatively non-desensitizing 
receptors, extrasynaptic α4βδ receptors in thalamus and dentate gyrus and 
extrasynaptic α6βδ receptors in cerebellum both exhibited slow, but extensive, 
macroscopic desensitization (Bianchi et al., 2002).  Desensitization of α4βδ and α6βδ 
currents actually preserved a population of receptors in non-conducting states that still 
could access open states in response to endogenous modulators such as 
phosphorylation.  Thus, tonic inhibition mediated by desensitized αβδ receptor 
isoforms has more potential for modulation.   
We have demonstrated differential modulation of steady-state (spontaneous 
and GABA-activated tonic currents) α4β3δ and α4β3γ2L currents by PKA (Tang et al., 
2010).  In Table 2, I summarized the effects by PKA on different components of the 
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different α4β3δ and α4β3γ2L receptor isoform currents.  This is not surprising since 
αβδ and αβγ GABAA receptor currents have distinct properties and are differentially 
regulated by a variety of modulators such as neurosteroids, barbiturates and propofol.  
In this study of two α4 subunit-containing receptors and a previous study of 
α1β1,3γ2L receptors  
 
(Hinkle and Macdonald, 2003), I found similar effects of PKA to increase the rate and 
extent of desensitization of phasic, non-equilibrium macroscopic currents, suggesting 
that PKA always causes more current desensitization and implying a common effect 
on synaptic phasic currents not restricted to specific receptor isoforms.  This 
consistency of PKA alteration of desensitization of different receptor isoforms could 
lead to uncovering a common regulatory mechanism for all GABAA receptors.   
Modulation of α4β3δ and α4β3γ2L current desensitization by PKA was not due to 
phosphorylation of the same sites. 
It was reasonable to ascribe the common effect on α4β3δ and α4β3γ2L current 
desensitization to the conserved PKA sites located in their common β3 subunit.  
However, I concluded the effects of PKA on α4β3δ and α4β3γ2L receptors were not 
Table 2. Comparison of PKA modulation of α4β3δ and α4β3γ2L GABAA receptors. 
Activation level No GABA nM GABA 1 μM GABA 1 mM GABA
Current type Spontaneous GABA-activated tonic Total tonic Phasic  
α4β3δ Increase Decrease No change Increased Desensitization
α4β3γ2L Small increase 
Small 
decrease No change 
Increased 
Desensitization
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due to the same sites in the β3 subunit.  Phosphorylation of the conserved β3 subunit 
sites (S408, 409) was responsible for the majority of the PKA effect on α4β3γ2L 
current desensitization but was not responsible for the PKA effect on α4β3δ current 
desensitization.  The easiest explanation for this phenomenon was that β3 subunit 
serines 408 and 409 were the major targets of PKA in α4β3γ2L receptors, but for 
α4β3δ receptors, other phosphorylation sites were involved in the effect on 
desensitization.  The alternate phosphorylation sites mediating the PKA effect on 
α4β3δ receptors could be located either on the receptor, such as on the δ subunit, or on 
other closely associated proteins.  To test this hypothesis, biochemical experiments to 
distinguish different PKA phosphorylation patterns on α4β3δ and α4β3γ2L receptor 
complexes will be necessary.   
Mechanisms for PKA regulation of spontaneous, tonic and phasic α4β3δ currents 
An allosteric activation scheme has been used previously to explain the 
presence of spontaneous openings (Chang and Weiss, 1999).  In the scheme, a 
spontaneously gated open state (Os) was connected to an unbound closed state (C) 
and each of those states was connected to a GABA-bound open or closed state, 
respectively (kinetic scheme I).  In this cyclic kinetic model, alteration of spontaneous 
opening efficacy (Es = βs/αs) was proposed to account for increased spontaneous 
openings, which for α4β3δ receptor channels obviously must also be modulated by 
PKA.   
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To explain the results, I expanded this kinetic scheme to include desensitized 
states (kinetic scheme II).  The three states in the upper layer of the cyclic model (C, 
Os and Ds) are unbound states, and the three in the lower layer (CG, OG and DG) are 
GABA-bound states.  It was also assumed that all connections between states in the 
two layers were driven by GABA binding.  Thus, in the absence of GABA, channel 
opening rates would depend only on transitions among GABA-unbound states in the 
upper layer of the scheme.  At saturating GABA concentrations, the transitions from 
GABA-unbound states (upper layer) to GABA-bound states (lower layer) is assumed 
to be very rapid (instantaneous) and complete, and thus occupancy of all three states 
in GABA-unbound layer would be immediately converted into the initial occupancy 
of their GABA-bound states in the lower layer at the onset of GABA application.  
This would be followed by redistribution among all GABA-bound states until the 
receptors reach equilibrium in the GABA-bound (lower) layer.  I present this 
oversimplified model to qualitatively illustrate effects of PKA.  Even relatively 
nondesensitizing α1β3δ channels have been shown to have at least two different open 
states and at least five closed states including several desensitized states (Haas and 
Macdonald, 1999).  A more complete model would be needed to quantitatively 
determine current kinetics.   
Kinetic Scheme I 
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Based on the results, PKA activation increased desensitization of both α4β3δ 
and α4β3γ2L currents at 1 mM GABA due to changes in relative amplitudes of the 
different exponential components of desensitization with no changes in time constants.  
Desensitization time constants reflect the rates at which open states relax into 
equilibrium with non-conducting (closed and desensitized) states and do not 
correspond to single microscopic transition rates; rather, they depend on both the 
forward and backward rates of the relevant transitions (Jones and Westbrook, 1996).  
Since receptors at this high GABA concentration should all be fully-liganded, the 
unaltered time constants of desensitization indicate that all of the rates in the GABA-
gated scheme (lower layer) were unchanged.  The coefficients of different 
desensitization exponential components, however, could be altered by changing the 
initial occupancy of different GABA-bound states (CG, OG and DG) at the onset of 
GABA application, which was determined by the equilibrium occupancy of GABA-
unbound states (C, Os and Ds) before GABA application.  It is clear that the 
equilibrium occupancy of spontaneously gated open states (Os) of α4β3δ receptors 
was increased by PKA activation, as well as increased or decreased equilibrium 
occupancy of C and Ds states.  As a result, the current would desensitize with the 
same exponential time constants, but because the distribution of starting states would 
Kinetic Scheme II 
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differ, the relative proportion of receptors relaxing into closed and desensitized states 
would differ with or without activation of PKA.   
In contrast to non-equilibrium current properties such as desensitization, 
steady-state currents (tonic currents) reflect open probabilities at equilibrium and are 
only determined by the rate constants and not by initial occupancy of different states.  
Therefore, no matter how differently receptors enter the GABA-bound scheme from 
GABA-unbound states, the equilibrium current after all the receptors enter the 
GABA-bound states would not be affected.  As 1 μM GABA has been shown to be a 
saturating concentration for steady-state α4β3δ currents (Lagrange and Macdonald, 
2006), it was high enough to drive most unbound receptors to GABA-bound states at 
steady-state.  With most receptors driven to GABA-bound states by 1 μM GABA and 
no alteration of the rate constants in GABA-bound layer, the equilibrium currents 
would be the same before and after PKA activation, consistent with that PKA 
activation produced no change in total tonic α4β3δ current activated by 1 μM GABA. 
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CHAPTER IV 
 
 
PROTEIN KINASE C HAS ADDITIVE EFFECTS ON DESENSITIZATION OF 
α4β3γ2L GABAA RECEPTOR CURRENTS  
 
Introduction  
Among all the phosphorylation sites found in GABAA receptors subunits, the 
most well characterized four sites (β3 S408,409 and γ2L S327,343) are subject to 
PKC phosphorylation.  In cultured cortical neurons, the shared PKA and PKC 
phosphorylation sites in β3 subunits (S408,409) are basally phosphorylated in a PKC-
dependent manner (McDonald et al., 1998;Brandon and Moss, 2000).  For PKA, the 
in vivo and in vitro phosphorylation patterns of GABAA receptors could be different 
and subunit composition-dependent.  For example, the β2 subunit, but not the β1 and 
β3 subunits, lacks the selective binding motif for A-kinase anchoring protein 150 
(AKAP150) to recruit PKA (McDonald et al., 1998;Brandon et al., 2003), and 
therefore, can only be phosphorylated by PKA in vitro.  Compared to the PKA 
phosphorylation sites, the four PKC phosphorylation sites characterized in vitro using 
GST-fusion proteins (S408,409 of the β3 and S327,343 of the γ2L) have been verified 
in native GABAA receptors and in recombinant GABAA receptors expressed in human 
embryonic kidney (HEK)-293 cells or cortical neurons (Brandon et al., 2000;Krishek 
et al., 1994;Moss et al., 1992;McDonald et al., 1998).   
Although the PKC phosphorylation sites were relative clear, studies of 
physiological actions of PKC on GABAA receptor function have reported complex 
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and even contradictory effects.  Activation of PKC by phorbol esters down-modulated 
GABAA receptors (Kellenberger et al., 1992;Krishek et al., 1994;Leidenheimer et al., 
1992;Sigel et al., 1991).  In contrast, the active catalytic domain of PKC (PKM) 
enhanced GABA-stimulated currents in L929 cells (Lin et al., 1994;Lin et al., 1996).  
These conflicting results may have been due to differences in methods used to activate 
PKC and diverse downstream signal pathways activated in different experimental cell 
systems, considering how many different isozymes of PKC might be activated by 
different approaches.  Given that both β and γ2 subunits are PKC substrates, it could 
also contribute to the diversity of PKC modulation if PKC has different efficiency for 
phosphorylation of two subunits or if phosphorylation of one subunit affects the 
interaction of the other subunit with PKC. 
Despite divergent results that have been reported, little effort has been made to 
compare the effects of different protein kinases on GABAA receptor function, and all 
of the studies of modulation by phosphorylation have been focused on α1βγ2 GABAA 
receptors.  In studies of PKA modulation, a common effect on the current kinetics of 
several GABAA receptor isoforms including α4β3δ, α4β3γ2L and α1β1,3γ2L 
receptors was observed.   Therefore, I was interested to determine if phosphorylation 
of the same β subunit serines by PKC caused increased current desensitization as 
PKA-activation did and to determine how the additional phosphorylation of γ2 
subunits by PKC could affect the regulatory effects on β subunits.  In the current 
study, I chose to study the effects of PKC-activation on α4βγ2L receptors.  Although 
α4βγ receptors only comprise a small population of native GABAA receptors in the 
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brain, the α4 subtype is relatively abundant in brain regions involved in both partial 
and generalized epilepsies, including cortex, hippocampus, and thalamus (Pirker et al., 
2000).  Furthermore, the α4 subtype has been consistently shown to be up-regulated in 
multiple animal models of chronic epilepsy (Peng et al., 2004). 
To understand the effects of PKC phosphorylation of β3 and γ2L subunits, I 
used several subunits with mutations of the phosphorylation sites.  For example, the 
full range of PKC phosphorylation of α4β3γ2L receptors could vary from full 
dephosphorylation to full phosphorylation of all four sites; therefore, I used four 
quadruple mutant receptors (α4β3AAγ2LAA, α4β3AAγ2LEE, α4β3EEγ2LAA and 
α4β3EEγ2LEE) to mimic the differential PKC phosphorylation levels.   In the current 
study, I used a rapid-perfusion system to deliver GABA or kinases modulators to 
lifted whole cells with transient transfection of wildtype or mutant GABAA receptors 
subunits.  By using rapid application with a short exchange time (<800 μs), I was able 
to obtain a rigorous study of current kinetics and to compare the modulatory effects of 
PKC on different subunits to PKA effects on different GABAA receptors.   
 
Methods and Materials 
Transient transfection of GABAA receptor subunits into HEK 293T cells 
The cDNAs encoding rat α4, β3, γ2L and δ GABAA receptor subunit subtypes 
were subcloned into the expression vector pCMVNeo.  Sixty mm cell dishes of HEK 
293T cells were co-transfected with 1 or 2 μg of each subunit plasmid with a 1:1:1 
cDNA ratio and 1 μg of the pHook-1 cDNA (Invitrogen, Carlsbad, CA) using a 
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modified calcium phosphate precipitation method.  pHook-1 was used as a marker of 
positively transfected cells, which were selected 24 hrs after transfection by magnetic 
hapten coated beads.  In some experiment, mutated β subunits were transfected in 
place of wildtype β subunits.  All point mutations in rat β3 subunit constructs were 
made using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) 
and were confirmed by DNA sequencing.   
Electrophysiological recordings 
All GABAA receptor currents were obtained using a lifted whole-cell voltage-
clamp recording technique.  Patch pipettes (resistance1-1.5 MΩ) were pulled from 
borosilicate capillary glass (World Precision Instruments, Sarasota, FL) on a P-2000 
laser puller (Sutter Instrument Co., San Rafael, CA) and filled with an internal 
solution containing 153 mM KCl, 1 mM MgCl2, 5 mM EGTA, 10 mM HEPES pH 
7.3, with 4 mM ATP added on the day of recording.  The cells were subjected to 
continuous background perfusion of the external solution consisting of 142 mM NaCl, 
8 mM KCl, 6 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.4.  All 
experiments were performed at room temperature.  Signals were processed by using 
200B amplifier (Molecular Devices, Union City, CA) in voltage-clamp mode.  All 
cells were voltage clamped at -20 mV during recordings.   
GABA and drug application system 
GABA and kinase modulators were delivered through a four parallel glass 
square barrel to HEK 293T cells using a modified SF-77B Perfusion Fast-Step 
application system (Warner Instrument Corp., Hamden, CT) (Hinkle et al., 2003).  
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The drug application was initiated by an analog pulse triggered by the pClamp 9.2 
software (Axon Instruments, Union City, CA) that caused the motor of the Warner 
Fast-Step to reposition the multi-barrel array from one barrel to another (e.g., external 
solution to GABA).  By using this modified application system, I consistently 
obtained rise times (10–90%) less than 800 μsec with open-tip electrodes stepped 
from standard bath solution to 90% bath solution. 
A high concentration of GABA (1 mM) was applied to lifted whole cells for 2 
sec or 8 sec.  Between every two applications of GABA, external solution was applied 
for at least 3 min to ensure maximal recovery from the GABA exposure.  I also added 
pre-application steps to the protocol for modulator experiments to enable us to pre-
apply a membrane-permeable modulator such as PMA.  In the pre-application 
experiments, GABA was first applied to lifted cells expressing wildtype or mutant 
GABAA receptor subunits as an initial pre-control.  After washout of GABA, the PKC 
activators or inhibitors were applied for different amounts of time to produce the 
effects and then the lifted cell was stepped back into external solution for a brief 
washout (3 sec) of any residual external PKC modulators before it was subjected to a 
second GABA application.  This second GABA-activated current recorded 
immediately after a pre-application was defined as the experimental current.  After the 
second GABA application, the cell was washed in external solution for more than 6 
min before it was subjected to the final GABA application to evoke a post-control 
current.  Due to the variability of currents among cells, the experimental currents were 
normalized to their matched pre-control currents so that differences made by pre-
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application were shown in percentage.  To control for current run-down during the 
whole set of pre-application experiment that were recorded over 10 min, I superfused 
cells with external solution during the pre-application process.  Significant differences 
between the experimental pre-application group and the external control group were 
used to identify specific and significant effects caused by PKC modulation. 
Kinase modulation 
The effect of PKA and PKC on GABAA receptor currents was assessed by 
using their activators and inhibitors (Calbiochem, San Diego, CA).  PKA and PKC 
were activated by extracellular 8-Br-cAMP (500-1000 μM; 8-Bromoadenosine-3',5'-
cyclic monophosphate, Sodium Salt) and DOG (1-10 μM; sn-1,2-dioctanoylglycerol), 
respectively.  PKA activity was blocked using extracellular application of H-89 (10 
μM; N-[2-((p-Bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide, 2HCl), and 
PKC activity was blocked by Calphostin C (1 μM).  In some experiments, the specific 
PKA inhibitory peptide, PKI (100 μg/ml), and the specific PKC inhibitory peptide, 
PKCI19-31 (50 μM) as well as some less specific but more potent protein kinase 
inhibitors like staurosporine were applied intracellularly by including them in the 
recording pipette to block PKA and PKC activity, respectively.   
Mutagenesis 
Subunit phosphorylation sites (β3 S408, 409 and γ2L S327, 343) were mutated 
using the QuikChange Site-Directed Mutagenesis kit (Stratagene) to either block 
receptor phosphorylation entirely with alanine substitutions or to mimic 
phosphorylation with glutamate substitutions.  In some experiments, deletions of 
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portions of GABAA receptor subunits like the binding motif of PKC were introduced 
to β subunits to interrupt the phosphorylation produced by protein-protein interaction. 
Data analysis 
Macroscopic currents were low pass filtered at 2 kHz, digitized at 10 kHz, and 
analyzed using pClamp9.2 software.  For comparison of desensitization among 
currents, currents were normalized first to their peak value (defined as a maximal 
response of 1).  I plotted the relative residual current, which was the residual current 
at the end of a prolonged GABA application divided by the current peak value and 
used it as indicator of the overall extent of desensitization.  In addition, the 
desensitization time course of some phasic currents activated by 1 mM GABA was 
fitted to a sum of exponential functions (Lagrange et al., 2007).  The entire 
desensitization time course was fitted with one to five exponential functions using the 
Levenberg–Marquardt least squares method with the form ∑An*e-t/τn + C, where n 
was the number of exponential components, t was time, A was relative amplitude of a 
given component at time 0, τ was the time constant for a given component, and C was 
a constant to account for residual current.  The number of exponential functions 
required to obtain the best fit was determined when adding an additional component 
did not significantly improve the fitting result based on an F test automatically 
performed by the analysis software on the sum of squared residuals.  All the two 
second and eight second GABA-activated phasic currents were fitted best with two to 
four exponential functions.  All numerical and bar graph data were expressed as mean 
± standard error.  Statistical significance was compared between kinase modulator 
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group and control solution group or between wild-type and mutant condition being 
examined.  Statistical analyses were performed using Graph Pad Prism 4.  Student’s 
paired or unpaired t tests were used to compare pairs of data, or appropriate ANOVA 
analyses were used for comparing three or more groups.  Statistical significance was 
taken as: *p<0.05, **p <0.01, or ***p<0.001.  
 
Results 
 “Phosphorylation” of both β3 and γ2L subunits had additive effects on increasing 
desensitization of α4β3γ2L currents.   
The β3 subunit serines S408 and S409 and the γ2L subunit serines S327 and 
S343 subunits were mutated to alanine or glutamate residues either to block 
phosphorylation (S>A) or to mimic constitutive phosphorylation (S>E).  Similar 
effects to increase α4β3γ2L current desensitization were observed with serine to 
glutamate mutation of the phosphorylation sites in both β3 (Fig. 4.1 A) and γ2L (Fig. 
4.1 B) subunits. The mutant receptors with glutamate substitution (gray traces) in both 
β3 (Fig. 4.1 A1) and γ2L (Fig. 4.1 B1) subunits had faster and more extensive 
desensitization compared to currents from receptors with the corresponding alanine 
mutations (Fig. 4.1 A1, B1; black traces).  I used the area under normalized currents 
as an indication of the relative rate and extent of current desensitization.  If a 
treatment changes current amplitude but not desensitization, it will have no effect on  
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Figure 4.1.  “Phosphorylation” of β3 and γ2L subunits respectively increased the 
desensitization of α4β3γ2L currents. 
 
A1 and A2, Representative α4β3AAγ2L and α4β3EEγ2L currents evoked by 1 mM GABA 
were normalized and superposed for comparison (A1).  Their current area under the 8 sec 
desensitization curve were measured and compared to wildtype α4β3γ2L receptor (A2).  
B1 and B2, Representative α4β3γ2LAA and α4β3γ2LEE currents evoked by 1 mM GABA 
were normalized and superposed for comparison (B1).  Their current area under the 8 sec 
desensitization curve were measured and compared to wildtype α4β3γ2L receptor (B2).   
 
the area under the normalized currents, but if it increases the rate or extent of 
desensitization, it will reduce the area.  The areas of currents evoked by 8 sec GABA 
applications (1 mM) to α4β3EEγ2L (Fig. 4.1 A2, gray bar) and α4β3γ2LEE (Fig. 4.1 B2, 
gray bar) receptors were slightly less than the areas of currents evoked from 
α4β3AAγ2L (Fig. 4.1 A2, solid bar) and α4β3γ2LAA (Fig. 4.1 B2, solid bar) receptors.  
Wildtype α4β3γ2L receptor currents (Fig. 4.1 A2, B2, open bars) had areas that were 
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intermediate between those currents evoked from receptors containing subunits with 
either glutamate or alanine mutations.   
Next, I studied current desensitization of α4β3γ2L receptors containing 
“dephosphorylated” and “phosphorylated” subunits combined in four ways: 
β3AAγ2LAA, β3AAγ2LEE, β3EEγ2LAA, β3EEγ2LEE.  The α4β3AAγ2LAA receptor was 
considered to mimic full dephosphorylation of both β3 and γ2L subunits, the 
α4β3AAγ2LEE and α4β3EEγ2LAA receptors to mimic only phosphorylated γ2L or β3 
subunits, respectively, and the α4β3EEγ2LEE receptor to mimic full phosphorylation of 
both subunits.  Currents evoked by 8 sec applications of GABA (1 mM) to wildtype 
and the four mutant α4β3γ2L receptors were compared (Fig. 4.2 A).  α4β3EEγ2LEE 
currents desensitized more rapidly and to a greater extent than wildtype currents and 
α4β3AAγ2LAA currents desensitized less rapidly and to a lesser extent than wildtype 
currents.  α4β3AAγ2LEE and α4β3EEγ2LAA currents desensitized at an intermediate rate 
and to an intermediate extent.  The normalized current areas of the four mutant 
receptors decreased as the number of S>E mutation increased (Fig. 4.2 B), suggesting 
an additive effect of each “phosphorylated” subunit to increase desensitization.  
Wildtype α4β3γ2L receptor currents desensitized at a rate and extent that was similar 
to the partially “phosphorylated” α4β3AAγ2LEE and α4β3EEγ2LAA receptor currents, 
suggesting that wildtype α4β3γ2L receptors were likely partially phosphorylated 
under basal conditions in HEK293T cells.  
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“Phosphorylation” of both β3 and γ2L subunits additively increased the relative 
portion of fast components of desensitization without affecting desensitization time 
constants.   
To understand the mechanism of increased desensitization produced by PKC-
activation, I studied the desensitization kinetic properties of wildtype α4β3γ2L and 
four quadruple-mutation receptors (α4β3AAγ2LAA, α4β3AAγ2LEE, α4β3EEγ2LAA, 
α4β3EEγ2LEE) currents.  The desensitization time course of all mutant and wildtype 
α4β3γ2L receptor currents were fitted best by four exponential components.  
Exponential relative proportions (Fig. 4.3 A), but not time constants (Fig. 4.3 B), were 
altered by the mutations.  “Phosphorylation” of the β3 and γ2L subunit serines by 
glutamate substitutions caused an increase in the relative proportion of the fastest 
component (A1) and a decrease in the relative proportion of the slowest component 
(A4), resulting a smaller residual current (C) compared to wildtype currents.  
“Dephosphorylation” of the β3 and γ2L subunit serines by alanine substitutions 
resulted in the opposite result, a decrease in the relative proportion of the fastest 
component (A1) and an increase in the relative proportion of the slowest component 
(A4) with a larger residual currents (C), compared to wildtype currents.  Interestingly, 
all the time constants of the four components of mutant receptors were the same as 
wildtype receptor.  The slight increase of α4β3AAγ2LAA receptor in τ1, the fastest time 
constant, might not indicate a real difference but might have been due to a technical 
error occurring when the one component has only a very small proportion in the 
whole fitting or due to an error caused by multiple comparisons.  This pattern of  
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Figure 4.2.  “Phosphorylation” of both β3 and γ2L subunits had additive effect on 
increasing the desensitization of α4β3γ2L current. 
 
A, Representative wildtype α4β3γ2L and α4β3AAγ2LAA, α4β3AAγ2LEE, α4β3EEγ2LAA 
α4β3EEγ2LEE current were evoked by 1 mM GABA applied for 8 sec.  B, The current 
areas under the 8 sec desensitization curve were plotted.  Current area decreased with 
increased numbers of glutamates to mimic phosphorylation.  Asterisks indicated 
significant differences compared to wildtype current areas.   
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kinetic changes was reported with PKA modulation of α4β3γ2L current 
desensitization mediated by phosphorylation of β subunits in chapter III.  The 
quadruple mutation further suggested that phosphorylation of β3 and γ2 subunits 
mediate similar and additive effects to increase current desensitization. 
 
Figure 4.3.  “Phosphorylation” of β3 and γ2L subunits additively increased the 
relative proportion of fast desensitization components without affecting the time 
constants.  
 
A, Relative amplitudes plus residual currents and B, their corresponding time 
constants of each component were obtained from fitting the desensitization time 
courses were plotted.  Asterisks indicated significant differences compared to 
wildtype.   
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PKC activation increased α4β3γ2L current desensitization.   
To determine PKC effects on α4β3γ2L current kinetics, I applied both PKC activators 
and inhibitors using the pre-application protocol and compared the currents to those 
obtained with pre-application of external control solution (Fig. 4.4 A1).  The 
normalized current areas evoked by 2 sec applications of GABA (1 mM) after pre-
application (Fig. 4.4 B, solid bars) were plotted as a percentage of their pre-control 
areas (Fig. 4.4 B, open bars).  Pre-application of external solution (Fig. 4.4 A1) did 
not cause any obvious change of current area (97.9 ± 2.2%, n=12; Fig. 4.4 B1, solid 
bar) and only a slight decrease of current area associated with rundown after a long 
time wash (86.1 ± 3.5%, n=12; Fig. 4.4 B1, gray bar).  I used both phorbol ester 
(PMA) and diacylglycerol analogue (sn-1,2-dioctanoylglycerol, DOG) to activate 
PKC.  The PKC inactive phorbol analogue (4-α phorbol) also did not alter current 
desensitization (Fig. 4.4 A2) with 95.1 ± 6.4% (n=11; Fig. 4.4 B2, solid bar) 
normalized area as a percentage of the pre-control area.  Pre-application of both PMA 
(1 μM, Fig. 4.4 C1) and DOG (1-10 μM, Fig. 4.4 D1) for 90 sec led to faster 
desensitization accompanied with a reduced peak current (data not shown).  Pre-
application of PMA (1 μM) reduced normalized current area to 59.6 ± 7.3% (n=7; p < 
0.001; Fig. 4.4 C2, solid bar) compared to the pre-control currents.  However, this 
effect of PMA was not reversible (Fig. 4.4 C1, silver trace), resulting in 52.2 ± 6.8% 
(n=7; p < 0.001; Fig. 4.4 C2, gray bar) current area left after extensive wash.  The 
other PKC activator, DOG (1 μM), reversibly increased current desensitization (Fig. 
4.4 D1, sliver trace), and decreased the normalized current area to 61.3 ± 2.3% (n=40;  
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Figure 4.4.  PKC activation increased the desensitization of α4β3γ2L current.   
A, B, C and D, Pre-application of external control (A), PKC inactive analogue 4-α 
phorbol (B), and two PKC activators, PMA (C) and DOG (D) to lifted HEK293T cells 
expressing α4β3γ2L GABAA receptors.  Pre-control (green), pre-application treated 
(black) and post-control (gray) α4β3γ2L currents (2 sec) evoked by 1 mM GABA 
were normalized to the peak currents and were superposed to facilitate comparison of 
the rate and extent of desensitization (A1, B1, C1 and D1).  Current area under the 2 
sec desensitization curve of pre-application treated (solid bar) and post-control (gray 
bar) were normalized to pre-control (open bar) and plotted in histogram (A2, B2, C2 
and D2).  Asterisks indicated significant differences compared to corresponding pre-
control group.  
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p < 0.001; Fig. 4.4 D2, solid bar).  The lack of effect of the inactive phorbol 4-α 
phorbol as well as similar area reduction by two different PKC activators (PMA and 
DOG) suggested that the increased α4β3γ2L current desensitization was due to PKC 
activation.  
Next, I applied different concentrations of the PKC activator DOG (1, 5, 10 μM) to 
achieve low to high activation of PKC and also pre-applied the PKC inhibitor 
Calphostin C (1 μM) to down-regulate basal PKC activity (Fig. 4.5).  Compared to the 
pre-application of external solution (96.4 ± 2.1%, n=16; Fig. 4.5, open bar), pre-
application of Calphostin C (1 μM, 3 min) increased current area to 148.8 ± 2.0% 
(n=8, p < 0.001; Fig. 4.5, solid bar), while pre-application of DOG (Fig. 4.5, gray bars)  
 
 
Figure 4.5.  Pre-application of PKC activator DOG increased the relative proportion 
of fast desensitization component without affecting all the time constants.   
 
Calphostin C, external control and increasing concentrations of DOG were pre-
applied to wildtype α4β3γ2L GABAA receptors.  The current area after each pre-
application was normalized to its pre-control current and plotted in the histogram.  
Asterisks indicated significant differences compared to external control.   
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caused a DOG concentration-dependent reduction of current areas (at 1 μM, 61.3 ± 
2.3%. n=40, p < 0.001; at 5 μM, 35.6 ± 2.9%. n=44, p < 0.001; at 10 μM, 18.5 ± 4.7%. 
n=40, p < 0.001).  By comparing current areas after treatment with a PKC inhibitor 
and with increasing concentrations of PKC activators, I observed, a negative 
relationship of current area with PKC activation, which indicated a positive 
correlation of current desensitization with PKC activation level.  The fact that currents 
desensitized more extensively at higher PKC activation levels was also consistent 
with the additive effect of the quadruple mutation of PKC phosphorylation sites to 
increase current desensitization.  
To further compare the effects of PKC-activation to those of the quadruple 
mutation, I also fitted the desensitization of the pre-control (open bars), DOG-treated 
(solid bars) and post control (gray bars) currents with multiple exponential functions 
(Fig. 4.6).  Consistently, I observed a change in current kinetic propertiesproduced by 
PKC-activation that was similar to that produced by the phosphorylation site 
mutations.  The relative amplitudes of the four components were reversibly altered by 
DOG (1 μM) with a significant increase of the proportion of the fastest component 
(A1) and a significant decrease of the slowest component (A4) and residual currents 
(C) (Fig. 4.6 A).  None of the time constants of the four components were altered 
significantly (Fig. 4.6 B).  Based on comparable findings with PKC-activation and 
phosphorylation site mutation, I propose that PKC can phosphorylate β3 and γ2L 
subunits and cause an increase of α4β3γ2L current desensitization.  When PKC is 
activated leading to phosphorylation of both β3 and γ2L current to a higher 
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stoichiometry, the current desensitization will be additively increased corresponding 
to the number of subunits being phosphorylated.  
 
 
Figure 4.6.  PKC enhancement of α4β3γ2L current desensitization was concentration-
dependent.   
 
A and B,  Current areas of pre-control (open bar), pre-application treated (solid bar) 
and post-control (gray bar) showing the relative amplitude (A) and time constant (B) 
of four desensitization components were plotted.  Asterisks indicated significant 
differences compared to wildtype. 
 
PKC activation by DOG extensively increased the desensitization of α4β3γ2L 
receptor currents only partially due to phosphorylation of β3(S408, 409) and 
γ2L(S327, 343) subunits.   
Although the results of the mutation at known phosphorylation sites can be well 
explained by the effects of DOG at low concentration like 1 μM, the increase of 
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desensitization by 10 μM DOG was too extensive even compared to the 
desensitization of fully “phosphorylated” α4β3EEγ2LEE receptors.  This raised a 
concern that the effects of high concentrations of DOG may have arisen from  
 
Figure 4.7.  Mutation of the PKC sites on β3(S408,409) and γ2L(S327,343) subunits 
did not block entirely the effect of PKC activator DOG.   
 
A,  Pre-application of DOG still cause increase of desensitization of α4β3AAγ2LAA 
currents.  Pre-control (green), pre-application treated (black) and post-control (gray) 
α4β3AAγ2LAA currents (2 sec) evoked by 1 mM GABA were normalized to the peak 
currents and were superposed.  B, Comparison of normalized current area of α4β3γ2L 
(solid bars) and α4β3AAγ2LAA (open bars) current after pre-application of external 
control or three concentration of DOG. 
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mechanisms independent of phosphorylation of the four β3 and γ2L subunit PKC sites 
and if these effects are PKC-specific.  First, to determine if the effects by DOG are 
mediated by the four β3 and γ2L subunit PKC sites, I applied three different 
concentrations (1, 5, 10 μM) of DOG to cells expressing α4β3AAγ2LAA receptors and 
compared them to the effects on wildtype α4β3γ2L receptors (Fig. 4.7).  DOG still 
had clear effects on α4β3AAγ2LAA currents.  Concentration-dependent effect on both 
wildtype α4β3γ2L currents (Fig. 4.7 B, solid bars) and mutant α4β3AAγ2LAA currents 
(Fig. 4.7B, open bars) were observed after pre-application of 1, 5 or 10 μM DOG 
(61.3 ± 2.3%, 35.6 ± 2.9%, 18.5 ± 4.7% vs. 63.4 ± 3.7%, 49.6 ± 4.8%, 26.1 ± 4.4%).  
Normalized current areas of α4β3γ2L and α4β3AAγ2LAA receptors only became 
slightly significantly different at 5 μM (35.6 ± 2.9%, n=44 vs. 49.6 ± 4.8%, n=21; p < 
0.5) and 10 μM (18.5 ± 4.7%, n=9 vs. 26.1 ± 4.4%, n=10; p > 0.5), indicating that 
phosphorylation of the β3 subunit serines 408 and 409 and γ2L subunit serines 327 
and 343 may only contribute marginally to the effects of DOG.  
To determine PKC-specific effects of DOG, I applied PKC inhibitors in the 
pipette solution to suppress PKC activities inside the cell and subjected those cells to 
the DOG pre-application protocol (Fig. 4.8).  I tested both the specific PKC inhibitory 
peptide (PKCI19-31, 50 μM) and the non-specific PKC inhibitors (staurosporine, 5 μM) 
to block the effect of DOG at 1 (Fig. 4.8, solid bars) and 5 (Fig. 4.8, gray bars) μM.  
Both inhibitors significantly reduced the effect of DOG at 1 μM.  Internal PKCI19-31 
reduced the effect of pre-application of 1 μM DOG (77.4 ± 2.9%, n=17 vs. 61.3 ± 
2.3%, n=40; p < 0.01), although there was still a significantly smaller current area left 
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after DOG pre-application than with external solution pre-application (77.4 ± 2.9%, 
n=17 vs. 96.4 ± 2.1%, n=16; p < 0.01).  Staurosporine is a potent inhibitor of PKC, 
but also a non-specific inhibitor that prevents ATP binding to the kinase and has a 
high affinity for other protein kinases including PKA, CaMKII, PKG, tyrosine kinase 
and myosin light chain kinase (MLCK).  Internal staurosporine led to a greater 
reduction of the effect of 1 μM DOG.   
 
 
Figure 4.8.  PKC inhibitors reduced effects of DOG pre-application on increasing the 
desensitization of α4β3γ2L current.   
 
1 and 5 μM DOG were pre applied to cells expressing wildtype α4β3γ2L GABAA 
receptors in the absence or presence of PKCI19-31 (50 μM) or staurosporine (5 μM). 
Normalized current areas to their pre-contorl current in each pre-application condition 
were plotted. 
 
The current area with DOG and staurosporine application was not significantly 
different from that obtained with application of the external control (91.9 ± 1.8%, 
n=17 vs. 96.4  ± 2.1%, n=16; p >0.5).  At 5 μM DOG, internal PKCI and 
staurosporine showed similar trends, with less inhibition by PKCI than by 
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staurosporine.  However, at this higher concentration of DOG, PKCI did not decrease 
significantly the area reduction produced by pre-application of 5 μM DOG (44.9 ± 
5.2%, n=14 vs. 35.6 ± 2.9%, n=44; p >0.5), and staurosporine did not block the entire 
effect of DOG at 5 μM (60.2 ± 3.1%, n=14 vs. 5 μM DOG, 35.6 ± 2.9%, n=44; p < 
0.01 and vs. external control, 96.4  ± 2.1%, n=16; p >0.5).  It seemed that the 
inhibition of PKC by a chosen concentration of inhibitor had not been saturated, so 
that the more potent PKC non-specific inhibitor staurosporine always caused more 
inhibition of the DOG effect than that of the more specific but less potent PKC 
inhibitory peptide.  It is possible that the extensive current area reduction produced by 
high concentrations of DOG might have been blocked completely by higher 
concentrations of PKCI or staurosporine, but these concentrations are very difficult to 
achieve since they disrupt patch formation and severely impair recording.  Therefore, 
it remains uncertain if the effects of DOG at high concentrations are PKC specific or 
non-specific. 
Enhancement of α4β3γ2L current desensitization by the PKC activator DOG was 
not due to additional PKC sites located specifically in α4 subunits.   
In several studies, β3 subunit serines 408 and 409 and γ2L subunit serines 327 
and 343 have been demonstrated to be the major sites of PKC phosphorylation of the 
two subunits, while α1 subunits have been shown to be poor PKC substrates.  
Although α4 subunits contain consensus sequences for PKC phosphorylation 
(Macdonald, 1995), and PKC modulation has been implied in many studies of the 
mechanisms of α4 subunit up-regulation, there is no direct evidence of PKC 
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phosphorylation of α4 subunits.  To determine if PKC sites in α4 subunits could 
contribute to the extensive increase of desensitization by DOG on α4β3AAγ2LAA 
currents, I also pre-applied DOG to wildtype α1β3γ2L (Fig. 4.9 A1) and mutant 
α1β3AAγ2LAA (Fig. 4.9 B1) receptors.  The time course of desensitization was similar 
for α1β3γ2L and α4β3γ2L currents, and the reduction in α1β3γ2L current area (to 
21.1 ± 4.4%, n=3, Fig. 4.9 A2, solid bar) after pre-application of 10 μM DOG was  
 
 
Figure 4.9.  PKC activation increased the desensitization of α1β3γ2L and 
α1β3AAγ2LAA currents.   
 
A and B, Pre-application of 10 μM DOG to α1β3γ2L (A) and α1β3AAγ2LAA (B) 
GABAA receptors.  Pre-control (green), pre-application treated (black) and post-
control (gray) α1β3γ2L (A1) or α1β3AAγ2LAA (B1) currents evoked by application of 
1 mM GABA for 2 sec were normalized to their peak currents and were superposed. 
Current area under the 2 sec desensitization curve of pre-application treated (solid 
bar) and post-control (gray bar) were normalized to pre-control (open bar) and plotted 
in a histogram (A2 and B2).  Asterisks indicated significant differences compared to 
the corresponding pre-control group. 
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also similar to that of α4β3γ2L currents (to 18.5 ± 4.7%).  Pre-application of DOG (10 
μM) also produced a similar reduction of α1β3AAγ2LAA current area (to 16.3 ± 2.6%, 
n = 4, Fig. 4.9 B2, solid bar), suggesting that the effects of DOG on current 
desensitization were not due to specific PKC phosphorylation of α4 subunits.  If the 
residual DOG effects on α1/4β3AAγ2LAA currents were due to phosphorylation of 
extra sites beside the four investigated serines, they are not likely to be PKC sites 
located specifically in α4 subunits. 
PKC βII binding sequences in β subunits were not required for mediating the effect 
of DOG on GABAA receptor current desensitization. 
There are numerous examples of protein kinase modulation that were 
independent of receptor phosphorylation (Chapell et al., 1998;Connolly et al., 
1999;Filippova et al., 2000), and so it is not surprising to discover that the β3 and γ2L 
subunit phosphorylation site mutations did not block the entire effect of DOG.  
Introduction of a charged phosphate residue to a receptor protein could have direct 
effects on receptor function by altering protein conformation.  However, sometimes, 
receptor modulation is not directly due to the charge transfer.  For example, PKC 
modulation of receptor internalization is mediated by the phospho-dependent binding 
of the clathrin AP2 adaptor complex to GABAA receptors (Kittler et al., 2005;Kittler 
et al., 2008).  Indeed, phosphorylation of GABAA receptors or receptor-associated 
proteins that affect formation of protein complexes might affect multiple receptor 
properties through several different pathways.  Because the receptor occurs in a 
dynamic protein complex, I should not focus on only receptor phosphorylation, but 
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should also determine how PKC could affect the whole receptor-protein complex.  
One receptor-protein interaction affected by PKC phosphorylation is the kinase itself.  
PKCβII was found to be associated with GABAA receptors by directly binding to all β 
subunits itself or indirectly through an anchoring protein RACK1, and this binding is 
impaired by phosphorylation of β subunits and decreased with PKC activation 
(Brandon et al., 2002).   
To determine if disruption of PKCβII binding to GABAA receptors had any 
effect on GABA-activated currents, I deleted the PKCβII and/or RACK1 binding 
sequences located adjacent to each other in the M3-M4 loop of the β2 subunit to 
generate three mutant β2 subunits: β2(PKCΔ), β2(RACKΔ) and β2(PKC+RACKΔ).  
I co-transfected α4 and γ2L subunits with wildtype β2 or one of the three mutant β2 
subunits.  Only α4β2(PKC+RACKΔ)γ2L currents with the deletion of both β2 subunit 
motifs showed a slight increase of current desensitization.  The normalized current 
areas of α4β2(PKC+RACKΔ)γ2L receptor currents (607.3 ± 79.2 ms, n=10; Fig. 4.10 
B, open bar) were significantly smaller than those of α4β2γ2L receptor currents 
(882.7 ± 115.0 ms, n=9, p < 0.5; Fig. 4.10 B, solid bar), but neither α4β2(PKCΔ)γ2L 
or α4β2(RACKΔ)γ2L currents from receptors with deletion of only one motif were 
different from wildtype α4β2γ2L currents (Fig. 4.10 A).  This is consistent with a 
report that phosphorylation of β subunits reduced PKC binding to the subunit 
(Brandon et al., 2002), since deletion of PKC and RACK binding motifs and 
phosphorylation of β subunits both disrupted binding of PKC to the receptor.  
Therefore, faster desensitization of α4β2(PKC+RACKΔ)γ2L currents similar to that  
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Figure 4.10.  Deletion of PKC and RACK binding sequence in β2 subunit also caused 
an increase of the desensitization of α4β2γ2L current.   
 
A, Representative current of wildtype α4β2γ2L and α4β2(PKCΔ)γ2L, 
α4β2(RACKΔ)γ2L, α4β2(PKC+RACKΔ)γ2L, α4β2(α1 loop swap)γ2L mutant 
receptors were stimulated by 1 mM GABA for prolong 2 sec. B, The current area 
under the 2 sec desensitization curve were plotted in histogram.  Asterisks indicated 
significant differences compared to wildtype. 
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produced by the “phosphorylated” mutant receptor are consistent.  However, the 
double deletion of PKC and RACK binding sequence only caused a small reduction of 
current area.  I obtained a mutant subunit with  replacement of the β2 subunit M3-M4 
loop by the α1 subunit M3-M4 loop (β2(α1 loop swap)) (Dr. Wen-yi Lo). 
 
 
Figure 4.11.  Deletion of PKC and RACK binding sequences in the β2 subunit did not 
eliminate DOG effects to increase desensitization of α4β2γ2L and α1β2 currents.  
 
A1 and A2, Pre-application of 5 μM DOG still increased desensitization of 
α4β2(PKC+RACKΔ)γ2L (A1) and α1β2(PKC+RACKΔ) (A2) GABAA receptors.  
Pre-control (green), pre-application treated (black) and post-control (gray) 
α4β2(PKC+RACKΔ)γ2L or α1β2(PKC+RACKΔ) currents (2 sec) evoked by 1 mM 
GABA were normalized to the peak currents and were superposed.  B1 and B2,  
Current areas of different receptor isoforms under the 2 sec desensitization curve after 
pre-application of DOG were normalized to pre-control (open bar) and plotted in a 
histogram. 
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α4β2(α1 loop swap)γ2L receptors had substantially decreased current area (215.1 ± 
35.2 ms, n=6, p < 0.001; Fig. 4.10 B, gray bar), suggesting that the M3-M4 loop of 
β2 subunit was important in shaping macroscopic current desensitization, and that 
PKC binding had a minor effect on determining the desensitization rate.  When I 
applied DOG (5 μM) to α4β2(PKC+RACKΔ)γ2L receptors, the current 
desensitization was still increased significantly (Fig. 4.11 A1).  Current area after 
DOG pre-application to α4β2(PKC+RACKΔ)γ2L receptors (31.0%, n=1, Fig. 4.11 B1, 
gray bar) was similar to that of wildtype α4β2γ2L receptors (38.5 ± 10.5%, n=4, Fig. 
4.11 B1, gray bar).  Since γ2 subunits might also mediate protein-protein interactions 
with PKC, I applied DOG (5 μM) to α1β2, α1β2(PKCΔ) and α1β2(PKC+RACKΔ) 
receptors (Fig. 4.11 A2).  However, neither of the two mutant α1β2 receptors (69.9 ± 
5.2%, n=6, α1β2(PKCΔ), striped bar and 56.7 ± 7.4%, n=3, α1β2(PKC+RACKΔ), 
gray bar, Fig. 4.11 B2) was less insensitive to DOG than wildtype α1β2 receptors 
(69.1 ± 4.2%, n=7, Fig. 4.11 B2, solid bar), implying again that PKC binding to the 
receptor was not necessary for increased current desensitization caused by DOG. 
Activation of other kinases may underlie a portion of the enhancement of current 
desensitization produced by DOG. 
There is no clear evidence that the increased desensitization caused by DOG is 
PKC- specific or partially PKC-specific.  It is possible that other protein kinases could 
be activated by DOG, dependent on or independent of PKC activation.  There is 
substantial evidence that Ser/Thr and tyrosine kinases can interact.  For example, PKC 
has been shown to influence the activity of the non-receptor tyrosine kinase Src in 
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neurons (Lu et al., 1999).  Meanwhile, RasGPR1 was shown to be a high affinity 
diacylglycerol/phorbol-ester receptor, which acts as an activator of Ras and thus 
stimulates the Ras/Raf/MEK/ERK pathway.  Thus, DOG could activate tyrosine 
kinases with or without PKC activation, to allow tyrosine phosphorylation of GABAA 
receptors, which might contribute to the effect on α4β3AAγ2LAA receptors.   
To determine if other protein kinases were activated by DOG, the tyrosine 
kinase inhibitor, genistein (1 μM) or the CaMKII inhibitor, KN-93 (1 μM) was co-
applied with DOG (5 μM).  Co-application of genistein (46.8 ± 7.6%, n=5) or KN-93 
(25.0%, n=1) did not decrease significantly the reduction in current area caused by 
DOG (35.6 ± 2.9%, n=44) (Fig. 4.12).  There might be a slight decrease of area  
 
 
Figure 4.12.  Different protein kinase inhibitors were used to reduce the effects of 
DOG pre-application on increasing the desensitization of α4β3γ2L current. 
 
DOG (5 μM) was pre applied to cells expressing wildtype α4β3γ2L GABAA receptors 
with co-application of KN-93 (1 μM, horizontal striped bar) or genistein (1 μM, 
vertical striped bar) or with inclusion of internal PKCI19-31 (50 μM, gray bar) or 
staurosporine (5 μM, solid bar).  Normalized current areas to their pre-control currents 
in each pre-application condition were plotted. 
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reduction by co-application of genistein with DOG.  Higher concentrations of 
genistein and longer pre-incubation time prior to DOG application might cause 
significant reduction of the DOG effect.   
Using different receptor isoforms, mutant subunits and multiple protein kinase 
inhibitors, it is still not clear what mechanism is responsible for the major DOG 
effects on current desensitization.  The extensive increase of desensitization produced 
by DOG was not mimicked by S to E mutations to produce full “phosphorylation” of 
all known PKC sites and was not blocked entirely by the investigated protein kinase 
inhibitors.  A similar extent of increased desensitization was only observed with an 
increased calcium concentration in the internal solution.  When the cells were broken 
into with an internal solution containing 5 mM Ca++ to form whole cell patches, 
increased current desensitization and decreased current amplitude were recorded that 
increased over several minutes (Fig. 4.13 A , normalized currents in the black circle).  
If I recorded with internal control solution that contained no calcium plus EGTA 
chelator, the initial current area (1 min after patch formation) averaged 1081 ± 148.3 
(n=11, Fig. 4.13 B, red dot) and was relatively stable for up to 30 min.  If I recorded 
with 2 mM Ca++ in the internal solution, the initial normalized current area (1 min 
after patch formation) was similar to internal control currents (1065 ± 196.8, n=2, Fig. 
4.13 B, gray dot) but quickly declined (at 5 min) after patch formation (604.1 ± 183.5, 
n=2).  With 5 mM Ca++ in the internal solution, the first current recorded was already 
desensitized extensively, and the normalized current area after patch formation was 
already reduced (295.6 ± 43.0, n=9, Fig. 4.13 B, black dot) and decreased to 159.5 ± 
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37.5 (n=5) at 3 min and to 103.3 ± 18.9 (n=3) at 5 min.  At this time, all currents were 
highly desensitized and had very small amplitudes.   
 
Figure 4.13.  Increase of calcium ion inside cell activate similar pathway to increase 
the desensitization of α4β3γ2L current. 
  
A,  Smaller α4β3γ2L currents accompanied with increased current desensitization (see 
normalized currents in the circle) were recorded with increased time with whole-cell 
patch recording using an internal solution containing 5 mM Ca++.  B, Normalized 
current areas were plotted as a function of time after patch formation with internal 
control solution (red) or with 2 (gray) and 5 (black) or 5 mM Ca++ without or with 
staurosporine or Calphostin C. 
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To determine if the Ca++-induced increase of desensitization was due to 
protein kinase phosphorylation, I included staurosporine (Fig. 4.13 B, green line) or 
the PKC inhibitor Calphostin C (Fig. 4.13 B, orange line) in the internal solution with 
5 mM Ca++.  Although current areas recorded with 5 mM Ca++ and staurosporine 
(581.8 ± 100.1, n=11, Fig. 4.13 B, green dot) or Calphostin C (526.5 ± 82.4, n=3, Fig. 
4.13 B, yellow dot) in the internal solution had larger initial current areas, only 
staurosporine maintained the current desensitization and slowed down the reduction 
of current area.  Inclusion of Calphostin C in the internal solution did not alter the 
extent of desensitization (136.9 ± 13.3, n=2) compared to inclusion of only 5 mM 
Ca++ at 5 minutes.  Therefore, this Ca++ induced-increase of current desensitization 
may be mediated also by a protein kinase sensitive to staurosporine.  PKC might also 
have been involved in this Ca++ induced-effect since Calphostin C also had a smaller 
effect temporarily in the first few minutes after patch formation.  The progressive 
extensive increased desensitization and decreased current amplitude produced by 
internal Ca++ was very similar to the reversible effect produced by pre-application of 
DOG.  It is possible that a common mechanism is activated in the two different 
experiments and causes similar effects on the currents.  
 
Discussion 
Phosphorylation is an important mechanism of receptor regulation since it 
represents a covalent modification of receptors, which can have important 
implications for ion channel function (Moss and Smart, 1996;Levitan, 1994).  
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GABAA receptors, the major sites of synaptic inhibition in the brain, can be 
modulated by a variety of protein kinases that can have a significant functional impact.  
Previous studies have shown that PKA phosphorylation increased the fast phases of 
macroscopic desensitization of α1β1γ2L and α1β3γ2L GABAA receptor currents 
mediated by consensus phosphorylation sites β1 S409 and β3 S408, 409 in β subunits 
(Hinkle and Macdonald, 2003).  In the current study, I found that phosphorylation by 
PKA or PKC affected the macroscopic kinetics of the α4β3γ2L GABAA receptor 
currents in the same manner, and that this effect may be related to the number of 
phosphate groups transferred to the PKA and PKC sites located in the major 
intracellular loop of β3 and γ2L subunits in the receptor. 
Increased macroscopic current desensitization is a common effect of both PKA and 
PKC on several GABAA receptor isoforms. 
Diversity is always the theme for modulation by various protein kinases.  It is 
easy to image different downstream targets specifically activated by different protein 
kinases that produce receptor modulation.  However, there should also be some 
common mechanisms shared by different protein kinases.  The net charge brought by 
phosphate transfer and the resultant conformational change of the receptor protein are 
the most direct consequences shared by multiple protein kinases.  There are clearly 
some regulatory mechanisms such as PKC modulation of receptor internalization that 
are independent of phosphorylation of the GABAA receptor itself (Chapell et al., 
1998;Connolly et al., 1999), which might be mediated by regulation of associated 
protein involved in protein trafficking.  The most direct consequence of charge 
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transfer and receptor conformational change by protein phosphorylation could be 
alteration of receptor gating properties, which usually can be reflected in current 
kinetics.  In this study, I focused on modulation of current kinetics by protein 
phosphorylation to search for any shared mechanism of receptor modulation by both 
PKA and PKC.  I compared the effects by PKA and PKC on current desensitization of 
α4β3γ2L currents.  The change of current desensitization by PKA and PKC were 
similar and comparable.  Both PKA and PKC increased current desensitization by 
altering the relative amplitude of different desensitization components and not altering 
the associated time constants.  The different extents of increased α4β3γ2L current 
desensitization by PKA and PKC might be contributed by extra PKC sites located in 
γ2L subunits, or due to different permeability and potency of 8Br-cAMP and DOG 
that were used to activate PKA and PKC.  Moreover, similar effects on desensitization 
kinetics were achieved by glutamate substitution to the phosphorylation sites of PKA 
and PKC to mimic phosphorylation.  These results suggest that PKA and PKC share a 
regulatory mechanism to increase desensitization of α4β3γ2L GABAA receptor 
currents, which is very likely due to phosphorylation of GABAA receptor subunits. 
This modulation of current kinetics was not observed only with one GABAA 
receptor isoform.  Similar extents of current desensitization increase produced by 
PKC were found for different GABAA receptor isoforms including α1β2,3γ2L and 
α4β2,3γ2L receptors, and to a lesser extent for α1β2 receptors.  Microscopic current 
kinetic studies revealed similar single channel properties of α4β2γ2L and α1β2/3γ2L 
receptors (Akk et al., 2004;Fisher and Macdonald, 1997;Steinbach and Akk, 2001), 
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and macroscopic kinetic studies found that the time constants for the desensitization 
of α4β3γ2L and α1β3γ2L currents were similar and could be divided into the same 
four discrete groups (Lagrange et al., 2006), indicating that the underlying single 
channel kinetic schemes and open, close and desensitization states of α4βγ2L and 
α1βγ2L receptors were likely similar.  Thus, phosphorylation of β and γ2 subunits 
could favor entry into desensitization states of both α1β2,3γ2L and α4β2,3γ2L 
receptors.  Since the α4 subunit is often up-regulated in epileptic animals, it is 
important to compare α4βγ2L and α1βγ2L currents to understand how their up-
regulation may affect plasticity of receptor modulation and change seizure 
susceptibility in epileptic animals.  Although pharmacological characterization has 
shown different sensitivity of α4 subunit- and α1 subunit-containing receptors to some 
allosteric modulators such as diazepam and zinc, the modulatory effects of protein 
phosphorylation were similar on α4βγ2L and α1βγ2L receptors. 
Increased current desensitization mediated by phosphorylation of β and γ2L 
subunits were additive.   
By comparison of the S>A and S>E mutations of β3 or γ2L subunits, I knew 
that “phosphorylation” of each subunit caused increased current desensitization, and 
the effects of “phosphorylation” of single subunits are additive leading to a maximal 
increase of current desensitization for α4β3EEγ2LEE receptors by glutamate 
substitution at all four sites to mimic full PKC phosphorylation.  With pre-application 
of PKC activators, whether or not β or γ2L subunits were preferentially 
phosphorylated by PKC could not be controlled.  However, the magnitude of the 
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desensitization increase was found to be concentration-dependent on pre-applied 
DOG, a PKC activator.  The concentration-dependent effect of PKC activation 
suggested that α4β3γ2L currents desensitized more when the PKC activation level 
was higher and more receptor sites were phosphorylated by PKC.  Although the four 
well known PKC sites (β3 S408,409 and γ2L S327,343) currents did not account for 
the major effect of DOG, it is possible that PKC can phosphorylate many additional 
sites that could not be revealed by conventional methods used to detect 
phosphorylation. 
There is additional evidence suggesting that each β3 and γ2L subunit mediates 
partial effects of PKC.  In receptors without γ2L subunits, like binary α4β3 and α1β2 
receptors, current desensitization can still be increased by PKC-activation, but the 
area reduction was only about half of the reduction produced by PKC-activation of 
α4β3γ2L currents, consistent with the notion that partial effects of PKC are mediated 
by phosphorylation of both β3 and γ2L subunits and therefore more effect can be 
achieved with phosphorylation of α4β3γ2L than α4β3 receptors.  
An unknown mechanism instead of direct phosphorylation of four PKC sites or 
disruption of PKC binding to the intracellular loop of receptor contributes to the 
major effects of DOG.   
More extensive increases of α4β3γ2L current desensitization were achieved by 
application of high concentrations of DOG than were obtained with the β3 and γ2L 
S>E mutations.  Therefore, there must be mechanisms other than “phosphorylation” 
of the four sites in β3 and γ2L subunits that causes the effect.  I investigated the 
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possibility that extra phosphorylation sites in α4 subunits or phosphorylation-
mediated PKC binding to β subunits contributes to the increased current 
desensitization.  However, neither of the two mechanisms were found to be 
responsible for the major effects of DOG.  Next, I studied the possibility that other 
protein kinases such as CaMKII or tyrosine kinase were stimulated by PKC-activation, 
therefore causing phosphorylation of more sites.  I used reasonable concentrations of 
genistein and KN-93 to block tyrosine kinase and CaMKII respectively at the same 
time that PKC was activated.  I failed to see any significant difference in the DOG 
effect in the presence of the two inhibitors, and only a slight inhibition of the DOG 
effect by genistein was observed. 
Comparison of the DOG effect with results of another experiment, which also 
causes the similar increase of current desensitization and decrease of current 
amplitude in the presence of internal increase of Ca++ concentration, might provide 
some clue for the mechanism involved in both experiments.  Interestingly, both 
effects of DOG and internal Ca++ were inhibited partially by the non-specific protein 
kinase inhibitor staurosporine and even less inhibition by PKC specific inhibitors.  I 
think that PKC is activated in both two experiments, but the overall effects might due 
to protein phosphorylation of substrates in addition to the four known PKC sites.  It is 
very likely other protein kinases like tyrosine kinase are activated in the cascade of 
PKC activation, which amplifies the signal triggered by PKC activation.   
So far, I can not attribute the effects of DOG to any specific phosphorylation 
site or protein binding motif, but it should still be mediated by the major intracellular 
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loop of β3 and γ2L subunits given the fact that binary αβ currents were affected less 
by DOG than αβγ currents, and that the current desensitization was almost abolished 
by a β subunit mutation with the M3-M4 loop replaced by that from an α1 subunit.  
The large intracellular M3-M4 loops of GABAA subunits can contribute to receptor 
gating by affecting the diffusion rate of ions after crossing the transmembrane channel.  
Those loops also contain many protein phosphorylation sites and protein binding 
motifs including the sites and binding sequence for PKC, which are important in 
mediating modulatory effects on receptor proteins.  I hypothesize that the complex of 
the large intracellular loop and its associated proteins provides a high energy 
threshold for receptor gating by conformational change of the whole complex, which 
might allow the receptor to be slowly turned off by slow desensitization.  However, 
when the protein phosphorylation cascade is activated, it might cause a 
phosphorylation of the intracellular loop and the associated proteins leading to their 
dissociation.  In this case, the intracellular loops are not burdened by the associated 
proteins and fully charged for intracellular gating purposes, which might allow the 
receptor to be turned off quickly by desensitization.    
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CHAPTER V 
 
 
 
CONCLUSION 
 
 
 
Phosphorylation provides heterogeneous regulation of CNS GABAA receptors. 
Protein phosphorylation is an important endogenous mechanism for 
modulating neuronal electrical activity by regulating ion channels on the cell surface.  
Regulation by protein phosphorylation is not restricted to one class of ion channels or 
one generic mechanism of modulation.  There are reports of many different effects on 
ion channels ranging from regulation of subunit expression, current kinetics, 
pharmacological properties and postsynaptic clustering to regulation of receptor 
recycling.  Many of the modulatory effects on receptor ion channels have been shown 
to be protein kinase-specific or receptor isoform-specific, which contributes to their 
heterogeneous mechanisms of modulation.  In this dissertation, I demonstrated that 
the effects of protein kinase activation also depend on receptor localization as well as 
the receptor activation level that is determined by the GABA concentration to which 
neurons were exposed.   
The heterogeneity of receptor modulation by phosphorylation provides various 
mechanisms for cell type-specific modulation by endogenous protein kinases and 
phosphatases, which has implications for the precise and dynamic regulation of 
neuronal network excitability.  For example, receptor isoform-specific modulation of 
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α4β3δ and α4β3γ2L GABAA receptor currents may help clarify the pathogenesis of 
neurological diseases, since α4 subunit plasticity was found in several animal models 
of temporal lobe epilepsy (TLE) and the alcohol withdrawal syndrome (Brooks-Kayal 
et al., 1998;Cagetti et al., 2003;Peng et al., 2004;Zhang et al., 2007), and γ2 and δ 
subunits also showed plasticity in expression and might be co-regulated with α4 
subunits in these animal models.  The higher susceptibility of spontaneous α4β3δ 
currents than spontaneous α4β3γ2 currents to PKA modulation confers higher 
plasticity for modulation of tonic inhibition mediated by α4β3δ receptors.  The 
difference in modulation between α4β3δ and α4β3γ2L receptors is most significant at 
low concentrations of extracellular GABA and becomes less significant with 
increasing concentrations of extracellular GABA.  Tonic α4β3δ and α4β3γ2L currents 
should become more GABA-dependent and less PKA-sensitive at higher ambient 
GABA concentrations.  At 1 μM GABA, tonic currents mediated by both α4β3δ and 
α4β3γ2L receptors lost sensitivity to PKA modulation but desensitization of α4β3δ 
and α4β3γ2L phasic currents were both accelerated by PKA.  At a saturating 
concentration of GABA, PKA increased desensitization of phasic α4β3δ and α4β3γ2L 
currents to similar extents.  In a study of the subcellular locations of δ, α4 and γ2 
subunits on the dendrites of granule cells in the mouse pilocarpine model of TLE 
(Zhang et al., 2007), δ subunit labeling at perisynaptic locations in the molecular layer 
of the dentate gyrus was found to be decreased.  In dentate granule cells from 
pilocarpine mice, increased α4 and γ2 subunit labeling was found at perisynaptic 
locations accompanied by a decrease of γ2 subunit labeling in the center of synapses.  
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Thus there was a shift of γ2 subunits from synaptic to perisynaptic locations and a 
potential replacement of perisynaptic α4βδ receptors by α4βγ2 receptors to mediate 
tonic inhibition in the epileptic animals.  Interestingly, the magnitude of the tonic 
inhibition was not significantly affected, but neurosteroids modulation was reduced in 
dentate granule cells of pilocarpine-treated mice.  This result indicated that 
compensation for the loss of preisynaptic α4βδ receptors by α4βγ2 receptors provided 
a mechanism to maintain tonic inhibition in pilocarpine-treated animals.  However, 
the modulation of tonic inhibition in epileptic animals likely contributes to epilepsy 
pathogenesis.  The differences in modulation of δ or γ2 subunit-containing receptors 
include different sensitivity to those allosteric modulators and different modulation by 
protein phosphorylation.  According to my results, tonic currents mediated by peri-
synaptic α4β3δ and α4β3γ2 receptors have different sensitivities to PKA modulation 
only at very low concentrations of ambient GABA.  PKA activation can increase 
spontaneous tonic α4β3δ current in control animal to a greater extent than it can 
increase the compensatory α4β3γ2 receptor tonic current in epileptic mice.  This loss 
of sensitivity to PKA modulation by α4β3γ2 receptor replacement might contribute to 
increased seizure susceptibility in the epileptic mice. 
The difference in modulation of the kinetic properties of αβδ and αβγ2 
currents would also provide a mechanism to regulate differentially phasic and tonic 
currents in the same neuron.  In neurons with extrasynaptic α4β3δ and synaptic 
α4β3γ2 receptors, PKA could cause an increase of both phasic synaptic α4β3γ2 
receptor current and tonic extrasynaptic α4β3δ receptor current when minimal GABA 
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is present in the extracellular space and only spontaneous α4β3δ currents contribute to 
the tonic current.  However, when ambient GABA levels are elevated (as might occur 
during episodes of very high neuronal activity), PKA could also specifically enhance 
IPSCs by regulating phasic α4β3γ2 currents but would have no effect on tonic α4β3δ 
currents by buffering the extracellular GABA level to a relatively high micro-molar 
level.  Under these conditions, α4β3δ tonic currents would be mainly contributed by 
GABA-activation and would be PKA-insensitive.  This diversity of GABAA receptor 
modulation by protein phosphorylation would provide a mechanism to fine tune 
GABAergic inhibitory activities in specific brain areas with different receptor 
composition in response to various protein kinases.   
 
Modulation of GABAA receptors by direct phosphorylation 
There is substantial evidence indicating that the conserved GABAA receptor 
subunit phosphorylation sites (for example β3 subunit residues S408 and 409) are 
phosphorylated by multiple protein kinases including PKA and PKC in vitro.  Until 
the development of phosphospecific antisera in the last decade, the two sites were 
shown to be phosphorylated in mouse brain and the basal phosphorylation was 
dependent on PKC activity (Brandon et al., 2002b).  In studies of GABAA receptor 
modulation by phosphorylation, many effects have been reported to be mediated by 
phosphorylation of those sites.  While the conclusions have been made in recombinant 
systems based on blockade of modulatory effects by mutation of the phosphorylation 
sites, none of the physiological studies in native neurons have demonstrated direct 
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phosphorylation of GABAA receptor subunits at the conserved sites.  It is possible that 
auxiliary proteins were the actual targets of phosphorylation.  Although there is no 
direct proof of the same phosphorylation-dependent pathway activated in native brain 
regions, it is still believed that there is a common action of kinases to alter current 
kinetics by direct phosphorylation.  This alteration of receptor function is thought to 
be the consequence of a receptor conformational change due to changes in net charge 
by phosphate transfer.   
By comparing the actions of two different protein kinases with shared 
phosphorylation sites, I observed that both PKA and PKC activation increased current 
desensitization of receptors with different subunit compositions.  Moreover, glutamate 
substitution at PKA and/or PKC phosphorylation sites to mimic constitutive 
phosphorylation also produced similar changes in current desensitization, supporting 
the assumption that this change in current kinetics is due to direct phosphorylation of 
conserved sites.  The greater increase of α4β3γ2L current desensitization by PKC than 
by PKA can be explained by the presence of additional PKC sites located in γ2L 
subunits.  Consistent with this, I found that increasing concentrations of PKC and 
PKA activators resulted in a greater extent and rate of desensitization.   
There is one result, however, that challenges the hypothesis that regulation of 
current kinetics is due to direct phosphorylation.  Mutation of the conserved 
phosphorylation sites did not always block the kinase effects on current 
desensitization, suggesting a role for phosphorylation of associated proteins in the 
receptor-protein complexes.  The large intracellular M3-M4 loops of GABAA subunits, 
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which contain binding sequences for several adaptor proteins, were proven important 
in mediating the effects of protein kinases on current kinetics.  The PKC-induced 
increase of binary αβ current desensitization was less than the PKC-induced increase 
of αβγ current desensitization, and this effect was abolished almost completely by 
replacement of the β subunit M3-M4 loop with that of the α1 subunit.  This major 
intracellular receptor protein domain may affect the diffusion rate of ions crossing the 
transmembrane channel.  The interaction of this loop sequence with other associated 
proteins could be the most susceptible targets of modulation by protein 
phosphorylation in a cell type-specific manner, since specific, different cellular 
pathways and specific anchoring proteins may be involved in different neurons.   
 
The physiological significance of plasticity of GABAergic inhibition regulated by 
protein phosphorylation 
It is apparent that GABAA receptors at inhibitory synapses are dynamic 
entities with great plasticity for endogenous modulation.  In the CNS, a prime 
mechanism for mediation of ion channel plasticity is phosphorylation (Levitan, 
1999;Luscher and Keller, 2004)).  It has been demonstrated in many studies that 
changes in the level of phosphorylation underlie some forms of activity-dependent 
GABAergic plasticity such as long-term potentiation (LTP) and long-term depression 
(LTD), often by cross-talk with other receptors expressed in the same synapses.  
Several signaling pathways have been found to regulate GABAA receptor functions in 
the same neuron by acting through various protein kinase or phosphatases.  Activation 
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of NMDA and AMPA receptors, voltage-dependent Ca2+ channels (VDCCs), D1 
dopamine receptors, M1 muscarinic acetylcholine receptors, serotonin type 4 
receptors, and insulin receptors and activation of TrKB receptors by brain-derived 
neurotrophic factor (BDNF) have been shown to regulate GABAA receptors by 
causing influx of Ca2+ inside cells as secondary messenger or through downstream 
signaling of G-protein coupled receptors (GPCRs), which contributes to plasticity of 
GABAergic inhibition.  Involvement of several protein kinases or phosphatases has 
been implicated in different studies, obviously including PKA, PKC and protein 
kinase B (Akt), CaMKII, Ca2+-sensitive phosphatase calcineurin (Kittler and Moss, 
2003;Brandon et al., 2002a).   
For example dopamine receptor activation results in GABAA receptor 
phosphorylation and functional modulation in neostriatal neurons.  Activation of D1 
receptors in neostriatal neurons results in a decrease in GABA-evoked currents, which 
can be mimicked by cyclic AMP analogues and blocked with PKA inhibitors.  It has 
also been demonstrated that activation of D1 receptors in neostriatal neurons enhances 
GABAA receptor β1/3-subunit phosphorylation via a PKA-dependent mechanism 
(Yan & Surmeier,1997; Flores-Hernandez et al., 2000).  Therefore, activation of D1 
receptors increases phosphorylation of the GABAA receptor β1 subunit and inhibits 
receptor function, as predicted from studies of recombinant receptors.  However, there 
are also examples without clear correlation of receptor activation with a specific 
protein kinase being involved in the signal pathway.  In a similar study of olfactory 
bulb granule cells with predominant expression of β3 subunits, intracellular 
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application of purified PKA increased the amplitude of mIPSCs similar to the effect 
of PKA on β3 subunit-containing recombinant receptors in HEK-293 cells (Nusser et 
al., 1999; McDonald et al., 1998).  In contrast to the potentiation of β3 subunit-
containing receptor currents, activation of PKA via D1 receptors in olfactory bulb 
neurons decreased GABA-activated currents (Brunig et al. 1999).  This discrepancy 
may due to the insensitivity of immunohistochemistry resulting in failure of detecting 
low levels of other GABAA receptor β subunits.  Alternatively, there may be 
difference in the signal pathways stimulated by D1 receptor activation in different 
neuronal population, such as D2 receptor pathway that could also get involved 
through activation of D1/D2 heterodimer.  Therefore, it is important to be aware of 
different expression pattern of GABAA receptor subunits in specific cell types, as well 
as the distinct modulatory effects associated with different receptor isoforms. 
Additional evidence for GABAA receptor modulation by phosphorylation was 
obtained by studying activation of TrkB receptors by BDNF, which produces even 
more complex and profound regulation of GABAergic inhibition.  The 
phosphorylation state of β3 subunits has been suggested to underlie BDNF-induced 
down-regulation of mIPSCs in cultured hippocampal and cortical neurons.  However, 
instead of simple reduction of currents as reported earlier by Bru¨nig et al. (2001), a 
later report revealed, before a lasting depression of mIPSCs, a rapid and transient 
BDNF-induced up-regulation occurs (Jovanovic et al., 2004). Coincidently, this 
biphasic change in inhibitory synaptic activity occurred in parallel with 
phosphorylation status of GABAA receptor. Upon stimulus of BDNF, PKC and 
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anchoring protein receptor for activated C kinase-1 (RACK-1) are transiently 
recruited to β3 subunits, associated with a delayed but lasting association of PP2A 
with GABAA receptors.  Sequential association of PKC/RACK-1 and PP2A with 
GABAA receptors result in transiently increase of receptor phosphorylation by PKC 
and then dephosphorylation by PP2A to below basal levels.  Collectively, these 
observations indicate the delayed BDNF-induced and PP2A-mediated 
dephosphorylation of β3 subunits result in a major reduction in mIPSC amplitude 
despite the surface expression of GABAA receptor might be significantly increased.  
This conclusion conflicts with other studies, which argued that the BDNF-induced 
down-regulation of mIPSCs without the transient up-regulation was due to PKC-
induced endocytosis of GABAA receptors that was independent of direct 
phosphorylation of GABAA receptors (Connolly et al., 1999; Cinar & Barnes, 2001).  
Thus, BDNF might induce effects on GABAA receptors by altering receptor surface 
expression or function, and acute stimulation by growth factors or drugs might have 
profound effects on GABAergic input in synapses.  
 
The relationship of modulation by phosphorylation of GABAA receptors with 
epilepsy 
A major challenge in epilepsy research is to understand how the initial injury 
involved in the induction of epileptogenesis can produce long-term changes in 
neuronal excitability.  Although different types of injuries may lead to epileptogenesis, 
some of the underlying mechanisms may still be the same.  The search for such 
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common pathways of epileptogenesis may thus provide the foundation for the 
development of novel antiepileptogenic drugs and thus preventative therapies.  One 
common consequence of epileptic seizure is hyperactivation of excitatory glutamate 
receptors leading to accumulation of calcium ions inside cells that activate 
downstream signal cascades, which is widely accepted to be important in shaping the 
strength of inhibitory synapses.  One consequence of the elevation of internal Ca2+ is 
activation of Ca2+-dependent protein kinases and pathways linked to them.   
In the introduction (Chapter I), I reviewed the abnormalities of protein 
phosphorylation reported in some animal models of epilepsy, such as elevated PKC 
activation after seizures during status epilepticus, and elevated cAMP levels and PKA 
activity in epileptic animal’s hippocampus.  The relationship between phosphorylation 
and seizures is not unidirectional because elevation of cAMP in rat amygdala also 
promotes seizures.  Since protein phosphorylation by both PKA and PKC tend to 
decrease the response of GABAA receptors to prolonged or repetitive applications of 
GABA, the elevated PKA and PKC activities in epileptic animals could cause further 
disturbance of GABAergic inhibition and exacerbate the imbalance of excitatory and 
inhibitory signaling input that might contribute to the progress of status epilepticus.  
On the other hand, PKA increases spontaneous α4β3δ receptor currents, which would 
have the opposite effect by decreasing network excitability. 
In synapses of epileptic animals, during high frequency bursts the overall 
efficiency of GABAA receptors in conducting Cl- would be reduced due to the 
existence of more receptors in non-conducting desensitization states after 
159 
phosphorylation by PKA or PKC.  The reduced efficiency of conducting chloride ion 
would result in less membrane hyperpolarization.  When the membrane is not held 
below the action potential threshold, seizures could be triggered in the preferred 
phosphorylated condition.  This provides a potential basis for maintenance of status 
epilepticus by promoting receptor phosphorylation after the initiation of status 
epilepticus.  In this way, the endogenous protein kinases might become a good target 
for antiepileptogenic therapies to enhance GABAergic current by blocking receptor 
phosphorylation and preventing further development of status epilepticus. 
This mechanism may also be relevant to modulation of mutant GABAA 
receptor in epileptic animals.  While the membrane potential might be maintained 
below the threshold under basal conditions, protein phosphorylation might serve as a 
conditional trigger and cause more disinhibition that initiates seizures only in mutant 
animals.  Therefore, treating epileptic animals with protein kinase antagonists to 
reduce the likelihood of seizures might be a novel approach to treat this disease.  
 
Future directions 
In this dissertation, I have described differential modulation by PKA and PKC 
of different GABAA receptors.  However, there is no clear correlation of the 
modulatory effects of all the known phosphorylation sites in β and γ2 subunits.  The 
conclusion is that receptor modulation is not necessarily due to direct phosphorylation 
of receptor proteins.  I have shown some preliminary results indicating that only part 
of the observed effects, such as increased α4β3γ2 current desensitization by PKA, are 
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mediated by direct phosphorylation of those sites,.  A number of effects of PKA and 
PKC are actually independent of phosphorylation of all of the investigated sites on β3 
or γ2 subunits, such as the increased α4β3δ current desensitization produced by PKA 
and increased α4β3γ2 current desensitization produced by PKC.  There are many 
examples of protein kinase modulation of receptor currents that are independent of 
receptor phosphorylation, such as phosphorylation-independent internalization of 
GABAA receptors induced by PKC (Chapell et al., 1998;Connolly et al., 
1999;Filippova et al., 2000).  I propose the hypothesis of association of a 
macromolecular complex with the intracellular loop of GABAA subunits that can be 
regulated by protein phosphorylation and may be involved in the regulation of 
receptor function.  
Studies to explore receptor phosphorylation-independent effects should be 
focused on the regulation of associated proteins in the receptor-protein complex by 
specific protein kinases.  I had tested the most likely protein, which is the protein 
kinase itself, because the interaction of PKC with GABAA receptors directly to all β 
subunits or indirectly through anchoring protein receptor for RACK-1 will be affected 
by PKC activation (Brandon et al., 2002b).  I made three mutations with single or 
double binding motif deletions to disrupt the interactions of PKC and/or RACK-1 
with GABAA receptor β subunits at their binding sequences (α4β2(PKCΔ)γ2L, 
α4β2(RACKΔ)γ2L, α4β2(PKC+RACKΔ)γ2L).  The mutant with the double deletion 
(α4β2(PKC+RACKΔ)γ2L) that should produce complete abolition of PKC 
association at the two sites, failed to reduce PKC effects on current desensitization, 
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implying that the PKC interaction with the receptor was not a determinant in 
mediating the effects on current desensitization.  Thus, the studies need to be 
expanded to other associated proteins.  There are scattered reports of protein 
interactions with GABAA receptors that are regulated by PKC phosphorylation.  For 
example, PKC can also modulate the binding of the clathrin AP2 adaptor complex to 
the YECL motif in the GABAA receptor γ2 subunits (Kittler et al., 2005;Kittler et al., 
2008).  It may be a large associated protein complex instead of each small protein that 
is involved in mediating the PKC effects on current desensitization.  To further test 
the hypothesis of an associated protein that participates in GABAA receptor 
modulation, it will be necessary to have a more comprehensive understanding of how 
PKC regulates the interaction of all the associated proteins in the receptor-protein 
complex.  Then, the effects of disrupting the interaction of the protein complex and 
the receptor could contribute to the effects on current kinetics by PKC could be 
determined.  
GABAA receptors also contain consensus sequences for other protein kinases, 
such as CaMKII and PTK, and the two protein kinases have been reported to 
modulate GABAA receptors (Moss et al., 1995;Houston et al., 2008).  I am also 
interested in determining how the other protein kinases affect GABAA receptor 
currents in comparison with the modulation by PKA and PKC.  I need to investigate 
the effects of other protein kinases such as CaMKII and PTK on GABAA receptor 
current kinetic properties because phosphorylation signaling can be easily transduced 
and amplified by protein kinase signaling cascades in the interacting network of 
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protein kinase and phosphatase.  In the experiments, I failed to block the effects of 
PKC activators by using multiple PKC-specific inhibitors.  So far, the non-specific 
protein kinase inhibitor staurosporine was most effective in inhibiting effects 
stimulated by PKC activator, DOG.  It is possible that other protein kinases were 
activated by PKC and the amplified protein kinase signaling caused a massive 
phosphorylation of GABAA receptors and its associated protein complex which 
contributes to the extensive kinetic effects on GABAA receptor currents.  
Based on numerous investigations and my own study of modulation of 
GABAA receptors by protein phosphorylation, I confirmed the diversity and 
complexity of the effects conferred by this endogenous modulatory mechanism.  The 
final goal is to collect all the information to fully understand how the protein kinases 
regulate neuronal excitability and affect brain electrical signaling by altering GABAA 
receptor function in their native state, and how modification of endogenous 
phosphorylation levels might contribute to the pathogenesis of neurological and/or 
neuropsychiatric diseases.  The study of modulatory mechanism might be useful in 
developing new therapeutic methods to specifically target the dysfunctional receptor 
isoforms and modify the designed properties of the receptor. 
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